10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2013

Commission file number 1-5467

VALHI, INC.

(Exact name of Registrant as specified in its charter)

Delaware	87-0110150
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
5430 LBJ Freeway, Suite 1700, Dallas, Texas	75240-2697
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:(972) 233-1700

Indicate by check mark:

Whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Whether the Registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Act).

Large accelerated filer	¨	Accelerated filer	x
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨

Whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨     No  x.

Number of shares of the Registrant’s common stock outstanding on November 1, 2013: 339,120,449

   

VALHI, INC. AND SUBSIDIARIES

INDEX

			Page number
Part I.	FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Condensed Consolidated Balance Sheets – December 31, 2012 and September 30, 2013 (unaudited)		3
		Condensed Consolidated Statements of Operations (unaudited) – Three and nine months ended September 30, 2012 and 2013		5
		Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) – Three and nine months ended September 30, 2012 and 2013		7
		Condensed Consolidated Statements of Cash Flows (unaudited) – Nine months ended September 30, 2012 and 2013		8
		Condensed Consolidated Statement of Equity (unaudited) – Nine months ended September 30, 2013		9
		Notes to Condensed Consolidated Financial Statements (unaudited)		10
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.		29
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk		47
	Item 4.	Controls and Procedures		47
Part II.	OTHER INFORMATION
	Item 1.	Legal Proceedings		49
	Item 1A.	Risk Factors		49
	Item 6.	Exhibits		50

Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report.

       

- 2 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions)

	December 31, 2012		September 30, 2013
			(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	366.9	$	115.7
Restricted cash equivalents		8.1		5.3
Accounts and other receivables, net		302.5		352.0
Inventories, net		650.3		407.1
Other current assets		26.0		26.7
Deferred income taxes		9.6		22.9
Total current assets		1,363.4		929.7
Other assets:
Marketable securities		256.8		253.6
Investment in affiliates		126.1		121.3
Goodwill		379.7		379.7
Deferred income taxes		120.3		162.3
Other noncurrent assets		161.1		174.6
Total other assets		1,044.0		1,091.5
Property and equipment:
Land		48.3		48.7
Buildings		280.5		280.2
Equipment		1,127.7		1,136.4
Treatment, storage and disposal facility		158.7		158.9
Mining properties		72.3		64.6
Construction in progress		40.7		61.4
		1,728.2		1,750.2
Less accumulated depreciation		965.1		994.0
Net property and equipment		763.1		756.2
Total assets	$	3,170.5	$	2,777.4

- 3 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

(In millions)

	December 31, 2012			September 30, 2013
				(unaudited)
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	29.6		$	29.7
Accounts payable and accrued liabilities		334.6			331.7
Income taxes		23.1			.2
Deferred income taxes		11.2			11.2
Total current liabilities		398.5			372.8
Noncurrent liabilities:
Long-term debt		880.5			701.6
Deferred income taxes		454.8			431.3
Accrued pension costs		202.9			195.4
Accrued environmental remediation and related costs		42.6			53.6
Accrued postretirement benefits costs		21.2			20.6
Other liabilities		78.3			91.3
Total noncurrent liabilities		1,680.3			1,493.8
Equity:
Valhi stockholders’ equity:
Preferred stock		667.3			667.3
Common stock		3.6			3.6
Additional paid-in capital		78.9			44.7
Retained earnings (deficit)		75.4			(55.3	)
Accumulated other comprehensive loss		(42.0	)		(35.8	)
Treasury stock		(49.6	)		(49.6	)
Total Valhi stockholders’ equity		733.6			574.9
Noncontrolling interest in subsidiaries		358.1			335.9
Total equity		1,091.7			910.8
Total liabilities and equity	$	3,170.5		$	2,777.4

Commitments and contingencies (Notes 13 and 16)

See accompanying Notes to Condensed Consolidated Financial Statements.

- 4 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share data)

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012		2013
	(unaudited)
Revenues and other income:
Net sales	$	508.8		$	448.2		$	1,659.9	$	1,463.4
Other income, net		7.6			8.7			39.4		21.8
Total revenues and other income		516.4			456.9			1,699.3		1,485.2
Costs and expenses:
Cost of sales		411.3			399.6			1,140.0		1,384.7
Selling, general and administrative		63.1			101.1			210.0		253.5
Loss on prepayment of debt		—			2.3			7.2		8.9
Assets held for sale write-down		.4			—			.4		—
Interest		14.6			13.7			42.4		43.8
Total costs and expenses		489.4			516.7			1,400.0		1,690.9
Income (loss) from continuing operations before income taxes		27.0			(59.8	)		299.3		(205.7	)
Income tax expense (benefit)		(3.0	)		(18.9	)		89.7		(68.0	)
Income (loss) from continuing operations		30.0			(40.9	)		209.6		(137.7	)
Income from discontinued operations, net of tax		1.8			—			3.3		—
Net income (loss)		31.8			(40.9	)		212.9		(137.7	)
Noncontrolling interest in net income (loss) of subsidiaries		8.9			(6.7	)		56.7		(24.0	)
Net income (loss) attributable to Valhi stockholders	$	22.9		$	(34.2	)	$	156.2	$	(113.7	)

- 5 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (CONTINUED)

(In millions, except per share data)

	Three months ended September 30,					Nine months ended September 30,
	2012		2013			2012		2013
	(unaudited)
Amounts attributable to Valhi stockholders:
Income (loss) from continuing operations	$	21.7	$	(34.2	)	$	153.9	$	(113.7	)
Income from discontinued operations		1.2		—			2.3		—
Net income (loss) attributable to Valhi stockholders	$	22.9	$	(34.2	)	$	156.2	$	(113.7	)
Basic and diluted net income (loss) per share:
Income (loss) from continuing operations	$	.06	$	(.10	)	$	.45	$	(.33	)
Income from discontinued operations		.01		—			.01		—
Net income (loss) per share	$	.07	$	(.10	)	$	.46	$	(.33	)
Cash dividends per share	$	.05	$	.05		$	.142	$	.15
Basic and diluted weighted average shares outstanding		342.0		342.0			342.0		342.0

See accompanying Notes to Condensed Consolidated Financial Statements.

   

- 6 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In millions)

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(unaudited)
Net income (loss)	$	31.8		$	(40.9	)	$	212.9		$	(137.7	)
Other comprehensive income (loss), net of tax:
Currency translation		39.9			21.7			16.6			(.4	)
Marketable securities		6.1			13.0			(22.8	)		15.0
Defined benefit pension plans		2.0			2.7			5.9			8.1
Other postretirement benefit plans		(.3	)		(.3	)		(.9	)		(.9	)
Total other comprehensive income (loss), net		47.7			37.1			(1.2	)		21.8
Comprehensive income (loss)		79.5			(3.8	)		211.7			(115.9	)
Comprehensive income (loss) attributable to noncontrolling interest		19.1			10.7			45.5			(8.4	)
Comprehensive income (loss) attributable to Valhi stockholders	$	60.4		$	(14.5	)	$	166.2		$	(107.5	)

See accompanying Notes to Condensed Consolidated Financial Statements.

   

- 7 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

	Nine months ended September 30,
	2012			2013
	(unaudited)
Cash flows from operating activities:
Net income (loss)	$	212.9		$	(137.7	)
Depreciation and amortization		50.3			55.7
Litigation settlement gain		(14.7	)		—
Loss on prepayment of debt		7.2			8.9
Call premium and interest paid on Senior Notes redeemed		(6.2	)		—
Asset held for sale write-down		.4			—
Reversal of accrued contingent consideration		(.8	)		—
Benefit plan expense greater (less) than cash funding requirements:
Defined benefit pension expense		.4			1.7
Other postretirement benefit expense		(1.1	)		(.9	)
Deferred income taxes		37.9			(78.5	)
Net distributions from (contributions to) Ti02 manufacturing joint venture, net		(30.1	)		4.0
Other, net		.9			6.4
Change in assets and liabilities:
Accounts and other receivables, net		(53.8	)		(35.5	)
Inventories, net		(157.8	)		241.0
Accounts payable and accrued liabilities		(36.8	)		20.1
Accounts with affiliates		54.1			(24.7	)
Income taxes		(6.8	)		(8.8	)
Other, net		(9.8	)		(3.3	)
Net cash provided by operating activities		46.2			48.4
Cash flows from investing activities:
Capital expenditures		(66.0	)		(54.4	)
Capitalized permit costs		(2.9	)		(.6	)
Purchases of marketable securities		(5.7	)		(5.2	)
Proceeds from:
Disposal of mutual funds		21.1			—
Disposal of other marketable securities		8.1			7.8
Disposal of assets held for sale		—			1.6
Collection of note receivable		—			3.0
Real estate-related litigation settlement		15.6			—
Change in restricted cash equivalents, net		(5.0	)		.9
Other, net		2.7			(.4	)
Net cash used in investing activities		(32.1	)		(47.3	)
Cash flows from financing activities:
Indebtedness:
Borrowings		503.3			377.7
Principal payments		(422.6	)		(565.0	)
Deferred financing costs paid		(7.1	)		—
Valhi cash dividends paid		(48.0	)		(50.9	)
Distributions to noncontrolling interest in subsidiaries		(13.9	)		(13.7	)
Other, net		—			(.7	)
Net cash provided by (used in) financing activities		11.7			(252.6	)
Cash and cash equivalents – net change from:
Operating, investing and financing activities		25.8			(251.5	)
Effect of exchange rate on cash		1.3			.3
Cash and cash equivalents at beginning of period		96.4			366.9
Cash and cash equivalents at end of period	$	123.5		$	115.7
Supplemental disclosures:
Cash paid (received) for:
Interest, net of capitalized interest (including call premium paid)	$	51.3		$	42.5
Income taxes, net		64.4			16.0
Noncash investing activities:
Accrual for capital expenditures		8.6			3.5
Accrual for capitalized permit costs		1.6			.4
Noncash financing activities:
Accrued construction retainage payable converted to note payable		—			2.8

See accompanying Notes to Condensed Consolidated Financial Statements.

   

- 8 -

VALHI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF EQUITY

Nine months ended September 30, 2013

(In millions)

(unaudited)

	Valhi Stockholders’ Equity
	Preferred stock		Common stock		Additional paid-in capital			Retained earnings (deficit)			Accumulated other comprehensive income (loss)			Treasury stock			Non- controlling interest			Total equity
Balance at December 31, 2012	$	667.3	$	3.6	$	78.9		$	75.4		$	(42.0	)	$	(49.6	)	$	358.1		$	1,091.7
Net loss		—		—		—			(113.7	)		—			—			(24.0	)		(137.7	)
Other comprehensive income, net		—		—		—			—			6.2			—			15.6			21.8
Cash dividends		—		—		(33.9	)		(17.0	)		—			—			(13.7	)		(64.6	)
Issuance of common stock and other, net		—		—		(.3	)		—			—			—			(.1	)		(.4	)
Balance at September 30, 2013	$	667.3	$	3.6	$	44.7		$	(55.3	)	$	(35.8	)	$	(49.6	)	$	335.9		$	910.8

See accompanying Notes to Condensed Consolidated Financial Statements.

   

- 9 -

VALHI, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2013

(unaudited)

Note 1—Organization and basis of presentation:

Organization—We are majority owned by Contran Corporation and one of its subsidiaries, which own approximately 94% of our outstanding common stock at September 30, 2013. Substantially all of Contran’s outstanding voting stock is held by trusts established for the benefit of certain children and grandchildren of Harold C. Simmons (for which Mr. Simmons is the sole trustee) or is held directly by Mr. Simmons or other persons or entities related to Mr. Simmons. Consequently, Mr. Simmons may be deemed to control Contran and us.

Basis of Presentation—Consolidated in this Quarterly Report are the results of our majority-owned and wholly-owned subsidiaries, including NL Industries, Inc., Kronos Worldwide, Inc., CompX International Inc., Tremont LLC and Waste Control Specialists LLC (“WCS”). Kronos (NYSE: KRO), NL (NYSE: NL), and CompX (NYSE MKT: CIX) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2012 that we filed with the SEC on March 15, 2013 (the “2012 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2012 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2012) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Our results of operations for the interim periods ended September 30, 2013 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2012 Consolidated Financial Statements contained in our 2012 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Valhi, Inc and its subsidiaries (NYSE: VHI), taken as a whole.

Note 2—Business segment information:

Business segment	Entity	% controlled at September 30, 2013
Chemicals	Kronos		80	%
Component products	CompX		87	%
Waste management	WCS		100	%

Our control of Kronos includes 50% we hold directly and 30% held directly by NL. We own 83% of NL. Our control of CompX is through NL. At  September 30, 2013 we had an aggregate of 12.0 million shares of our Kronos common stock pledged as collateral for certain debt obligations of Contran.  We receive a fee from Contran for pledging these Kronos shares, determined by a formula based on the market value of the shares pledged.

- 10 -

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)
Net sales:
Chemicals	$	472.9		$	419.1		$	1,579.5		$	1,363.8
Component products		21.4			24.2			63.9			69.7
Waste management		14.5			4.9			16.5			29.9
Total net sales	$	508.8		$	448.2		$	1,659.9		$	1,463.4
Cost of sales:
Chemicals	$	387.5		$	372.4		$	1,070.5		$	1,304.8
Component products		15.1			16.7			45.1			48.6
Waste management		8.7			10.5			24.4			31.3
Total cost of sales	$	411.3		$	399.6		$	1,140.0		$	1,384.7
Gross margin:
Chemicals	$	85.4		$	46.7		$	509.0		$	59.0
Component products		6.3			7.5			18.8			21.1
Waste management		5.8			(5.6	)		(7.9	)		(1.4	)
Total gross margin	$	97.5		$	48.6		$	519.9		$	78.7
Operating income (loss):
Chemicals	$	40.4		$	(35.2	)	$	364.1		$	(125.6	)
Component products		1.7			3.0			5.4			7.4
Waste management		(1.0	)		(10.3	)		(21.9	)		(16.3	)
Total operating income (loss)		41.1			(42.5	)		347.6			(134.5	)
Equity in earnings of investees		(.1	)		—			(.1	)		(.8	)
General corporate items:
Securities earnings		7.3			6.6			21.5			19.9
Insurance recoveries		1.2			2.2			2.6			3.8
Litigation settlement gain		—			—			14.7			—
Loss on prepayment of debt		—			(2.3	)		(7.2	)		(8.9	)
General expenses, net		(7.9	)		(10.1	)		(37.4	)		(41.4	)
Interest expense		(14.6	)		(13.7	)		(42.4	)		(43.8	)
Income (loss) from continuing operations before income taxes	$	27.0		$	(59.8	)	$	299.3		$	(205.7	)

Segment results we report may differ from amounts separately reported by our various subsidiaries and affiliates due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material.  The operating loss of our Chemicals Segment for the third quarter and first nine months of 2013 includes a $35 million charge related to a litigation settlement, see Note 16.

- 11 -

Note 3—Discontinued operations:

On December 28, 2012, CompX completed the sale of its furniture components operations to a competitor of that business. Please refer to Note 3 to our 2012 Annual Report for a complete description of the transaction.

Selected financial data for the operations of the disposed furniture components business is presented below:

	Three months ended September 30, 2012		Nine months ended September 30, 2012
	(In millions)
Income statement:
Net sales	$	15.8	$	46.4
Operating income	$	2.7	$	5.8
Income from discontinued operations:
Income before taxes	$	2.7	$	5.7
Income tax expense		.9		2.4
Income from discontinued operations, net of tax		1.8		3.3
Noncontrolling interest in income from discontinued operations		.6		1.0
Total discontinued operations, net of tax and noncontrolling interest	$	1.2	$	2.3

In accordance with generally accepted accounting principles, the assets and liabilities relating to the furniture components reporting unit were eliminated from the 2012 Consolidated Balance Sheet at the date of sale. We have reclassified our Condensed Consolidated Statements of Operations for the interim periods ended September 30, 2012 to reflect the disposed operations as discontinued operations. We have not reclassified our September 30, 2012 Condensed Consolidated Statement of Cash Flows to reflect discontinued operations.

In conjunction with the sale of CompX’s furniture components reporting unit, the buyer was not interested in retaining certain undeveloped land located in Taiwan owned by CompX’s Taiwanese Furniture Component subsidiary. We had no additional use for the undeveloped land in Taiwan and therefore expected the land to be sold to a third party with CompX receiving the net proceeds. Based on the legal form of how we completed the disposal transaction, our interest in the land was represented by a $3.0 million promissory note receivable at December 31, 2012, issued to CompX by its former Taiwanese subsidiary which retained legal ownership in the land to facilitate the future sale of the land to a third party. The proceeds from a future sale of the land were required to be used to settle the note receivable. During the first quarter of 2013, an agreement was entered into with a third party to sell the land for $3.0 million, $1.8 million of which was received during the first quarter and the remaining $1.2 million was received in the second quarter of 2013. Such note receivable was classified as part of other current assets in our Consolidated Balance Sheet at December 31, 2012.

- 12 -

Note 4—Marketable securities:

	Market value		Cost basis		Unrealized gains, net
	(In millions)
December 31, 2012:
Current assets:	$	.9	$	.9	$	—
Noncurrent assets:
The Amalgamated Sugar Company LLC	$	250.0	$	250.0	$	—
Other		6.8		6.7		.1
Total	$	256.8	$	256.7	$	.1
September 30, 2013:
Current assets	$	1.6	$	1.6	$	—
Noncurrent assets:
The Amalgamated Sugar Company LLC	$	250.0	$	250.0	$	—
Other		3.6		3.6		—
Total	$	253.6	$	253.6	$	—

All of our marketable securities are accounted for as available-for-sale, which are carried at fair value, with any unrealized gains or losses recognized through accumulated other comprehensive income. Our marketable securities are carried at fair value using quoted market prices, primarily Level 1 inputs as defined by Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, except for our investment in The Amalgamated Sugar Company LLC (“Amalgamated”). Our current marketable securities are included with “other current assets” on our Condensed Consolidated Balance Sheets. Our investment in Amalgamated is measured using significant unobservable inputs, which are Level 3 inputs. Please refer to Note 4 in our 2012 Annual Report for a complete description of the valuation methodology for our investment in Amalgamated. There have been no changes to the carrying value of this investment during the periods presented. See Note 17.

Note 5—Accounts and other receivables, net:

	December 31, 2012			September 30, 2013
	(In millions)
Trade accounts receivable:
Kronos	$	229.7		$	276.5
CompX		8.7			10.8
WCS		4.8			1.3
VAT and other receivables		42.2			40.4
Refundable income taxes		18.3			6.1
Receivable from affiliate:
Contran – trade items		.3			.2
LPC – trade items		—			18.1
Allowance for doubtful accounts		(1.5	)		(1.4	)
Total	$	302.5		$	352.0

- 13 -

Note 6—Inventories, net:

	December 31, 2012		September 30, 2013
	(In millions)
Raw materials:
Chemicals	$	151.5	$	69.3
Component products		3.3		4.0
Total raw materials		154.8		73.3
Work in process:
Chemicals		27.3		18.1
Component products		5.9		6.7
Total in-process products		33.2		24.8
Finished products:
Chemicals		395.6		237.8
Component products		2.1		2.2
Total finished products		397.7		240.0
Supplies (chemicals)		64.6		69.0
Total	$	650.3	$	407.1

Note 7—Other noncurrent assets:

	December 31, 2012		September 30, 2013
	(In millions)
Investment in affiliates:
TiO2 manufacturing joint venture, Louisiana Pigment Company, L.P. (“LPC”)	$	109.9	$	105.9
Other		16.2		15.4
Total	$	126.1	$	121.3
Other assets:
Waste disposal site operating permits, net	$	65.7	$	61.5
Restricted cash		20.9		22.4
Deferred financing costs		7.0		2.6
IBNR receivables		6.7		7.0
Capital lease deposit		6.2		6.2
Pension asset		5.1		5.8
Assets held for sale		2.6		1.1
Other		46.9		68.0
Total	$	161.1	$	174.6

In the fourth quarter of 2012, CompX entered into an agreement to sell one of its facilities classified as an asset held for sale. The transaction closed during the first quarter of 2013. The net proceeds from the sale of $1.6 million approximated the carrying value of the assets as of the date of the sale.

- 14 -

Note 8—Accounts payable and accrued liabilities:

	December 31, 2012		September 30, 2013
	(In millions)
Accounts payable	$	169.6	$	126.4
Payable to affiliates:
Contran – income taxes, net		2.6		3.1
Contran – trade items		26.8		26.4
LPC – trade items		23.4		19.5
Employee benefits		38.5		37.4
Accrued litigation settlement		—		35.0
Accrued sales discounts and rebates		14.9		15.0
Environmental remediation and related costs		7.6		6.4
Deferred income		5.4		3.7
Reserve for uncertain tax positions		3.0		3.1
Other		42.8		55.7
Total	$	334.6	$	331.7

The accrued litigation settlement is discussed in Note 16.

Note 9 —Other noncurrent liabilities:

	December 31, 2012		September 30, 2013
	(In millions)
Reserve for uncertain tax positions	$	29.4	$	41.4
Asset retirement obligations		23.8		25.1
Insurance claims and expenses		9.7		9.8
Employee benefits		11.3		10.9
Deferred income		1.0		1.0
Other		3.1		3.1
Total	$	78.3	$	91.3

- 15 -

Note 10 —Long-term debt:

	December 31, 2012		September 30, 2013
	(In millions)
Valhi:
Snake River Sugar Company	$	250.0	$	250.0
Contran credit facility		157.6		173.5
Total Valhi debt		407.6		423.5
Subsidiary debt:
Kronos:
Note payable to Contran		—		175.0
Term loan		384.5		—
Revolving European credit facility		13.2		—
Revolving North American credit facility		—		46.2
CompX:
Promissory note payable to Timet Finance Management Company		18.5		—
WCS:
Financing capital lease		69.9		68.9
6% promissory notes		7.2		7.3
Other		9.2		10.4
Total subsidiary debt		502.5		307.8
Total debt		910.1		731.3
Less current maturities		29.6		29.7
Total long-term debt	$	880.5	$	701.6

Valhi – Contran credit facility – During the first nine months of 2013, we had net borrowings of $15.9 million under our Contran credit facility. The average interest rate on the existing balance as of and for the nine months ended September 30, 2013 was 4.25%. At September 30, 2013, the equivalent of $51.5 million was available for borrowing under this facility.

Kronos – Term loan – In February 2013, Kronos voluntarily prepaid an aggregate $290 million principal amount of its term loan. We recognized a non-cash pre-tax interest charge of $6.6 million in the first quarter related to this prepayment consisting of the write-off of the unamortized original issue discount costs and deferred financing costs associated with such prepayment. Funds for such prepayment were provided by $100 million of Kronos’ cash on hand as well as borrowings of $190 million under a new loan from Contran as described below.  In July 2013 Kronos voluntarily prepaid the remaining $100 million principal amount outstanding under its term loan, using $50 million of its cash on hand as well as borrowings of $50 million under its North American revolving credit facility.  We recognized a non-cash pre-tax interest charge of $2.3 million in the third quarter of 2013 related to this prepayment consisting of the write-off of the unamortized original issue discount costs and deferred financing costs associated with such prepayment.  The average interest rate on the term loan for the year-to-date period ended July 30, 2013 (the payoff date) was 6.8%

Note payable to Contran – As discussed above, in February 2013 Kronos entered into a promissory note with Contran that allows it to borrow up to $290 million. This new loan from Contran contains terms and conditions similar to the terms and conditions of the term loan, except that the loan from Contran is unsecured and contains no financial maintenance covenant. The independent members of Kronos’ board of directors approved the terms and conditions of the loan from Contran. The note requires quarterly principal payments of $5.0 million which commenced in March 2013, with any remaining outstanding principal due by June 2018. Voluntary principal prepayments are permitted at any time without penalty. The note bears interest at LIBOR (with LIBOR no less than 1%) plus 5.125%, or the base rate (as defined in the agreement) plus 4.125%. Kronos is required to use the base rate method until such time as both (1) the term loan discussed above has been fully repaid and (2) the European credit facility has been amended on terms satisfactory to Contran, at which time Kronos would have the option to use either the base rate or LIBOR rate methods. The average interest rate on these borrowings as of and for the period from issuance to September 30, 2013 was 7.375%.

- 16 -

Revolving European credit facility – During the first nine months of 2013, Kronos borrowed €10 million ($12.8 million when borrowed) and repaid  the entire outstanding balance of €20 million ($26.5 million when repaid) in August under its European credit facility. The average interest rate on these borrowings for the year-to-date period ended August 31, 2013 when paid off was 2.02%. At September 30, 2013, there were no outstanding borrowings under this facility.  Our European revolving credit facility requires the maintenance of certain financial ratios.  At September 30, 2013, based on the current earnings before income tax, interest, depreciation and amortization expense of the borrowers, Kronos would not have met the financial test if it had any net debt outstanding under this facility, and accordingly its effective available borrowing under this facility at September 30, 2013 is approximately $32.4 million, the aggregate amount of cash held by the borrowers, net of the borrowers’ other outstanding indebtedness.  Kronos is in discussions with the lender to amend the facility to modify the covenant.  However, we do not currently anticipate the need to draw on this facility for the foreseeable future.   

Revolving North American credit facility – During the first nine months of 2013, Kronos borrowed $90.3 million and repaid an aggregate of $44.1 million. The average interest rate on these borrowings as of and for the period from borrowing to September 30, 2013 was 2.63% and 2.46%, respectively. At September 30, 2013 approximately $56.6 million was available for borrowing under this facility.

Canada – At September 30, 2013, an aggregate of Cdn. $7.5 million letters of credit were outstanding under Kronos’ Canadian subsidiary’s loan agreement with the Bank of Montreal which exists solely for the issuance of up to Cdn. $10.0 million in letters of credit.

In January 2013, Kronos borrowed Cdn. $1.8 million (USD $1.8 million) under its Canadian subsidiary’s agreement with an economic development agency of the Province of Quebec, Canada which was recorded net of Cdn. $.5 million (USD $.5 million) imputed interest.

CompX – In July 2013, CompX prepaid the remaining outstanding principal amount of the note, plus accrued interest, without penalty.  The average interest rate on the promissory note payable for the year-to-date period ended July 18, 2013 (the pay-off date) was 1.3%.   

Restrictions and other – Certain of the credit facilities with unrelated, third-party lenders described above require the respective borrowers to maintain minimum levels of equity, require the maintenance of certain financial ratios, limit dividends and additional indebtedness and contain other provisions and restrictive covenants customary in lending transactions of this type. We are in compliance with all of our debt covenants at September 30, 2013.

Note 11 —Employee benefit plans:

Defined benefit plans – The components of our net periodic defined benefit pension cost are presented in the table below.

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)
Service cost	$	2.5		$	3.2		$	7.7		$	9.7
Interest cost		6.2			6.0			19.1			17.9
Expected return on plan assets		(5.5	)		(5.8	)		(16.5	)		(17.8	)
Amortization of unrecognized:
Prior service cost		.4			.4			1.2			1.2
Net transition obligations		.1			.1			.3			.3
Recognized actuarial losses		2.3			3.4			6.9			10.2
Total	$	6.0		$	7.3		$	18.7		$	21.5

- 17 -

Other postretirement benefits – The components of our net periodic other postretirement benefit cost are presented in the table below.

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)						(In millions)
Service cost	$	.1		$	.1		$	.2		$	.3
Interest cost		.1			.3			.6			.5
Amortization of prior service credit		(.5	)		(.5	)		(1.4	)		(1.4	)
Recognized actuarial losses		.1			—			.1			.1
Total	$	(.2	)	$	(.1	)	$	(.5	)	$	(.5	)

Contributions – We expect to contribute the equivalent of $28.5 million and $1.6 million, respectively, to all of our defined benefit pension plans and other postretirement benefit plans during 2013.

Note 12 —Other income, net:

	Nine months ended September 30,
	2012			2013
	(In millions)
Securities earnings:
Dividends and interest	$	21.3		$	19.7
Securities transactions, net		.2			.2
Total		21.5			19.9
Equity in earnings of investees		(.1	)		(.9	)
Currency transactions, net		(.5	)		(1.5	)
Insurance recoveries		2.6			3.8
Litigation settlement gain		14.7			—
Other, net		1.2			.5
Total	$	39.4		$	21.8

Insurance recoveries reflect, in part, amounts we received from certain of our former insurance carriers and relate to the recovery of prior lead pigment and asbestos litigation defense costs incurred by NL.

In May 2012, we recognized a $14.7 million pre-tax gain related to the third and final closing associated with certain real property formerly owned by NL in New Jersey, based on the excess of the $15.6 million cash proceeds received over the carrying value of the property.  See Note 15 to our 2012 Annual Report.  

- 18 -

Note 13 —Income taxes:

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$	9.5		$	(21.0	)	$	104.8		$	(72.0	)
Incremental tax (benefit) on earnings of non-U.S. companies		(12.8	)		1.3			(7.1	)		(3.4	)
Non-U.S. tax rates		(.7	)		.8			(12.4	)		3.3
Adjustment to the reserve for uncertain tax positions, net		.3			.6			1.7			2.3
Nondeductible expenses		.8			.5			3.0			3.1
U.S. state income taxes and other, net		(.1	)		(1.1	)		(.3	)		(1.3	)
Income tax expense (benefit)	$	(3.0	)	$	(18.9	)	$	89.7		$	(68.0	)

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)
Comprehensive provision for income taxes (benefit) allocable to:
Continuing operations	$	(3.0	)	$	(18.9	)	$	89.7		$	(68.0	)
Discontinued operations		.9			—			2.4			—
Other comprehensive income (loss):
Marketable securities		3.2			6.3			(12.8	)		7.5
Currency translation		4.4			4.1			2.7			2.8
Pension plans		.8			1.2			2.5			3.6
OPEB plans		(.2	)		(.2	)		(.5	)		(.5	)
Total	$	6.1		$	(7.5	)	$	84.0		$	(54.6	)

Our income tax benefit in the third quarter of 2012 includes an incremental tax benefit of $11.1 million as we determined in the third quarter 2012 that due to global changes in our business, we would not remit certain dividends from our Chemicals Segment’s non-U.S. jurisdictions.  As a result, certain tax attributes were available for carryback to offset prior year tax expense.   

In the third quarter of 2012, France enacted certain changes in their income tax laws, including a 3% nondeductible surtax on all dividend distributions which is assessed at the time of the distribution against the company making such distribution.  Consequently, our Chemicals Segment’s French subsidiary will be required to pay an additional 3% tax on all future dividend distributions.  Our undistributed earnings in France are deemed to be permanently reinvested and such tax will be recognized as part of our income tax expense in the period during which the dividend is declared and will be remitted to the French government in accordance with the applicable tax law.  During the third quarter of 2012, our Chemicals Segment’s French subsidiary distributed a $1.8 million dividend.  There have been no dividend distributions from our Chemicals Segment’s French subsidiary during 2013.  At September 30, 2013, our French subsidiary has undistributed earnings of approximately $10.9 million that, if distributed, would be subject to the 3% surtax.

Tax authorities are examining certain of our U.S. and non-U.S. tax returns and have or may propose tax deficiencies, including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives and court and tax proceedings, we cannot guarantee that these matters will be resolved in our favor, and therefore our potential exposure, if any, is also uncertain. In 2011 and 2012, Kronos received notices of re-assessment from the Canadian federal and provincial tax authorities related to the years 2002 through 2004. We object to the re-assessments and believe the position is without merit. Accordingly, we are appealing the re-assessments and in connection with such appeal we were required to post letters of credit aggregating Cdn. $7.5 million (see Note 10). If the full amount of the proposed adjustment were ultimately to be assessed against us, the cash tax liability would be approximately $15.7 million. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of

- 19 -

operations or liquidity. We currently estimate that our unrecognized tax benefits may change by $4.4 million during the next twelve months related to certain adjustments to our prior year returns and the expiration of certain statutes of limitations.

Note 14 —Noncontrolling interest in subsidiaries:

	December 31, 2012		September 30, 2013
	(In millions)
Noncontrolling interest in net assets:
Kronos	$	267.0	$	239.1
NL		77.8		83.3
CompX		13.3		13.5
Total	$	358.1	$	335.9

	Nine months ended September 30,
	2012		2013
	(In millions)
Noncontrolling interest in net income (loss) of subsidiaries:
Kronos	$	46.2	$	(20.8	)
NL		9.7		(3.8	)
CompX		.8		.6
Total	$	56.7	$	(24.0	)

A portion of the noncontrolling interest in the net income of CompX in 2012 relates to discontinued operations. See Note 3.

The changes in our ownership interest in our subsidiaries and the effect on our equity is as follows:

	Nine months ended September 30,
	2012		2013
	(In millions)
Net income (loss) attributable to Valhi stockholders	$	156.2	$	(113.7	)
Transfers from noncontrolling interest — Issuance of subsidiaries’ common stock		—		(.3	)
Net income (loss) attributable to Valhi stockholders and change from noncontrolling interest in subsidiaries	$	156.2	$	(114.0	)

- 20 -

Note 15 —Accumulated other comprehensive loss:

Changes in accumulated other comprehensive loss attributable to Valhi stockholders for the three and nine months ended September 30, 2012 and 2013 are presented in the table below, net of related deferred income taxes.

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)
Accumulated other comprehensive income (loss), net of tax:
Marketable securities:
Balance at beginning of period	$	(5.6	)	$	1.9		$	6.4		$	2.1
Other comprehensive income (loss) – unrealized gains (losses) during the year		5.4			1.0			(6.6	)		.8
Balance at end of period	$	(.2	)	$	2.9		$	(.2	)	$	2.9
Currency translation adjustment:
Balance at beginning of period	$	19.5		$	36.3		$	37.5		$	53.3
Other comprehensive income (loss)		30.8			16.9			12.8			(.1	)
Balance at end of period	$	50.3		$	53.2		$	50.3		$	53.2
Defined benefit pension plans:
Balance at beginning of period	$	(69.6	)	$	(97.3	)	$	(72.6	)	$	(101.5	)
Other comprehensive income— amortization of prior service cost and net losses included in net periodic pension cost		1.5			2.1			4.5			6.3
Balance at end of period	$	(68.1	)	$	(95.2	)	$	(68.1	)	$	(95.2	)
OPEB plans:
Balance at beginning of period	$	4.9		$	3.6		$	5.4		$	4.1
Other comprehensive loss – amortization of prior service credit		(.3	)		(.3	)		(.8	)		(.8	)
Balance at end of period	$	4.6		$	3.3		$	4.6		$	3.3
Total accumulated other comprehensive loss:
Balance at beginning of period	$	(50.8	)	$	(55.5	)	$	(23.3	)	$	(42.0	)
Other comprehensive income		37.4			19.7			9.9			6.2
Balance at end of period	$	(13.4	)	$	(35.8	)	$	(13.4	)	$	(35.8	)

See Note 11 for amounts related to our defined benefit pension plans and OPEB plans.

Note 16—Commitments and contingencies:

Lead pigment litigation—NL

NL’s former operations included the manufacture of lead pigments for use in paint and lead-based paint. NL, other former manufacturers of lead pigments for use in paint and lead-based paint, and the Lead Industries Association (which discontinued business operations in 2002), have been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions have been filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others have been asserted as class actions. These lawsuits seek recovery under a variety of theories, including public and private nuisance, negligent product design, negligent failure to warn, strict liability, breach of warranty, conspiracy/concert of action, aiding and abetting, enterprise liability, market share or risk contribution liability, intentional tort, fraud and misrepresentation, violations of state consumer protection statutes, supplier negligence and similar claims.

- 21 -

The plaintiffs in these actions generally seek to impose on the defendants responsibility for lead paint abatement and health concerns associated with the use of lead-based paints, including damages for personal injury, contribution and/or indemnification for medical expenses, medical monitoring expenses and costs for educational programs. To the extent the plaintiffs seek compensatory or punitive damages in these actions, such damages are generally unspecified. In some cases, the damages are unspecified pursuant to the requirements of applicable state law. A number of cases are inactive or have been dismissed or withdrawn. Most of the remaining cases are in various pre-trial stages. Some are on appeal following dismissal or summary judgment rulings in favor of either the defendants or the plaintiffs. In addition, various other cases (in which we are not a defendant) are pending that seek recovery for injury allegedly caused by lead pigment and lead-based paint. Although NL is not a defendant in these cases, the outcome of these cases may have an impact on cases that might be filed against NL in the future.

We believe that these actions are without merit, and we intend to continue to deny all allegations of wrongdoing and liability and to defend against all actions vigorously. We do not believe it is probable that we have incurred any liability with respect to all of the lead pigment litigation cases to which we are a party, and liability to us that may result, if any, in this regard cannot be reasonably estimated, because:

· NL has never settled any of the market share, risk contribution, intentional tort, fraud, nuisance, supplier negligence, breach of warranty, conspiracy, misrepresentation, aiding and abetting, enterprise liability, or statutory cases;

· no final, non-appealable adverse verdicts have ever been entered against NL; and

· NL has never ultimately been found liable with respect to any such litigation matters, including over 100 cases over a twenty-year period for which NL was previously a party and for which NL has been dismissed without any finding of liability.

Accordingly, we have not accrued any amounts for any of the pending lead pigment and lead-based paint litigation cases. In addition, we have determined that liability to us which may result, if any, cannot be reasonably estimated because there is no prior history of a loss of this nature on which an estimate could be made, and there is no substantive information available upon which an estimate could be based.

New cases may continue to be filed against us. We cannot assure you that we will not incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against us or NL otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against us as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Environmental matters and related litigation

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. We have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, we may be subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe that all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations, including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (“PRP”) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization

- 22 -

Act (“CERCLA”), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities we or our predecessors, or our subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (“EPA”) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are also a party to a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the:

· complexity and differing interpretations of governmental regulations,

· number of PRPs and their ability or willingness to fund such allocation of costs,

· financial capabilities of the PRPs and the allocation of costs among them,

· solvency of other PRPs,

· multiplicity of possible solutions,

· number of years of investigatory, remedial and monitoring activity required,

· uncertainty over the extent, if any, to which our former operations might have contributed to the conditions allegedly giving rise to such personal injury, property damage, natural resource and related claims, and

· number of years between former operations and notice of claims and lack of information and documents about the former operations.

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. We cannot assure you that actual costs will not exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and we cannot assure you that costs will not be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our consolidated financial statements, results of operations and liquidity.

We record liabilities related to environmental remediation and related matters when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable. At December 31, 2012 and September 30, 2013, we have not recognized any receivables for recoveries.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of our accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

- 23 -

Changes in the accrued environmental remediation and related costs during the first nine months of 2013 are presented in the table below.

	Amount
	(In millions)
Balance at the beginning of the year	$	50.2
Additions charged to expense, net		12.7
Payments, net		(2.8	)
Changes in currency exchange rates		(.1	)
Balance at the end of period	$	60.0
Amounts recognized in our Condensed Consolidated Balance Sheet at the end of the period:
Current liabilities	$	6.4
Noncurrent liabilities		53.6
Total	$	60.0

NL – On a quarterly basis, NL evaluates the potential range of its liability for environmental remediation and related costs at sites where it has been named as a PRP or defendant. At September 30, 2013, NL had accrued approximately $58 million related to approximately 50 sites associated with remediation and related matters that it believes are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to NL for remediation and related matters for which we believe it is possible to estimate costs is approximately $154 million, including the amount currently accrued.

NL believes that it is not reasonably possible to estimate the range of costs for certain sites. At September 30, 2013, there were approximately 5 sites for which NL is not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and NL is unable to determine whether or not it actually had any association with the site, the nature of its responsibility, if any, for the contamination at the site and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of NL’s control, such as when the party alleging liability provides information to NL. At certain of these previously inactive sites, NL has received general and special notices of liability from the EPA and/or state agencies alleging that NL, sometimes with other PRPs, is liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that NL, along with any other alleged PRPs, is liable for past and/or future clean-up costs. As further information becomes available to NL for any of these sites which would allow NL to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our consolidated financial statements, results of operations and liquidity.

Other – We have also accrued approximately $2.0 million at September 30, 2013 for other environmental cleanup matters. This accrual is near the upper end of the range of our estimate of reasonably possible costs for such matters.

Insurance coverage claims

We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors and we cannot assure you that such insurance coverage will be available.

We have agreements with three former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery.

For additional discussion of certain litigation involving NL and certain of its former insurance carriers, please refer to our 2012 Annual Report.

- 24 -

Other litigation

NL — NL has been named as a defendant in various lawsuits in several jurisdictions, alleging personal injuries as a result of occupational exposure primarily to products manufactured by our former operations containing asbestos, silica and/or mixed dust. In addition, some plaintiffs allege exposure to asbestos from working in various facilities previously owned and/or operated by NL. There are 1,130 of these types of cases pending, involving a total of approximately 1,643 plaintiffs. In addition, the claims of approximately 8,298 plaintiffs have been administratively dismissed or placed on the inactive docket in Ohio, Indiana and Texas state courts. We do not expect these claims will be re-opened unless the plaintiffs meet the courts’ medical criteria for asbestos-related claims. We have not accrued any amounts for this litigation because of the uncertainty of liability and inability to reasonably estimate the liability, if any. To date, we have not been adjudicated liable in any of these matters. Based on information available to us, including:

· facts concerning historical operations,

· the rate of new claims,

· the number of claims from which we have been dismissed and

· our prior experience in the defense of these matters.

We believe that the range of reasonably possible outcomes of these matters will be consistent with our historical costs (which are not material). Furthermore, we do not expect any reasonably possible outcome would involve amounts material to our consolidated financial position, results of operations or liquidity. We have sought and will continue to vigorously seek, dismissal and/or a finding of no liability from each claim. In addition, from time to time, we have received notices regarding asbestos or silica claims purporting to be brought against former subsidiaries, including notices provided to insurers with which we have entered into settlements extinguishing certain insurance policies. These insurers may seek indemnification from us.

WCS – Previously, the Sierra Club has filed various lawsuits in Texas District Court against the Texas State Commission on Environmental Quality (“TCEQ”). WCS has intervened in these lawsuits.  These lawsuits challenge WCS’ by-product and low-level radioactive waste disposal licenses. Subsequently, the District Court upheld the TCEQ’s determination that the Sierra Club lacked standing to pursue a challenge to the by-product disposal license. The Sierra Club appealed.  WCS’ by-product disposal license remains in effect pending resolution of the appeal. In May 2012, the same District Court subsequently held that TCEQ erred in denying Sierra Club’s request for an administrative contested case hearing regarding the low-level radioactive waste disposal license, and ordered the TCEQ to undertake a contested case hearing in which the Sierra Club could participate.

Shortly thereafter, both the TCEQ and WCS appealed the District Court’s order with respect to the low-level radioactive waste disposal license, and the District Court’s order is suspended.  WCS’ low-level radioactive waste disposal license remains in effect, pending resolution of this appeal. On the same day that WCS filed its appeal with regard to the District Court’s order with respect to its low-level radioactive waste disposal license, the Sierra Club filed another lawsuit in the same District Court, challenging a routine TCEQ action relating to administration of the low-level radioactive waste disposal license. Both the TCEQ and WCS filed a motion to dismiss this latest lawsuit filed by the Sierra Club for lack of jurisdiction, which the District Court denied. TCEQ and WCS took an interlocutory appeal to the denial of TCEQ’s plea to jurisdiction.  The interlocutory appeal remains pending and the Sierra Club filed a related petition for writ of injunction with the same appellate court in Austin; that petition was denied. WCS believes all of these actions by the Sierra Club are without merit and that the Sierra Club has no proper standing to challenge any of its licenses and permits. This position has been reinforced by two recent Texas Supreme Court rulings narrowing the basis for a challenge to environmental permits.  WCS intends to continue to defend against any and all such actions vigorously, and to continue to operate its West Texas facilities in accordance with the terms of its licenses and permits.

Kronos – In March 2010, Kronos was served with two complaints which were subsequently consolidated as Haley Paint et al. v. E.I. Du Pont de Nemours and Company, et al. (United States District Court, for the District of Maryland, Case No. 1:10-cv-00318-RDB).  A third plaintiff intervened into the case in July 2011.  The defendants included Kronos, E.I. Du Pont de Nemours & Company, Huntsman International LLC, Millennium Inorganic Chemicals, Inc. and the National Titanium Dioxide Company Limited (d/b/a Cristal).  Plaintiffs sought to represent a class consisting of all persons and entities that purchased titanium dioxide in the United States directly from one or more of the defendants on or after March 1, 2002.  The complaint alleged that the defendants conspired and combined to fix, raise, maintain, and stabilize the price at which titanium dioxide was sold in the United States and engaged in other anticompetitive conduct.  In May 2010, defendants filed a motion to dismiss, which plaintiffs opposed.  In March 2011, the court denied the motion to dismiss.  In February 2012, the plaintiffs submitted their motion for class certification, which defendants opposed.  In August 2012, the court

- 25 -

granted the plaintiffs’ motion for class certification and trial was set for September 2013.  On September 10, 2013, and following the agreement by the three other defendants in the third quarter of 2013 to enter into settlement agreements with the class plaintiffs, Kronos also entered into a settlement agreement with the class plaintiffs, without admitting any fault or wrongdoing, and agreed to pay an aggregate of $35 million (payable in two installments at specified times, expected to occur by mid-2014).  Following the service of the Class Action Fairness Notice and the Order of Final Approval from the court, we, and the other defendants, will be dismissed with prejudice from this matter.  Selling, general and administrative expense in the third quarter of 2013 includes a $35 million charge related to this settlement.  See also Note 8.

 In March 2013, Kronos was served with the complaint, Los Gatos Mercantile, Inc. d/b/a Los Gatos Ace Hardware, et al v. E.I. Du Pont de Nemours and Company, et al. (United States District Court, for the Northern District of California, Case No. 3:13-cv-01180-SI).  The defendants include Kronos, E.I. Du Pont de Nemours & Company, Huntsman International LLC and Millennium Inorganic Chemicals, Inc.  Plaintiffs seek to represent a class consisting of indirect purchasers of titanium dioxide in the states of Arizona, Arkansas, California, the District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, South Carolina, South Dakota, Tennessee, Utah, Vermont, West Virginia and Wisconsin that indirectly purchased titanium dioxide from one or more of the defendants on or after March 1, 2002.  The complaint alleges that the defendants conspired and combined to fix, raise, maintain, and stabilize the price at which titanium dioxide was sold in the United States and engaged in other anticompetitive conduct.  This matter had been stayed by the court pending a resolution in the Haley Paint Matter.  The case is now proceeding in the trial court.  We believe the action is without merit, will deny all allegations of wrongdoing and liability and intend to defend against the action vigorously.  

Other – For a discussion of other legal proceedings to which we are a party, please refer to our 2012 Annual Report.

In addition to the litigation described above, we and certain of our affiliates are also involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect any additional material insurance coverage for our environmental claims.

We currently believe that the disposition of all of these various other claims and disputes, individually or in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

Note 17—Fair value measurements and financial instruments:

The following table summarizes the valuation of our marketable securities, financial instruments and other items recorded on a fair value basis as of:

	Fair Value Measurements
	Total			Quoted Prices in Active Markets (Level  1)			Significant Other Observable Inputs (Level  2)		Significant Unobservable Inputs (Level  3)
	(In millions)
Asset (liability)
December 31, 2012:
Marketable securities:
Current	$	.9		$	—		$	.9	$	—
Noncurrent		256.8			3.5			3.3		250.0
Currency forward contracts		1.8			1.8			—		—
September 30, 2013:
Marketable securities:
Current	$	1.6		$	—		$	1.6	$	—
Noncurrent		253.6			—			3.6		250.0
Currency forward contracts		(.5	)		(.5	)		—		—

See Note 4 for information on how we determine fair value of our noncurrent marketable securities.

- 26 -

Certain of our Chemicals Segment’s sales generated by its non-U.S. operations are denominated in U.S. dollars. Our Chemicals Segment periodically uses currency forward contracts to manage a very nominal portion of currency exchange rate risk associated with trade receivables denominated in a currency other than the holder’s functional currency or similar exchange rate risk associated with future sales.  We have not entered into these contracts for trading or speculative purposes in the past, nor do we currently anticipate entering into such contracts for trading or speculative purposes in the future. Derivatives used to hedge forecasted transactions and specific cash flows associated with financial assets and liabilities denominated in currencies other than the U.S. dollar and which meet the criteria for hedge accounting are designated as cash flow hedges. Consequently, the effective portion of gains and losses is deferred as a component of accumulated other comprehensive income and is recognized in earnings at the time the hedged item affects earnings. Contracts that do not meet the criteria for hedge accounting are marked-to-market at each balance sheet date with any resulting gain or loss recognized in income currently as part of net currency transactions. The fair value of the currency forward contracts is determined using Level 1 inputs based on the currency spot forward rates quoted by banks or currency dealers.

At September 30, 2013, our Chemicals Segment had currency forward contracts to exchange:

· an aggregate of $45.0 million for an equivalent value of Canadian dollars at  exchange rates ranging from Cdn. $1.02 to Cdn. $1.06 per U.S. dollar; these contracts with Wells Fargo Bank, N.A. mature from October 2013 through December 2014 at a rate of $3.0 million per month, subject to early redemption provisions at our option;

· an aggregate $25.0 million for an equivalent value of Norwegian kroner at exchange rates ranging from kroner 5.84 to kroner 6.14 per U.S. dollar; these contracts with DnB Nor Bank ASA mature at a rate of $5.0 million per month in certain months from October 2013 through April 2014; and

· an aggregate €16.0 million for an equivalent value of Norwegian kroner at exchange rates ranging from kroner 7.55 to kroner 8.07 per euro; these contracts with DnB Nor Bank ASA mature at a rate ranging from €2.0 million to €5.0 million per month in certain months from October 2013 through April 2014.

The estimated fair value of our currency forward contracts at September 30, 2013 was a net liability of $.5 million, of which $.8 million is recognized as part of accounts and other receivables and $1.3 million is recognized as part of accounts payable and accrued liabilities in our Condensed Consolidated Balance Sheets. There is also a corresponding $.5 million currency transaction loss recognized in our Condensed Consolidated Statement of Operations. Our Chemicals Segment is not currently using hedge accounting for its outstanding currency forward contracts at September 30, 2013, and it did not use hedge accounting for any of such contracts previously held in 2012.

- 27 -

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

	December 31, 2012				September 30,2013
	Carrying amount		Fair value		Carrying amount		Fair value
	(In millions)
Cash, cash equivalents and restricted cash equivalents	$	395.9	$	395.9	$	143.4	$	143.4
Long-term debt (excluding capitalized leases):
Kronos note payable to Contran	$	—	$	—	$	175.0	$	175.0
Kronos term loan		384.5		396.8		—		—
Snake River Sugar Company fixed rate loans		250.0		250.0		250.0		250.0
WCS fixed rate debt		77.1		77.1		76.2		76.2
Valhi credit facility with Contran		157.6		157.6		173.5		173.5
Kronos variable rate bank credit facilities		13.2		13.2		46.2		46.2
CompX variable rate promissory note		18.5		18.5		—		—
Noncontrolling interest in:
Kronos common stock	$	267.0	$	442.6	$	239.1	$	350.9
NL common stock		77.8		94.8		83.3		94.0
CompX common stock		13.3		23.4		13.5		21.3
Valhi stockholders’ equity	$	733.6	$	4,238.9	$	574.9	$	6,768.8

The fair value of our publicly-traded marketable securities, noncontrolling interest in NL, Kronos and CompX and our common stockholders’ equity are all based upon quoted market prices, Level 1 inputs at each balance sheet date. At December 31, 2012, the estimated market price of Kronos’ term loan was $1,017.5 per $1,000 principal amount.   The fair value of Kronos’ term loan was based on quoted market prices; however, these quoted market prices represent Level 2 inputs because the markets in which the term loan trades were not active. The fair value of our fixed-rate nonrecourse loans from Snake River Sugar Company is based upon the $250 million redemption price of our investment in Amalgamated, which collateralizes the nonrecourse loans (this is a Level 3 input). Fair value variable interest debt and other fixed-rate debt are deemed to approximate book value, which represents Level 2 inputs. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. See Notes 5 and 8.

           

- 28 -

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

Business Overview

We are primarily a holding company. We operate through our wholly-owned and majority-owned subsidiaries, including NL Industries, Inc., Kronos Worldwide, Inc., CompX International Inc., Tremont LLC and Waste Control Specialists LLC (“WCS”). Kronos (NYSE: KRO), NL (NYSE: NL) and CompX (NYSE MKT: CIX) each file periodic reports with the U.S. Securities and Exchange Commission (“SEC”).

We have three consolidated operating segments:

· Chemicals – Our chemicals segment is operated through our majority control of Kronos. Kronos is a leading global producer and marketer of value-added titanium dioxide pigments (“TiO₂”). TiO₂ is used to impart whiteness, brightness, opacity and durability to a wide variety of products, including paints, plastics, paper, fibers and ceramics. Additionally, TiO₂ is a critical component of everyday applications, such as coatings, plastics and paper, as well as many specialty products such as inks, foods and cosmetics.

· Component Products – We operate in the component products industry through our majority control of CompX. CompX is a leading manufacturer of engineered components utilized in a variety of applications and industries. CompX manufactures engineered components that are sold to a variety of industries including recreational transportation (including boats), office and institutional furniture, cabinetry, tool storage and healthcare.

· Waste Management – WCS is our subsidiary which operates a West Texas facility for the processing, treatment, storage and disposal of a broad range of low-level radioactive, hazardous, toxic and other wastes. WCS obtained a byproduct disposal license in 2008 and began disposal operations at this facility in October 2009. WCS received a low-level radioactive waste (“LLRW”) disposal license in September 2009. The Compact LLRW disposal facility was fully certified and operational in April 2012, and the Federal LLRW site was fully certified and operational in September 2012 and received its first federal waste shipments in the latter part of the second quarter of 2013.

General

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements in this Quarterly Report that are not historical facts are forward-looking in nature and represent management’s beliefs and assumptions based on currently available information. In some cases, you can identify forward-looking statements by the use of words such as “believes,” “intends,” “may,” “should,” “could,” “anticipates,” “expects” or comparable terminology, or by discussions of strategies or trends. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we do not know if these expectations will be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly impact expected results. Actual future results could differ materially from those predicted. The factors that could cause actual future results to differ materially from those described herein are the risks and uncertainties discussed in this Quarterly Report and those described from time to time in our other filings with the SEC include, but are not limited to, the following:

· Future supply and demand for our products;

· The extent of the dependence of certain of our businesses on certain market sectors;

· The cyclicality of certain of our businesses (such as Kronos’ TiO₂ operations);

· Customer and producer inventory levels;

· Unexpected or earlier-than-expected industry expansion;

· Changes in raw material and other operating costs (such as energy, ore and steel costs) and our ability to pass those costs on to our customers or offset them with reductions in other operating costs;

· Changes in the availability of raw materials (such as ore);

· General global economic and political conditions (such as changes in the level of gross domestic product in various regions of the world and the impact of such changes on demand for, among other things, TiO₂ and component products);

- 29 -

· Competitive products and prices, including increased competition from low-cost manufacturing sources (such as China);

· Possible disruption of our business or increases in the cost of doing business resulting from terrorist activities or global conflicts;

· Customer and competitor strategies;

· Potential consolidation of our competitors;

· Potential consolidation of our customers;

· The impact of pricing and production decisions;

· Competitive technology positions;

· The introduction of trade barriers;

· The ability of our subsidiaries to pay us dividends;

· The impact of current or future government regulations (including employee healthcare benefit related regulations);

· Uncertainties associated with new product development and the development of new product features;

· Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and each of the euro, the Norwegian krone and the Canadian dollar) or possible disruptions to our business resulting from potential instability resulting from uncertainties associated with the euro;

· Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, explosions, unscheduled or unplanned downtime and transportation interruptions);

· The timing and amounts of insurance recoveries;

· Our ability to renew, amend, refinance or establish credit facilities;

· Our ability to maintain sufficient liquidity;

· The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters;

· Our ultimate ability to utilize income tax attributes or changes in income tax rates related to such attributes, the benefits of which have been recognized under the more-likely-than-not recognition criteria (such as Kronos’ ability to utilize its German net operating loss carryforwards);

· Environmental matters (such as those requiring compliance with emission and discharge standards for existing and new facilities, or new developments regarding environmental remediation at sites related to our former operations);

· Government laws and regulations and possible changes therein (such as changes in government regulations which might impose various obligations on former manufacturers of lead pigment and lead-based paint, including NL, with respect to asserted health concerns associated with the use of such products);

· The ultimate resolution of pending litigation (such as NL’s lead pigment litigation, environmental and other litigation and Kronos’ class action litigation);

· Our ability to comply with covenants contained in our revolving bank credit facilities;

· Our ability to complete and comply with the conditions of our licenses and permits;

· Our ability to successfully defend against any currently-pending or possible future challenge to WCS’ operating licenses and permits;

· Unexpected delays in the delivery or licensing of shipping containers being procured by WCS, or in their operational start-up; and

· Possible future litigation.

Should one or more of these risks materialize (or the consequences of such development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those currently forecasted or expected. We disclaim any intention or obligation to update or revise any forward-looking statement whether as a result of changes in information, future events or otherwise.

- 30 -

Operations Overview

Quarter Ended September 30, 2013 Compared to the Quarter Ended September 30, 2012—

Net loss from continuing operations attributable to Valhi stockholders was $34.2 million, or $.10 per diluted share, in the third quarter of 2013 compared to net income from continuing operations attributable to Valhi stockholders of $21.7 million, or $.06 per diluted share, in the third quarter of 2012. As more fully discussed below, our diluted income per share decreased from 2012 to 2013 primarily due to the net effects of:

· an operating loss from our Chemicals Segment in 2013 compared to operating income in 2012;

· a loss on the prepayment of debt in the third quarter of 2013;

· higher operating losses at our Waste Management segment in 2013; and

· higher general expenses in 2013, primarily due to increased litigation and related costs.

Our net loss attributable to Valhi stockholders in 2013 includes a charge of $.05 per diluted share related to a litigation settlement of Kronos.

Nine Months Ended September 30, 2013 Compared to the Nine Months Ended September 30, 2012—

Net loss from continuing operations attributable to Valhi stockholders was $113.7 million, or $.33 per diluted share, in the first nine months of 2013 compared to net income from continuing operations attributable to Valhi stockholders of $153.9 million, or $.45 per diluted share, in the first nine months of 2012. As more fully discussed below, our diluted income per share decreased from 2012 to 2013 primarily due to the net effects of:

· an operating loss from our Chemicals Segment in 2013 compared to operating income in 2012;

· lower operating losses at our Waste Management segment in 2013 compared to 2012;

· higher general expenses in 2013, primarily due to increased litigation and related costs ;and

· a real-estate related litigation settlement gain in 2012.

Our net loss attributable to Valhi stockholders in 2013 includes an aggregate charge of $.01 per diluted share related to the first quarter and third quarter voluntary prepayments of $290 million and $100 million principal amount, respectively, of Kronos’ term loan and a third quarter charge of $.05 per diluted share related to a litigation settlement of Kronos.

Our net income attributable to Valhi stockholders in 2012 includes income of $.02 per diluted share related to a real-estate related litigation settlement gain and a loss on the prepayment of debt of $.01 per diluted share.

In December 2012, our Component Products Segment completed the sale of its furniture components business. See Note 3 to our Condensed Consolidated Financial Statements. Unless otherwise noted, the results of operations in management’s discussion and analysis are focused on our continuing operations.

Current Forecast for 2013 – 

We currently expect to report lower net income from continuing operations attributable to Valhi stockholders in 2013 as compared to the same period in 2012 primarily due to the net effects of:

· an expected operating loss from our Chemicals Segment in 2013 compared to operating income in 2012;

· higher general expenses in 2013, primarily due to increased litigation and related costs; and

· a real-estate related litigation settlement gain in 2012.

Segment Operating Results—2012 Compared to 2013 – 

Chemicals – 

We consider TiO₂ to be a “quality of life” product, with demand affected by gross domestic product, or GDP, and overall economic conditions in our markets located in various regions of the world. Over the long-term, we expect demand for TiO₂ will grow by 2% to 3% per year, consistent with our expectations for the long-term growth in GDP. However, even if we and our competitors maintain consistent shares of the worldwide market, demand for TiO₂ in any interim or annual

- 31 -

period may not change in the same proportion as the change in GDP, in part due to relative changes in the TiO₂ inventory levels of our customers. We believe that our customers’ inventory levels are influenced in part by their expectations for future changes in market TiO₂ selling prices as well as their expectations for future availability of product. Although certain of our TiO₂ grades are considered specialty pigments, the majority of our grades and substantially all of our production are considered commodity pigment products, with price and availability being the most significant competitive factors along with quality and customer service.

The factors having the most impact on our reported operating results are:

— our TiO2 sales and production volumes,

— TiO2 selling prices,

— currency exchange rates (particularly the exchange rate for the U.S. dollar relative to the euro, the Norwegian krone and the Canadian dollar) and

— manufacturing costs, particularly raw materials, maintenance and energy-related expenses.

Our Chemicals Segment’s key performance indicators are our TiO₂ average selling prices and our TiO₂ sales and production volumes. TiO₂ selling prices generally follow industry trends and prices will increase or decrease generally as a result of competitive market pressures.

	Three months ended September 30,									Nine months ended September 30,
	2012			2013			% Change			2012			2013			% Change
	(Dollars in millions)
Net sales	$	472.9		$	419.1			(11	)%	$	1,579.5		$	1,363.8			(14	)%
Cost of sales		387.5			372.4			(4	)		1,070.5			1,304.8			22
Gross margin	$	85.4		$	46.7			(45	)%	$	509.0		$	59.0			(88	)%
Operating income (loss)	$	40.4		$	(35.2	)		(187	)%	$	364.1		$	(125.6	)		(135	)%
Percent of net sales:
Cost of sales		82	%		89	%					68	%		96	%
Gross margin		18			11						32			4
Operating income (loss)		9			(8	)					23			(9	)
Ti02 operating statistics:
Sales volumes*		116			121			4	%		368			397			8	%
Production volumes*		98			113			15			356			359			1
Percent change in net sales:
Ti02 product pricing								(18	)%								(21	)%
Ti02 sales volumes								4									8
Ti02 product mix								1									(2	)
Changes in currency exchange rates								2									1
Total								(11	)%								(14	)%

* Thousands of metric tons

Current Industry Conditions – In the second quarter of 2013, we announced price increases for our TiO₂ products in all of our markets, implementation of which began in June 2013.  In the third quarter of 2013, we notified customers of additional price increases to be implemented beginning in October 2013.  As a result, after about a year of decreasing selling prices within the TiO₂ industry, our selling prices have generally stabilized.  Our average selling prices at the end of the third quarter of 2013 were 1% higher than at the end of the second quarter of 2013, and were 7% lower than at the end of 2012.  Demand for TiO₂ products has generally been strong in 2013, primarily in European and export markets, as customers have generally depleted their inventories in response to general global economic uncertainty.

While we operated our production facilities at full practical capacity rates in the first quarter of 2012, we operated our facilities at reduced rates during the remainder of 2012 (approximately 86% of practical capacity in the second quarter, approximately 71% in the third quarter and approximately 80% in the fourth quarter) to align production levels and inventories to current and anticipated near-term customer demand levels. We continued to operate our production facilities at reduced capacity rates in the first nine months of 2013 (approximately 92% of practical capacity in the first quarter, approximately 90% in the second quarter and approximately 82% in the third quarter).  

- 32 -

We experienced significantly higher costs for our raw materials such as third party feedstock ore and petroleum coke in 2012.  We operate two ilmenite mines in Norway, the production from which provides all of the feedstock for our European sulfate process facilities as well as third party ilmenite ore sales.  Our cost of sales per metric ton of TiO₂ sold in the first half of 2013 was significantly higher than TiO₂ sold in the first half of 2012, as a substantial portion of the TiO₂ products we sold in the first quarter of 2012 (and a portion of the TiO₂ products we sold in the second quarter of 2012) was produced with lower-cost feedstock ore purchased in 2011, while a substantial portion of the TiO₂ products we sold in the first quarter of 2013 (and a portion of the TiO₂ products we sold in the second quarter of 2013) was produced with higher-cost feedstock ore purchased in 2012.  We have seen some moderation in the cost of TiO₂ feedstock ore procured from third parties in 2013, but such reductions did not begin to be significantly reflected in our cost of sales until the third quarter of 2013.  As expected, our cost of sales per metric ton of TiO₂ sold in the third quarter of 2013 was lower than the cost of sales per metric ton of TiO₂ sold in the third quarter of 2012, primarily due to the lower feedstock ore costs.  

Net Sales – Our Chemicals Segment’s net sales in the third quarter of 2013 decreased 11% compared to the third quarter of 2012 primarily due to the effects of an 18% decrease in average TiO₂ selling prices (which decreased net sales by approximately $85 million) and a 4% increase in sales volumes (which increased net sales by approximately $19 million).  Net sales in the nine months ended September 30, 2013 decreased 14%, compared to the nine months ended September 30, 2012 primarily due to the net effects of a 21% decrease in average TiO₂ selling prices (which decreased net sales by approximately $332 million) and an 8% increase in sales volumes (which increased net sales by approximately $126 million). TiO₂ selling prices will increase or decrease generally as a result of competitive market pressures, changes in the relative level of supply and demand as well as changes in raw material and other manufacturing costs.

Our Chemicals Segment’s sales volumes increased 4% in the third quarter of 2013 as compared to the third quarter of 2012 due to higher customer demand in European markets partially offset by lower sales in export and North American markets.   We estimate the favorable effect of changes in currency exchange rates increased net sales by approximately $12 million as compared to the third quarter of 2012.  Our Chemicals Segment’s sales volumes increased 8% in the first nine months of 2013 as compared to the first nine months of 2012 due to increased customer demand, primarily in European and certain export markets, partially offset by decreased demand in North American markets.  We estimate the favorable effect of changes in currency exchange rates increased our net sales by approximately $10 million as compared to the first nine months of 2012.

Cost of Sales – Our Chemicals Segment’s cost of sales decreased 4% in the third quarter of 2013 compared to the same period in 2012 due to the net impact of lower raw material costs of approximately $28 million (primarily feedstock ore), a 4% increase in sales volumes, a 15% increase in TiO₂ production volumes and currency fluctuations (primarily the euro).  As expected, the cost of sales per metric ton of TiO₂ sold in the third quarter of 2013 was lower than the cost of sales per metric ton of TiO₂ sold in the third quarter of 2012 primarily due to the lower feedstock ore costs.  In the third quarter of 2012 we operated our facilities at a reduced rate in an effort to align inventory levels with lower demand.  The reduction in our TiO₂ production volumes during that time resulted in approximately $25 million of unabsorbed fixed production costs which were charged directly to cost of sales.  Cost of sales as a percentage of net sales increased to 89% in the third quarter of 2013 compared to 82% in the in the same period of 2012 primarily due to the net effects of lower average selling prices, lower raw materials costs and lower unabsorbed fixed costs, as discussed and quantified above.

Our Chemicals Segment’s cost of sales increased 22% in the first nine months of 2013 compared to the same period in 2012 due to the net impact of higher raw material costs of approximately $108 million (primarily feedstock ore), an 8% increase in sales volumes, a 1% increase in production volumes and currency fluctuations (primarily the euro).  Our cost of sales per metric ton of TiO₂ sold in the first half of 2013 was significantly higher than TiO₂ sold in the first half of 2012, as a substantial portion of the TiO₂ products we sold in the first quarter of 2012 (and a portion of the TiO₂ products we sold in the second quarter of 2012) was produced with lower-cost feedstock ore purchased in 2011, while a substantial portion of the TiO₂ products we sold in the first quarter of 2013 (and a portion of the TiO₂ products we sold in the second quarter of 2013) was produced with higher-cost feedstock ore purchased in 2012.  As expected, the cost of sales per metric ton of TiO₂ sold in the third quarter of 2013 was lower than the cost of sales per metric ton of TiO₂ sold in the third quarter of 2012 primarily due to the lower feedstock ore costs as discussed and quantified above.  Cost of sales as a percentage of net sales increased to 96% in the first nine months of 2013 compared to 68% in the same period of 2012 primarily due to the net effects of higher raw materials costs and to approximately $25 million of unabsorbed fixed production costs which were charged directly to cost of sales in 2012, as discussed above.

Unionized employees in our Canadian TiO₂ production facility are covered by a collective bargaining agreement that expired June 15, 2013.  The Canadian facility represents approximately 19% of our worldwide TiO₂ production capacity.  The union employees represented by the Confederation des Syndicat National (CSN) rejected our revised global offer, and we declared a lockout of unionized employees upon the expiration of the existing contract.  As of the date of this report, no agreement has been reached with the CSN and the unionized employees remain locked out.  We are currently operating our

- 33 -

Canadian plant at approximately 15% of the plant’s capacity with non-union management employees, and have implemented a strategy to reduce the financial impact of operating the plant during the lockout.  Since the lockout began, we have been able to fill customer orders with inventory on hand or through production from our other facilities, and we expect to similarly continue meeting customer demand for the foreseeable future.  There is no assurance that we will be able to reach an agreement with the CSN on the terms of a new collective bargaining agreement, or reach an agreement on terms that will not have a material adverse effect on our Chemicals Segment’s operating results.

Gross Margin and Operating Income (Loss) – Our Chemicals Segment’s results decreased from operating income of $40.4 million in the third quarter of 2012 to an operating loss of $35.2 million in the third quarter of 2013 and operating income as a percentage of net sales decreased to (8)% in the third quarter of 2013 from 9% in the same period of 2012. This decrease was driven by the decline in gross margin, which decreased to 11% for the third quarter of 2013 compared to 18% for the third quarter of 2012. As discussed and quantified above, our gross margin decreased primarily due to the net effects of lower selling prices, higher manufacturing costs (primarily raw materials), higher sales volumes and higher production volumes. Additionally, changes in currency exchange rates have positively affected our gross margin and operating income.  We estimate that changes in currency exchange rates increased operating income by approximately $1 million in the third quarter of 2013 as compared to the same period in 2012.  Also included in our Chemicals Segment’s third quarter 2013 operating loss is a $35 million litigation settlement charge, please see Note 16 to our Condensed Consolidated Financial Statements.

Our Chemicals Segment’s results decreased from operating income of $364.1 million in the first nine months of 2012 to an operating loss of $125.6 million in the first nine months of 2013 and operating income as a percentage of net sales decreased to (9)% in the first nine months of 2013 from 23% in the same period of 2012. This decrease was driven by the decline in gross margin, which decreased to 4% for the first nine months of 2013 compared to 32% for the first nine months of 2012. As discussed and quantified above, our gross margin decreased primarily due to the effects of lower selling prices, higher manufacturing costs (primarily raw materials), higher sales volumes and lower unabsorbed fixed costs related to higher production volumes in 2013 over 2012.  Additionally, changes in currency exchange rates have negatively affected our gross margin and income from operations.  We estimate that changes in currency exchange rates decreased operating income by approximately $7 million in the first nine months of 2013 as compared to the same period in 2012.  Also included in our Chemicals Segment’s year-to-date 2013 operating loss is the $35 million third quarter litigation settlement charge.

Our Chemicals Segment’s operating income is net of amortization of purchase accounting adjustments made in conjunction with our acquisitions of interests in NL and Kronos. As a result, we recognize additional depreciation expense above the amounts Kronos reports separately, substantially all of which is included within cost of sales. We recognized additional depreciation expense of $1.9 million in each of the first nine months of 2012 and 2013 which reduced our reported Chemicals Segment operating income as compared to amounts reported by Kronos.

Currency Exchange Rates – Our Chemicals Segment has substantial operations and assets located outside the United States (primarily in Germany, Belgium, Norway and Canada). The majority of our sales generated from foreign operations are denominated in currencies other than the U.S. dollar, principally the euro, other major European currencies and the Canadian dollar. A portion of our sales generated from our foreign operations is denominated in the U.S. dollar. Certain raw materials used worldwide, primarily titanium-containing feedstocks, are purchased in U.S. dollars, while labor and other production costs are purchased primarily in local currencies. Consequently, the translated U.S. dollar value of our foreign sales and operating results are subject to currency exchange rate fluctuations which may favorably or unfavorably impact reported earnings and may affect the comparability of period-to-period operating results. In addition to the impact of the translation of sales and expenses over time, our foreign operations also generate currency transaction gains and losses which primarily relate to the difference between the currency exchange rates in effect when non-local currency sales or operating costs are initially accrued and when such amounts are settled with the non-local currency.

- 34 -

Overall, we estimate that fluctuations in currency exchange rates had the following effects on our Chemicals Segment’s net sales and operating income (loss) for the periods indicated:

Impact of changes in currency exchange rates

Three months ended September 30, 2013 vs. September 30, 2012

	Transaction gains /(losses) recognized							Translation gain - impact of rate changes		Total currency impact 2013 vs. 2012
	2012			2013		Change
	(In millions)
Impact on:
Net sales	$	—		$	—	$	—	$	12	$	12
Operating income		(1	)		—		1		—		1

Impact of changes in currency exchange rates

Nine months ended September 30, 2013 vs. September 30, 2012

	Transaction losses recognized								Translation gain (loss) - impact of rate changes			Total currency impact 2013 vs. 2012
	2012		2013			Change
	(In millions)
Impact on:
Net sales	$	—	$	—		$	—		$	10		$	10
Operating income		—		(1	)		(1	)		(6	)		(7	)

Outlook  – During the first nine months of 2013 we operated our Chemicals Segment’s production facilities at 88% of practical capacity, which was a higher utilization rate as compared to the last three quarters of 2012.  Assuming economic conditions do not deteriorate in the various regions of the world in the remainder of 2013, we would expect our sales volumes to continue to be higher in 2013 as compared to 2012.  We will continue to monitor current and anticipated near-term customer demand levels and align our production and inventories accordingly.

We have seen some moderation in the cost of TiO₂ feedstock ore procured in 2013; however, these reductions did not begin to be significantly reflected in our cost of sales until the third quarter of 2013.  As expected, our cost of sales per metric ton of TiO₂ sold in the third quarter of 2013 was lower than the cost of sales per metric ton of TiO₂ sold in the third quarter of 2012, primarily due to the lower feedstock ore costs, and our cost of sales per metric ton of TiO₂ sold in the fourth quarter of 2013 is similarly expected to be lower than the cost of sales per metric ton of TiO₂ sold in the fourth quarter of 2012.  Consequently, our cost of sales per metric ton of TiO₂ sold in the first half of 2013 was significantly higher than what we expect our cost of sales per metric ton of TiO₂ to be in the second half of 2013, as a substantial portion of the TiO₂ products we sold in the first half of 2013 was produced with the higher-cost feedstock ore procured in 2012.  Although the cost of feedstock ore has and continues to moderate, such reductions have been inadequate to compensate for the decline in selling prices for our products over the past year.  We started 2013 with selling prices 16% lower than the beginning of 2012, and prices declined by an additional 7% in the first quarter of 2013.  After only moderate movement in the second and third quarters of 2013, our average selling prices at the end of the third quarter are 7% below prices at the end of 2012.  In the second quarter of 2013, we announced price increases for our TiO₂ products in all of our markets, implementation of which began in June 2013.  In the third quarter of 2013, we notified customers of additional price increases to be implemented beginning in October 2013.  Industry data indicates that overall TiO₂ inventory held by producers has been significantly decreased and we believe most customers hold very low inventories of TiO₂ with many operating on a just-in-time basis.  As a result lead times for delivery are increasing.  With the strong sales volumes experienced in the first nine months of the year, we continue to see evidence of improvement in demand for our TiO₂ products, which we believe will support implementation of additional selling price increases in the near term.  The extent to which we will be able to achieve these and other possible additional price increases during the remainder of 2013 and into 2014 will depend on market conditions.

Overall, we expect that operating income in 2013 will be significantly lower as compared to 2012, but we also expect operating income in the fourth quarter of 2013 will improve from the quarterly levels in the first nine months of the year.  Our Chemicals Segment’s operating income in the first nine months of 2012 was positively affected by the sale in the first half of 2012 of TiO₂ produced with lower-cost feedstock ore purchased in 2011, while operating losses in the first nine months of 2013 were negatively impacted by the sale in the first half of 2013 of TiO₂ produced with higher-cost feedstock ore purchased in 2012, as well as the third quarter litigation settlement charge.  The negative effect of such higher-cost

- 35 -

feedstock ore and the legal settlement charge on our full year 2013 operating results is expected to more than offset any favorable effect of higher sales and production volumes that would result assuming demand levels continue to improve, as well as the favorable impact of increases in our selling prices that we may be able to achieve during the remainder of 2013.

Due to the constraints, high capital costs and extended lead time associated with adding significant new TiO₂ production capacity, especially for premium grades of TiO₂ products produced from the chloride process, we believe increased and sustained profit margins will be necessary to financially justify major expansions of TiO₂ production capacity required to meet expected future growth in demand.  As a result of customer decisions over the last year and the resulting adverse effect on global TiO₂ pricing, industry projects to increase TiO₂ production capacity have been cancelled or deferred indefinitely. Given the lead time required for such production capacity expansions, we expect a prolonged shortage of TiO₂ products will occur as economic conditions improve and global demand levels for TiO₂ continue to increase.

Our expectations as to the future of the TiO₂ industry are based upon a number of factors beyond our control, including worldwide growth of gross domestic product, competition in the marketplace, continued operation of competitors, unexpected or earlier-than-expected capacity additions or reductions and technological advances.  If actual developments differ materially from our expectations, our results of operations could be unfavorably affected.

Component Products – 

Our Component Products Segment’s product offerings consist of a significantly large number of products that have a wide variation in selling price and manufacturing cost, which results in certain practical limitations on our ability to quantify the impact of changes in individual product sales quantities and selling prices on our net sales, cost of goods sold and gross margin. In addition, small variations in period-to-period net sales, cost of goods sold and gross margin can result from changes in the relative mix of our products sold. The key performance indicator for our Component Products Segment is operating income margins.

	Three months ended September 30,									Nine months ended September 30,
	2012			2013			% Change			2012			2013			% Change
	(Dollars in millions)
Net sales	$	21.4		$	24.2			14	%	$	63.9		$	69.7			9	%
Cost of sales		15.1			16.7			12			45.1			48.6			8
Gross margin	$	6.3		$	7.5			19	%	$	18.8		$	21.1			12	%
Operating income	$	1.7		$	3.0			82	%	$	5.4		$	7.4			37	%
Percent of net sales:
Cost of sales		70	%		69	%					71	%		70	%
Gross margin		30			31						29			30
Operating income		8			12						8			11

Net Sales – Our Component Products Segment’s net sales increased 14% in the third quarter of 2013 compared to the same period of 2012 and increased 9% in the first nine months of 2013 compared to 2012 principally due to higher demand for high security pin tumbler locks within security products and to a lesser extent an increase in marine components sales outside of the high performance boat market (primarily ski/wakeboard towboat market) through gains in market share.  Sales of high security pin tumbler locks increased $2.5 million in the third quarter of 2013 and $5.3 million in the first nine months of 2013.  Growth of our security products business was aided by ongoing efforts to diversify our products and customers.

Cost of Sales – Our Component Products Segment’s cost of sales percentage decreased by 1% in the third quarter of 2013 compared to the same period in 2012 and 1% in the first nine months of 2013 compared to 2012. As a result, gross profit and related margin increased over the same periods.  The increase in gross margin is primarily due to the improved cost efficiencies from higher sales, partially offset by higher self-insurance medical expenses of $.1 million and $.3 million in the third quarter and first nine months of 2013, respectively.

Gross Margin and Operating Income – Gross margin increased by 19% and operating income increased by 82%  in the third quarter of 2013 compared to 2012 and increased 12% and 37%, respectively,  in the first nine months of 2013 compared to 2012 primarily due to the factors impacting cost of sales above.  Also favorably impacting our Component Products Segment’s operating income comparisons for 2013 was an asset held for sale write-down of $.4 million recognized in the

- 36 -

third quarter of 2012.   As a percentage of net sales, operating costs and expenses for the third quarter and first nine months of 2013 are comparable to the same periods in 2012.

Outlook  – Consistent with the current state of the North American economy, overall demand from our Component Products Segment’s customers continues to be subject to instability.  While we experienced a total increase in sales in the first nine months of 2013, this was the net result of sales growth in certain markets and flat or slightly decreased sales in other markets. As a result, we are uncertain as to the extent that total sales will continue to grow for the remainder of 2013 and into 2014. While changes in market demand are not within our control, we are focused on the areas we can impact. Staffing levels are continuously evaluated in relation to sales order rates which may result in headcount adjustments, to the extent possible, to match staffing levels with demand. We expect our continuous lean manufacturing and cost improvement initiatives to positively impact our productivity and result in a more efficient infrastructure. Additionally, we continue to seek opportunities to gain market share in markets we currently serve, to expand into new markets and to develop new product features in order to broaden our sales base and mitigate the impact of changes in demand.

Volatility in the costs of commodity raw materials is ongoing. Our primary commodity raw materials are zinc, brass and stainless steel, which together represent approximately 10% of our total cost of goods sold. We generally seek to mitigate the impact of fluctuations in commodity raw material costs on our margins through improvements in production efficiencies or other operating cost reductions. In the event we are unable to offset commodity raw material cost increases with other cost reductions, it may be difficult to recover those cost increases through increased product selling prices or surcharges due to the competitive nature of the markets served by our products. Consequently, overall operating margins may be negatively affected by commodity raw material cost pressures.

Waste Management – 

	Three months ended September 30,						Nine months ended September 30,
	2012			2013			2012			2013
	(In millions)
Net sales	$	14.5		$	4.9		$	16.5		$	29.9
Cost of sales		8.7			10.5			24.4			31.3
Gross margin	$	5.8		$	(5.6	)	$	(7.9	)	$	(1.4	)
Operating loss	$	(1.0	)	$	(10.3	)	$	(21.9	)	$	(16.3	)

General – We have operated our Waste Management Segment’s waste management facility on a relatively limited basis while we navigated the regulatory licensing and permitting requirements for the disposal of byproduct waste material and a broad range of LLRW and mixed LLRW. In May 2008, the TCEQ issued us a license for the disposal of byproduct material. Byproduct material includes uranium or thorium mill tailings as well as equipment, pipe and other materials used to handle and process the mill tailings. We began construction of the byproduct facility infrastructure at our site in Andrews County, Texas in the first quarter of 2008, and this facility began disposal operations in October 2009. In January 2009, the TCEQ issued a near-surface LLRW disposal license to us. This license was signed in September 2009. Construction of the Compact and Federal LLRW sites began in January 2011. The Compact LLRW site was fully certified and operational in April 2012, and the Federal LLRW site was fully certified and operational in September 2012 and received its first waste for disposal in the latter part of the second quarter of 2013.

Net Sales and Operating Loss – The Waste Management Segment’s sales increased significantly in the first nine months of 2013 compared to the same period of 2012, as we continued to accept shipments for disposal at our recently-completed Compact LLRW disposal facility and we received our first shipments for disposal in the Federal LLRW disposal facility in the latter part of the second quarter of 2013. The Waste Management Segment’s sales declined in the third quarter of 2013 compared to the same period in 2012 due to lower volumes of shipments received for disposal in the Compact LLRW disposal facility, as there has been an industry wide temporary shortage of shipping containers needed to transport LLRW.  We currently expect this issue to be resolved in early 2014; see below.  Our Waste Management Segment’s operating loss was lower in the first nine months of 2013 compared to the same period of 2012 due to our increased sales while our operating loss increased in the third quarter of 2013 compared to 2012 due to the lower disposal volumes noted above.  We recognized an operating loss in both periods of 2013 because we have not yet achieved sufficient revenues to offset the high cost structure associated with operating under our byproduct and LLRW disposal licenses relative to the waste treatment and disposal volume, in part because we did not receive LLRW for disposal in the Federal LLRW disposal facility until the latter part of the second quarter of 2013. We continue to seek to increase our Waste Management Segment’s sales volumes from waste streams permitted under our current licenses.

- 37 -

Outlook – Having obtained the final regulatory license needed to commence full scale operations, and with both of the Compact LLRW disposal facility and the Federal LLRW disposal facility certified and operational , we can now provide “one-stop shopping” for hazardous, toxic and LLRW and radioactive byproduct material. WCS has the broadest range of capabilities of any commercial enterprise in the U.S. for the storage, treatment and permanent disposal of these materials, which we believe gives WCS a significant and valuable competitive advantage in the industry. We are also exploring opportunities to obtain certain types of new business (including disposal and storage of certain other types of waste) that, if obtained, could increase our Waste Management Segment’s sales, and decrease our Waste Management Segment’s operating loss. Our ability to increase our Waste Management Segment’s sales volumes through these waste streams, particularly as it relates to the Compact and Federal LLRW disposal facilities, together with improved operating efficiencies through further cost reductions and increased capacity utilization, are important factors in improving our Waste Management operating results and cash flows. We have obtained long-term disposal contracts with several waste generators and are actively pursuing additional contracts. While achieving increased sales volumes could result in operating profits, we currently do not believe we will report any significant levels of Waste Management operating profit until we have started to generate revenues sufficient to cover the high fixed costs of operating our disposal facilities. We received a national disposal contract for our Federal LLRW disposal facility in April 2013. The contract is for a period of five years and up to $300 million; however, tasks awarded under the contract to date have been for smaller volume waste streams. We have regularly received small volumes of waste for disposal since the end of the second quarter of 2013 for the Federal LLRW disposal facility, but it may be difficult for us to generate positive operating results until we begin routinely receiving large Federal LLRW streams for disposal.   In the near term we have been limited in the volume of waste we can receive for disposal due to the shortage of shipping containers needed to transport LLRW.   We have a contract to purchase additional shipping containers, expected to be delivered in early 2014, which we believe will resolve our transportation issues.

We believe WCS can become a viable, profitable operation; however, we do not know if we will be successful in improving WCS’ cash flows. We have in the past, and we may in the future, consider strategic alternatives with respect to WCS. We could report a loss in any such strategic transaction.

General Corporate Items, Other Items, Interest Expense, Income Taxes and Noncontrolling Interest—2013 Compared to 2012

Interest and Dividend Income – A significant portion of our interest and dividend income in both 2013 and 2012 relates to the distributions we received from The Amalgamated Sugar Company LLC. We recognized dividend income from the LLC of $6.3 million and $19.0 million in each of the third quarters and first nine months of 2012 and 2013, respectively.

Insurance Recoveries – Insurance recoveries relate to amounts NL received from certain of its former insurance carriers, and relate principally to the recovery of prior lead pigment and asbestos litigation defense costs incurred by NL. NL has agreements with certain former insurance carriers pursuant to which the carriers reimburse NL for a portion of its future lead pigment litigation defense costs, and one such carrier reimburses NL for a portion of its future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by NL because of certain issues that arise regarding which defense costs qualify for reimbursement.

Litigation Settlement Gain – In May 2012, we reported a $14.7 million pre-tax gain related to the third and final closing associated with certain real property NL formerly owned in New Jersey.  Please refer to our 2012 Annual Report for a discussion of such gain.

Corporate Expenses and Other Items, Net – Corporate expenses were 31% higher at $10.1 million in the third quarter of 2013 compared to $7.9 million in the same period in 2012, primarily due to higher litigation and related costs at NL in the third quarter of 2013. Corporate expenses were 11% higher at $41.4 million in the first nine months of 2013 compared to $37.4 million in the same period in 2012. Included in corporate expense are:

· litigation and related costs at NL of $3.9 million in the third quarter of 2013 compared to $1.6 million in third quarter of 2012, and $8.1 million in first nine months of 2013 compared to $5.6 million in first nine months of 2012, and

· environmental remediation and related credit of $.3 million in the third quarter of 2013 compared to costs of $.2 million in third quarter of 2012, and costs of $12.7 million in the first nine months of 2013 compared to $14.2 million in first nine months of 2012.

The level of our litigation and related costs varies from period to period depending upon, among other things, the number of cases in which we are currently involved, the nature of such cases and the current stage of such cases (e.g. discovery, pre-trial motions, trial or appeal, if applicable). See Note 16 to our Condensed Consolidated Financial Statements.

- 38 -

Obligations associated with environmental remediation and related matters are difficult to assess and estimate, and it is possible that actual costs will exceed accrued amounts or that costs will be incurred in the future for sites in which we cannot currently estimate our liability. If these events were to occur in the remainder of 2013, our corporate expenses would be higher than we currently estimate. In addition, we adjust our accruals for environmental remediation and related matters as further information becomes available to us or as circumstances change. Further information or changed circumstances could result in an increase or reduction in our accrued costs. See Note 16 to our Condensed Consolidated Financial Statements.

Overall, we currently expect that our net general corporate expenses in 2013 will be higher than 2012. If our current expectations regarding the number of cases or sites in which we expect to be involved during 2013, or if the nature of such cases or sites were to change, our corporate expenses could be higher than we currently estimate and involve amounts that are material.

Loss on Prepayment of Debt and Interest Expense – We recognized an aggregate $8.9 million pre-tax charge, consisting of the write-off of unamortized original issue discount costs and deferred financing costs, in the first and third quarters of 2013 related to the voluntary prepayment of our Chemicals Segment’s term loan by $290 million in the first quarter of 2013 and the remaining $100 million in the third quarter of 2013.  In June 2012, our Chemicals Segment entered into a new $400 million term loan. Our Chemicals Segment used a portion of the net proceeds of the term loan to redeem the remaining outstanding 6.5% Senior Secured Notes due April 2013 (€279.2 million principal amount outstanding). As a result, we recognized an aggregate $7.2 million pre-tax charge in the second quarter of 2012 related to the early extinguishment of debt, consisting of the call premium paid, interest from the June 14, 2012 indenture discharge date to the July 20, 2012 redemption date and the write-off of unamortized deferred financing costs and original issue discount associated with the redeemed Senior Notes. See Note 10 to our Condensed Consolidated Financial Statements.

Interest expense decreased to $13.7 million in the third quarter of 2013 from $14.6 million in the third quarter of 2012 primarily due to lower average debt balances at Kronos and CompX partially offset by interest expense on the Valhi credit facility.  Interest expense increased to $43.8 million in the first nine months of 2013 compared to $42.4 million in the first nine months of 2012 primarily due to the refinancing of a Valhi credit facility. During substantially all of 2012, Valhi had a credit facility with borrowings from Kronos, and interest expense associated with Valhi’s borrowings from Kronos was eliminated in consolidation. In December 2012, Valhi repaid the Kronos facility with borrowings under a similar facility from Contran. Interest expense on Valhi’s credit facility with Contran was approximately $1.8 million and $5.2 million for the third quarter and first nine months of 2013, respectively.

Income Tax Expense (Benefit) – Our tax rate varies as the contribution of income from our business units change. We had an income tax benefit of $18.9 million and $3.0 million in the third quarters of 2013 and 2012, respectively.  Our income tax benefit in the third quarter of 2012 includes an incremental tax benefit of $11.1 million as we determined in the third quarter that due to global changes in our Chemicals Segment’s business we would not remit certain dividends from our foreign jurisdictions.  As a result, certain Chemicals Segment tax attributes were available for carryback to offset prior year tax expense.   We had an income tax benefit of $68.0 million in the first nine months of 2013 compared to an income tax provision of $89.7 million in the first nine months of 2012, primarily due to operating losses during the third quarter and first nine months of 2013 compared to operating income in the third quarter and first nine months of 2012.

We have substantial net operating loss carryforwards in Germany (the equivalent of $744 million and $100 million for German corporate and trade tax purposes, respectively, at December 31, 2012). At September 30, 2013, we have concluded that no deferred income tax asset valuation allowance is required to be recognized with respect to such carryforwards, principally because (i) such carryforwards have an indefinite carryforward period, (ii) we have utilized a portion of such carryforwards during the most recent three-year period and (iii) we currently expect to utilize the remainder of such carryforwards over the long term. However, prior to the complete utilization of such carryforwards, particularly if we were to generate losses in our German operations for an extended period of time, it is possible that we might conclude the benefit of such carryforwards would no longer meet the more-likely-than-not recognition criteria, at which point we would be required to recognize a valuation allowance against some or all of the then-remaining tax benefit associated with the carryforwards.

See Note 13 to our Condensed Consolidated Financial Statements for more information about our 2013 income tax items and a tabular reconciliation of our statutory tax expense to our actual tax expense.

Noncontrolling Interest in Net Income (Loss) of Subsidiaries – Noncontrolling interest in net loss was $6.7 million in the third quarter of 2013, compared to noncontrolling interest in net income of $8.9 million in the same period of 2012. Noncontrolling interest in net loss was $24.0 million in the first nine months of 2013, compared to noncontrolling interest in net income of $56.7 million in the same period of 2012. The decrease is primarily due to an operating loss of Kronos in the third quarter and first nine months of 2013 compared to operating income in the same periods of 2012.

- 39 -

LIQUIDITY AND CAPITAL RESOURCES

Consolidated Cash Flows

Operating Activities—

Trends in cash flows from operating activities (excluding the impact of significant asset dispositions and relative changes in assets and liabilities) are generally similar to trends in our earnings.

Cash flows from operating activities improved from $46.2 million cash provided by operations in the first nine months of 2012 to $48.4 million in the first nine months of 2013. This $2.2 million net improvement in the amount of cash from operations was primarily due to the net effects of the following items:

· consolidated operating loss in the first nine months of 2013 of $134.5 million, a $482.1 million decline compared to operating income of $347.6 million in the first nine months of 2012;

· a $392.9 million reduction in the amount of net cash used in relative changes in receivables, inventories, payables and accrued liabilities in 2013, primarily due to the relative changes in Kronos’ inventories as discussed below;

· higher net distributions from our TiO₂ manufacturing joint venture in 2013 of $34.1 million, primarily due to the timing of the joint venture’s working capital needs;

· lower net cash paid for income taxes in 2013 of $48.4 million resulting from our decreased profitability; and

· lower cash paid for interest in 2013 of $8.8 million, primarily due to the call premium paid on Kronos’ Senior Secured Notes redeemed in June 2012 and lower average debt balances.

As shown below, changes in working capital were affected by accounts receivable and inventory changes.

· Kronos’ average days sales outstanding (“DSO”) increased from December 31, 2012 to September 30, 2013 due to higher average net sales resulting from higher sales volumes partially offset by lower selling prices.

· Kronos’ average days sales in inventory (“DSI”) decreased from December 31, 2012 to September 30, 2013 principally due to lower inventory raw material costs and lower inventory volumes in 2013.

· CompX’s average DSO was flat from December 31, 2012 to September 30, 2013 and is in line with our expectations.

· CompX’s average DSI decreased from December 31, 2012 to September 30, 2013 and is in line with our expectations.

For comparative purposes, we have also provided comparable prior period numbers below.

	December 31, 2011		September 30, 2012		December 31, 2012		September 30, 2013
Kronos:
Days sales outstanding		55 days		60 days		61 days		67 days
Days sales in inventory		104 days		79 days		102 days		57 days
CompX:
Days sales outstanding		40 days		41 days		40 days		40 days
Days sales in inventory		83 days		69 days		74 days		70 days

- 40 -

We do not have complete access to the cash flows of our majority-owned subsidiaries, due in part to limitations contained in certain credit agreements of our subsidiaries and because we do not own 100% of these subsidiaries. A detail of our consolidated cash flows from operating activities is presented in the table below. Intercompany dividends have been eliminated.

	Nine months ended September 30,
	2012			2013
	(In millions)
Cash provided by (used in) operating activities:
Valhi exclusive of subsidiaries	$	53.5		$	50.2
Kronos		57.2			60.5
NL exclusive of its subsidiaries		5.0			15.5
CompX		6.4			(7.9	)
WCS		(13.8	)		(9.1	)
Tremont		.3			(1.0	)
Other		(.4	)		(.4	)
Eliminations		(62.0	)		(59.4	)
Total	$	46.2		$	48.4

Investing Activities – 

We spent $54.4 million in capital expenditures during the first nine months of 2013 including:

· $49.9 million in our Chemicals Segment;

· $2.6 million in our Component Products Segment; and

· $1.9 million in our Waste Management Segment.

Our Waste Management Segment also had $.6 million in expenditures for capitalized permit costs.

During the first nine months of 2013 we had net sales of $2.6 million of marketable securities, collected $3.0 million on a note receivable and had proceeds of $1.6 million from the disposal of assets held for sale.

Financing Activities—

During the nine months ended September 30, 2013, we:

· voluntarily prepaid $390.0 million principal amount of Kronos’ term loan;

· borrowed $190.0 million under Kronos’ new note payable to Contran, and subsequently repaid $15.0 million;  

· borrowed $90.3 million under Kronos’ North American credit facility and subsequently repaid $44.1 million;

· borrowed €10 million ($12.8 million when borrowed) on Kronos’ European credit facility and subsequently repaid €20 million ($26.5 million when repaid);

· borrowed $1.8 million from a Canadian economic development agency;

· prepaid $18.5 million remaining principal amount under CompX’s promissory note payable to Timet Finance Management Company;

· borrowed a net $15.9 million on Valhi’s credit facility with Contran; and

· paid quarterly dividends to Valhi stockholders aggregating $.15 per share ($50.9 million).

Distributions to noncontrolling interest in subsidiaries in the first nine months of 2013 are primarily comprised of CompX dividends paid to shareholders other than NL, NL dividends paid to shareholders other than us and Kronos dividends paid to shareholders other than us and NL.

- 41 -

Outstanding Debt Obligations

At September 30, 2013, our consolidated indebtedness was comprised of:

· Valhi’s $250 million loan from Snake River Sugar Company due in 2027;

· Valhi’s $173.5 million outstanding on its $225 million credit facility with Contran which is due no earlier than December 31, 2014;

· $175.0 million under Kronos’ note payable to Contran due in June 2018;

· $46.2 million under Kronos’ North American credit facility which matures in June 2017

· WCS’ financing capital lease with Andrews County, Texas ($68.9 million outstanding) which has an effective interest rate of 7.0% and is due in monthly installments through August 2035;

· WCS’ two 6.0% promissory notes ($7.3 million outstanding) due in 2013 through 2014; and

· approximately $10.4 million of other indebtedness, primarily capital lease obligations.

Certain of our credit facilities require the respective borrowers to maintain minimum levels of equity, require the maintenance of certain financial ratios, limit dividends and additional indebtedness and contain other provisions and restrictive covenants customary in lending transactions of this type.  Kronos’ European revolving credit facility also requires the maintenance of certain financial ratios.  Certain of our credit agreements also contain provisions which could result in the acceleration of indebtedness prior to their stated maturity for reasons other than defaults for failure to comply with typical financial or payment covenants. For example, certain credit agreements allow the lender to accelerate the maturity of the indebtedness upon a change of control (as defined in the agreement) of the borrower. In addition, certain credit agreements could result in the acceleration of all or a portion of the indebtedness following a sale of assets outside the ordinary course of business. We are in compliance with all of our debt covenants at September 30, 2013. We believe we will be able to continue to comply with the financial covenants contained in all of our credit facilities through the maturity of the respective facilities; however if future operating results differ materially from our expectations we may be unable to maintain compliance. In such an event, we believe we have alternate sources of liquidity, including cash on hand and borrowings under Kronos’ North American revolver or additional borrowings from Contran (neither of which contain any financial maintenance covenants) in order to adequately address any compliance issues which might arise. See Note 10 to our Condensed Consolidated Financial Statements.

Future Cash Requirements

Liquidity – 

Our primary source of liquidity on an ongoing basis is our cash flows from operating activities and borrowings under various lines of credit and notes. We generally use these amounts to (i) fund capital expenditures, (ii) repay short-term indebtedness incurred primarily for working capital purposes and (iii) provide for the payment of dividends (including dividends paid to us by our subsidiaries) or treasury stock purchases. From time-to-time we will incur indebtedness, generally to (i) fund short-term working capital needs, (ii) refinance existing indebtedness, (iii) make investments in marketable and other securities (including the acquisition of securities issued by our subsidiaries and affiliates) or (iv) fund major capital expenditures or the acquisition of other assets outside the ordinary course of business. Occasionally we sell assets outside the ordinary course of business, and we generally use the proceeds to (i) repay existing indebtedness (including indebtedness which may have been collateralized by the assets sold), (ii) make investments in marketable and other securities, (iii) fund major capital expenditures or the acquisition of other assets outside the ordinary course of business or (iv) pay dividends.

We routinely compare our liquidity requirements and alternative uses of capital against the estimated future cash flows we expect to receive from our subsidiaries, and the estimated sales value of those units. As a result of this process, we have in the past sought, and may in the future seek, to raise additional capital, refinance or restructure indebtedness, repurchase indebtedness in the market or otherwise, modify our dividend policies, consider the sale of our interests in our subsidiaries, affiliates, business units, marketable securities or other assets, or take a combination of these and other steps, to increase liquidity, reduce indebtedness and fund future activities. Such activities have in the past and may in the future involve related companies. From time to time, we and our subsidiaries may enter into intercompany loans as a cash management tool. Such notes are structured as revolving demand notes and pay and receive interest on terms we believe are generally more favorable than current debt and investment market rates. The companies that borrow under these notes have sufficient borrowing

- 42 -

capacity to repay the notes at any time upon demand. All of these notes and related interest expense and income are eliminated in our Condensed Consolidated Financial Statements.

We periodically evaluate acquisitions of interests in or combinations with companies (including our affiliates) that may or may not be engaged in businesses related to our current businesses. We intend to consider such acquisition activities in the future and, in connection with this activity, may consider issuing additional equity securities and increasing indebtedness. From time to time, we also evaluate the restructuring of ownership interests among our respective subsidiaries and related companies.

Based upon our expectations of our operating performance, and the anticipated demands on our cash resources, we expect to have sufficient liquidity to meet our short term obligations (defined as the twelve-month period ending September 30, 2014) and our long-term obligations (defined as the five-year period ending September 30, 2018, our time period for long-term budgeting). In this regard, see the discussion above in “Outstanding Debt Obligations.” If actual developments differ from our expectations, our liquidity could be adversely affected.

At September 30, 2013, we had credit available under existing facilities of approximately $140.5 million, which was comprised of:

· $56.6 million under Kronos’ North American revolving credit facility;

· $32.4⁽¹⁾  million under Kronos’ European credit facility; and

· $51.5⁽²⁾ million under Valhi’s Contran credit facility.

⁽¹⁾ Kronos’ European revolving credit facility (of which the full €120 million ($161.9 million) is undrawn at September 30, 2013) requires the maintenance of certain financial ratios.  Based on the current earnings before income tax, interest, depreciation and amortization expense of the borrowers, Kronos would not meet the financial test if it had any net debt outstanding under this facility, and accordingly our effective available borrowing under this facility at September 30, 2013 is approximately $32.4 million, the aggregate amount of cash held by the borrowers, net of the borrowers’ other outstanding indebtedness.  We are in discussions with the lender to amend the facility to modify such financial ratio covenant, but there is no assurance that we would be able to obtain an amendment to the facility to modify the covenant.  However, we do not currently anticipate the need to draw on this facility for the foreseeable future. 

⁽²⁾ Amounts available under this facility are at the sole discretion of Contran.

We could borrow all of the amounts noted above without violating any covenants of the credit facilities.

At September 30, 2013, we had an aggregate of $148.4 million of restricted and unrestricted cash, cash equivalents and marketable securities, including $64.0 million held by our non-U.S. subsidiaries. A detail by entity is presented in the table below.

	Total		Amount held outside U.S.
	(In millions)
Kronos	$	68.9	$	64.0
CompX		36.6		—
NL exclusive of its subsidiaries		20.6		—
WCS		13.3		—
Tremont		8.8		—
Valhi exclusive of its subsidiaries		.2		—
Total restricted and unrestricted cash, cash equivalents and marketable securities	$	148.4	$	64.0

Capital Expenditures – 

We currently expect our aggregate capital expenditures for 2013 will be approximately $75 million as follows:

· $65 million by our Chemicals Segment;

· $4 million by our Component Products Segment; and

- 43 -

· $6 million by our Waste Management Segment.

The WCS amount includes approximately $1 million in capitalized operating permit costs. Capital spending for 2013 is expected to be funded through cash generated from operations and borrowings from existing credit facilities.

Planned capital expenditures in 2013 at Kronos and CompX will primarily be to maintain and improve the cost-effectiveness of our facilities. A significant portion of the increase in our Component Products Segment’s expected capital expenditures for 2013 relates to the implementation of new manufacturing and accounting systems.

Repurchases of Common Stock – 

We, Kronos and CompX have programs to repurchase common stock from time to time as market conditions permit. These stock repurchase programs do not include specific price targets or timetables and may be suspended at any time. Depending on market conditions, these programs may be terminated prior to completion. Cash on hand will be used to acquire the shares and repurchased shares will be added to treasury shares and cancelled.   

At September 30, 2013 Valhi had approximately 4.0 million shares of our common stock available to repurchase under the authorizations made by our board of directors.

In December 2010, Kronos’ board of directors authorized the repurchase of up to 2.0 million shares of its common stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices and over an unspecified period of time.  In the third quarter of 2013 Kronos repurchased approximately 49,000 shares for an aggregate of $.7 million under its repurchase program.  The third quarter purchases are the only purchases Kronos has made to date under the plan and at September 30, 2013 approximately 1.95 million shares are available for repurchase.

CompX’s board of directors authorized the repurchase of its Class A common stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices and over an unspecified period of time. At September 30, 2013 approximately 678,000 shares were available for purchase under these authorizations.

Dividends – 

Because our operations are conducted primarily through subsidiaries and affiliates, our long-term ability to meet parent company level corporate obligations is largely dependent on the receipt of dividends or other distributions from our subsidiaries and affiliates. If Kronos pays its regular dividend of $.15 per share in each quarter of 2013, based on the 58.0 million shares we held of Kronos common stock at September 30, 2013, we would receive aggregate annual regular dividends from Kronos of $34.8 million. NL’s current quarterly cash dividend is $.125 per share. If NL pays its regular quarterly dividends in cash, based on the 40.4 million shares we held of NL common stock at September 30, 2013, we would receive aggregate annual dividends from NL of $20.2 million. We do not expect to receive any distributions from WCS during 2013. All of our ownership interest in CompX is held through our ownership in NL, as such we do not receive any dividends from CompX. Instead any dividend CompX declares is paid to NL.

Our subsidiaries have various credit agreements with unrelated third-party lenders which contain customary limitations on the payment of dividends, typically a percentage of net income or cash flow; however, these restrictions in the past have not significantly impacted their ability to pay dividends.

Investment in our Subsidiaries and Affiliates and Other Acquisitions – 

We have in the past, and may in the future, purchase the securities of our subsidiaries and affiliates or third parties in market or privately-negotiated transactions. We base our purchase decision on a variety of factors, including an analysis of the optimal use of our capital, taking into account the market value of the securities and the relative value of expected returns on alternative investments. In connection with these activities, we may consider issuing additional equity securities or increasing our indebtedness. We may also evaluate the restructuring of ownership interests of our businesses among our subsidiaries and related companies.

We generally do not guarantee any indebtedness or other obligations of our subsidiaries or affiliates. Our subsidiaries are not required to pay us dividends. If one or more of our subsidiaries were unable to maintain its current level of dividends, either due to restrictions contained in a credit agreement or to satisfy its liabilities or otherwise, our ability to service our liabilities or to pay dividends on our common stock could be adversely impacted. If this were to occur, we might consider reducing or eliminating our dividends or selling interests in subsidiaries or other assets. If we were required to liquidate assets

- 44 -

to generate funds to satisfy our liabilities, we might be required to sell at what we believe would be less than the long-term value of such assets.

WCS’ primary source of liquidity currently consists of intercompany borrowings from one of our wholly-owned subsidiaries under the terms of a revolving credit facility. We eliminate these intercompany borrowings in our Consolidated Financial Statements. It is probable WCS will borrow additional amounts from us during 2013 under the terms of the revolving credit facility. At September 30, 2013, WCS had $13 million outstanding and could borrow an additional $27 million under this facility, which matures in March 2014.

We have an unsecured revolving demand promissory note with NL whereby, as amended, we agreed to loan NL up to $40 million. We also eliminate any such intercompany borrowings in our Consolidated Financial Statements. At September 30, 2013, NL had no balance outstanding and could borrow an additional $40 million under this facility, which as amended matures no earlier than June 30, 2014 and no later than December 31, 2014. Our obligation to loan NL money under this note is at our discretion.

We have an unsecured revolving credit facility with Kronos which, as amended, provides for borrowings from Kronos of up to $100 million. We also eliminate any such intercompany borrowings in our Consolidated Financial Statements. At September 30, 2013 we had no balance outstanding and could borrow an additional $100 million under this facility, which, as amended is due on demand, but in any event no earlier than December 31, 2014. Kronos’ obligation to lend money to us under this note is at Kronos’ discretion.

Investment in The Amalgamated Sugar Company LLC – 

The terms of The Amalgamated Sugar Company LLC Company Agreement provide for an annual “base level” of cash dividend distributions (sometimes referred to as distributable cash) by the LLC of $26.7 million, from which we are entitled to a 95% preferential share. Distributions from the LLC are dependent, in part, upon the operations of the LLC. We record dividend distributions from the LLC as income when they are declared by the LLC, which is generally the same month in which we receive the distributions, although distributions may in certain cases be paid on the first business day of the following month. To the extent the LLC’s distributable cash is below this base level in any given year, we are entitled to an additional 95% preferential share of any future annual LLC distributable cash in excess of the base level until such shortfall is recovered. Based on the LLC’s current projections for 2013, we expect distributions received from the LLC in 2013 will exceed our debt service requirements under our $250 million loans from Snake River Sugar Company by approximately $1.8 million.

We may, at our option, require the LLC to redeem our interest in the LLC and the LLC has the right to redeem our interest in the LLC beginning in 2027. The redemption price is generally $250 million plus the amount of certain undistributed income allocable to us, if any. In the event we require the LLC to redeem our interest in the LLC, Snake River has the right to accelerate the maturity of and call our $250 aggregate million loans from Snake River. Redemption of our interest in the LLC would result in us reporting income related to the disposition of our LLC interest for income tax purposes, although we would not be expected to report a gain in earnings for financial reporting purposes at the time our LLC interest is redeemed. However, because of Snake River’s ability to call our $250 million loans from Snake River upon redemption of our interest in the LLC, the net cash proceeds (after repayment of the debt) generated by the redemption of our interest in the LLC could be less than the income taxes that we would be required to pay as a result of the disposition.

Off-balance Sheet Financing

We do not have any off-balance sheet financing agreements other than the operating leases discussed in our 2012 Annual Report.

Commitments and Contingencies

There have been no material changes in our contractual obligations since we filed our 2012 Annual Report (other than the prepayment Kronos’ of term loan and of CompX’s outstanding promissory note payable to TIMET in July 2013, as discussed above), and we refer you to that report for a complete description of these commitments.

We are subject to certain commitments and contingencies, as more fully described in Notes 12 and 17 to our 2012 Annual Report, or in Notes 13 and 16 to our Condensed Consolidated Financial Statements and in Part II, Item 1 of this Quarterly Report, including:

· certain income tax examinations which are underway in various U.S. and non-U.S. jurisdictions;

- 45 -

· certain environmental remediation matters involving NL, Tremont and Valhi;

· certain litigation related to NL’s former involvement in the manufacture of lead pigment and lead-based paint; and

· certain other litigation to which we are a party.

In addition to such legal proceedings various legislation and administrative regulations have, from time to time, been proposed that seek to (i) impose various obligations on present and former manufacturers of lead pigment and lead-based paint (including NL) with respect to asserted health concerns associated with the use of such products and (ii) effectively overturn court decisions in which NL and other pigment manufacturers have been successful. Examples of such proposed legislation include bills which would permit civil liability for damages on the basis of market share, rather than requiring plaintiffs to prove that the defendant’s product caused the alleged damage, and bills which would revive actions barred by the statute of limitations. While no legislation or regulations have been enacted to date that are expected to have a material adverse effect on our consolidated financial position, results of operations or liquidity, enactment of such legislation could have such an effect.

Recent Accounting Pronouncements

None

Critical Accounting Policies

There have been no changes in the first nine months of 2013 with respect to our critical accounting policies presented in Management’s Discussion and Analysis of Financial Condition and Results of Operation in our 2012 Annual Report.

   

- 46 -

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk, including currency exchange rates, interest rates and security prices, and raw material prices. There have been no material changes in these market risks since we filed our 2012 Annual Report, and refer you to Part I, Item 7A.—“Quantitative and Qualitative Disclosure About Market Risk” in our 2012 Annual Report. See also Note 17 to our Condensed Consolidated Financial Statements.

We have substantial operations located outside the United States for which the functional currency is not the U.S. dollar. As a result, our assets and liabilities, results of operations and cash flows will fluctuate based upon changes in currency exchange rates.

We periodically use currency forward contracts to manage a nominal portion of currency exchange rate market risk associated with trade receivables, or similar exchange rate risk associated with future sales, denominated in a currency other than the holder’s functional currency. These contracts generally relate to our Chemicals operations. We have not entered into these contracts for trading or speculative purposes in the past, nor do we currently anticipate entering into such contracts for trading or speculative purposes in the future. Some of the currency forward contracts we enter into meet the criteria for hedge accounting under GAAP and are designated as cash flow hedges. For these currency forward contracts, gains and losses representing the effective portion of our hedges are deferred as a component of accumulated other comprehensive income, and are subsequently recognized in earnings at the time the hedged item affects earnings. For the currency forward contracts we enter into which do not meet the criteria for hedge accounting, we mark-to-market the estimated fair value of such contracts at each balance sheet date, with any resulting gain or loss recognized in income currently as part of net currency transactions. See Note 17 to our Condensed Consolidated Financial Statements.

ITEM  4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures – 

We maintain a system of disclosure controls and procedures. The term “disclosure controls and procedures,” as defined by Exchange Act Rule 13a-15(e), means controls and other procedures that are designed to ensure that information required to be disclosed in the reports we file or submit to the SEC under the Securities Exchange Act of 1934, as amended (the “Act”), is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports we file or submit to the SEC under the Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions to be made regarding required disclosure. Each of Steven L. Watson, our President and Chief Executive Officer, and Bobby D. O’Brien, our Vice President and Chief Financial Officer, have evaluated the design and operating effectiveness of our disclosure controls and procedures as of September 30, 2013. Based upon their evaluation, these executive officers have concluded that our disclosure controls and procedures were effective as of September 30, 2013.

Internal Control Over Financial Reporting – 

We also maintain internal control over financial reporting. The term “internal control over financial reporting,” as defined by regulations of the SEC, means a process designed by, or under the supervision of, our principal executive and principal financial officers, or persons performing similar functions, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, and includes those policies and procedures that:

· pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of our assets,

· provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are made only in accordance with authorizations of our management and directors, and

· provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our Condensed Consolidated Financial Statements.

- 47 -

As permitted by the SEC, our assessment of internal control over financial reporting excludes (i) internal control over financial reporting of our equity method investees and (ii) internal control over the preparation of our financial statement schedules required by Article 12 of Regulation S-X. However, our assessment of internal control over financial reporting with respect to our equity method investees did include our controls over the recording of amounts related to our investment that are recorded in our Condensed Consolidated Financial Statements, including controls over the selection of accounting methods for our investments, the recognition of equity method earnings and losses and the determination, valuation and recording of our investment account balances.

Changes in Internal Control Over Financial Reporting – 

There has been no change to our internal control over financial reporting during the quarter ended September 30, 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

- 48 -

Part II. OTHER INFORMATION

Item 1. Legal Proceedings.

In addition to the matters discussed below and in Note 16 to our Condensed Consolidated Financial Statements, please refer to Note 17 to our Consolidated Financial Statements included in our 2012 Annual Report and to Note 16 to our Condensed Consolidated Financial Statements included in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2013 and June 30, 2013.

County of Santa Clara v. Atlantic Richfield Company, et al. (Superior Court of the State of California, County of Santa Clara, Case No. 1-00-CV-788657).  In July and August 2013, the case was tried. In September 2013, Proposed Statement of Decision briefs were filed by the parties followed by oral arguments with a tentative Statement of Decision to be issued by the  judge within 90 days thereafter.

Lewis, et al. v. Lead Industries Association, et al.  (Circuit Court of Cook County, Illinois, County Department, Chancery Division, Case No. 00CH09800). In October 2013, the judge denied plaintiffs’ motion to vacate the decertification of the class but set a status conference for November 2013 to see if the plaintiffs have a plan to cure the decertification.

Circuit Court Cases in Milwaukee County, Wisconsin.  In July 2013, the plaintiff in Burton moved to amend his complaint to add a request for declaratory judgment that the new Wisconsin statute is unconstitutional and NL responded asking for the stay to remain in place. In September 2013, the U.S. 7^th Circuit Court of Appeals in Gibson sought and received briefing on whether the new Wisconsin statute is applicable in this case and whether the Court should decide its constitutionality before addressing the original Eastern Enterprises question.

Bullock, et al. v. Weed Property Management, LLC., et al (District of Oklahoma County, Oklahoma, Case No. CJ-2011-8912).  In July 2013, the plaintiffs dismissed their case against NL and one other defendant.

Unilateral Administrative Order with Doe Run, formerly-owned mine/mill in Park Hills, Missouri. Doe Run is completing the remainder of the construction work not completed in 2012. A Removal Action Report and Post-Removal Site Control plan will be submitted to the EPA after completion of the work which is expected in the first half of 2014.

New Jersey Department of Environmental Protection v. Occidental Chemical Corp., et al. (L-009868-05, Superior Court of New Jersey, Essex County).  In August 2013, NL entered into a settlement agreement with Third-Party Plaintiffs.  This settlement agreement concludes the matter.

Los Angeles Unified School District v. Pozas Brothers Trucking Co., et al. (Los Angeles Superior Court, Central Civil West, LASC Case No. BC 391342).  In August 2013, NL entered into a settlement agreement with the plaintiff, which was entered with and approved by the court.   This settlement agreement concludes the matter.

Item 1A. Risk Factors.

For a discussion of the risk factors related to our businesses, please refer to Part I, Item 1A, “Risk Factors,” in our 2012 Annual report. There have been no material changes to such risk factors during the first nine months of 2013.

- 49 -

Item 6. Exhibits.

Item No.	Exhibit Index
31.1	Certification
31.2	Certification
32.1	Certification
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase

- 50 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		VALHI, INC.
		(Registrant)
Date	November 8, 2013	/s/ Bobby D. O’Brien
		Bobby D. O’Brien (Vice President and Chief Financial Officer)
Date	November 8, 2013	/s/ Gregory M. Swalwell
		Gregory M. Swalwell (Vice President and Controller, Principal Accounting Officer)

   

- 51 -

EX-31

Exhibit 31.1

I, Steven L. Watson, certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Valhi, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2013

/s/ Steven L. Watson

Steven L. Watson

President and Chief Executive Officer

   

EX-31

Exhibit 31.2

I, Bobby D. O’Brien, certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Valhi, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8 , 2013

/s/  Bobby D. O’Brien

Bobby D. O’Brien

Vice President and Chief Financial Officer

       

EX-32

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Valhi, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Steven L. Watson, President and Chief Executive Officer of the Company, and I Bobby D. O’Brien, Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Steven L. Watson	/s/ Bobby D. O’Brien
Steven L. Watson	Bobby D. O’Brien
President and Chief Executive Officer	Vice President and Chief Financial Officer
November 8, 2013	November 8, 2013

Note: The certification the registrant furnishes in this exhibit is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Registration Statements or other documents filed with the Securities and Exchange Commission shall not incorporate this exhibit by reference, except as otherwise expressly stated in such filing.

   

XML

Employee Benefit Plans

9 Months Ended

Sep. 30, 2013

Employee Benefit Plans

Note 11 —Employee benefit plans:

Defined benefit plans – The components of our net periodic defined benefit pension cost are presented in the table below.

	Threemonthsended September30,						Ninemonthsended September30,
	2012			2013				2012			2013
	(In millions)
Service cost	$	2.5		$	3.2			$	7.7		$	9.7
Interest cost		6.2			6.0				19.1			17.9
Expected return on plan assets		(5.5	)		(5.8	)			(16.5	)		(17.8	)
Amortization of unrecognized:
Prior service cost		.4			.4				1.2			1.2
Net transition obligations		.1			.1				.3			.3
Recognized actuarial losses		2.3			3.4				6.9			10.2
Total	$	6.0		$	7.3			$	18.7		$	21.5

Other postretirement benefits – The components of our net periodic other postretirement benefit cost are presented in the table below.

	Threemonthsended September30,							Ninemonthsended September30,
	2012			2013				2012				2013
	(In millions)							(In millions)
Service cost	$	.1			$	.1			$	.2			$	.3
Interest cost		.1				.3				.6				.5
Amortization of prior service credit		(.5	)			(.5	)			(1.4	)			(1.4	)
Recognized actuarial losses		.1				—				.1				.1
Total	$	(.2	)		$	(.1	)		$	(.5	)		$	(.5	)

Contributions – We expect to contribute the equivalent of $28.5 million and $1.6 million, respectively, to all of our defined benefit pension plans and other postretirement benefit plans during 2013.

XML

Other Noncurrent Liabilities - Other Noncurrent Liabilities (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Other Liabilities Disclosure [Abstract]
Reserve for uncertain tax positions	$ 41.4	$ 29.4
Asset retirement obligations	25.1	23.8
Insurance claims and expenses	9.8	9.7
Employee benefits	10.9	11.3
Deferred income	1.0	1.0
Other	3.1	3.1
Total	$ 91.3	$ 78.3

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net income (loss)	$ (40.9)	$ 31.8	$ (137.7)	$ 212.9
Other comprehensive income (loss), net of tax:
Currency translation	21.7	39.9	(0.4)	16.6
Marketable securities	13.0	6.1	15.0	(22.8)
Total other comprehensive income (loss), net	37.1	47.7	21.8	(1.2)
Comprehensive income (loss)	(3.8)	79.5	(115.9)	211.7
Comprehensive income (loss) attributable to noncontrolling interest	10.7	19.1	(8.4)	45.5
Comprehensive income (loss) attributable to Valhi stockholders	(14.5)	60.4	(107.5)	166.2
Defined Benefit Pension Plans
Other comprehensive income (loss), net of tax:
Pension and other postretirement benefit plan	2.7	2.0	8.1	5.9
OPEB
Other comprehensive income (loss), net of tax:
Pension and other postretirement benefit plan	$ (0.3)	$ (0.3)	$ (0.9)	$ (0.9)

XML

Marketable Securities

9 Months Ended

Sep. 30, 2013

Marketable Securities

Note 4—Marketable securities:

	Market value		Cost basis			Unrealized gains, net
	(In millions)
December31, 2012:
Current assets:	$	.9		$	.9		$	—
Noncurrent assets:
The Amalgamated Sugar Company LLC	$	250.0		$	250.0		$	—
Other		6.8			6.7			.1
Total	$	256.8		$	256.7		$	.1
September30, 2013:
Current assets	$	1.6		$	1.6		$	—
Noncurrent assets:
The Amalgamated Sugar Company LLC	$	250.0		$	250.0		$	—
Other		3.6			3.6			—
Total	$	253.6		$	253.6		$	—

All of our marketable securities are accounted for as available-for-sale, which are carried at fair value, with any unrealized gains or losses recognized through accumulated other comprehensive income. Our marketable securities are carried at fair value using quoted market prices, primarily Level 1 inputs as defined by Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, except for our investment in The Amalgamated Sugar Company LLC (“Amalgamated”). Our current marketable securities are included with “other current assets” on our Condensed Consolidated Balance Sheets. Our investment in Amalgamated is measured using significant unobservable inputs, which are Level 3 inputs. Please refer to Note 4 in our 2012 Annual Report for a complete description of the valuation methodology for our investment in Amalgamated. There have been no changes to the carrying value of this investment during the periods presented. See Note 17.

XML

Organization and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2013

Organization

Organization—We are majority owned by Contran Corporation and one of its subsidiaries, which own approximately 94% of our outstanding common stock at September30, 2013. Substantially all of Contran’s outstanding voting stock is held by trusts established for the benefit of certain children and grandchildren of Harold C. Simmons (for which Mr.Simmons is the sole trustee) or is held directly by Mr.Simmons or other persons or entities related to Mr.Simmons. Consequently, Mr.Simmons may be deemed to control Contran and us.

Basis of Presentation

Basis of Presentation—Consolidated in this Quarterly Report are the results of our majority-owned and wholly-owned subsidiaries, including NL Industries, Inc., Kronos Worldwide, Inc., CompX International Inc., Tremont LLC and Waste Control Specialists LLC (“WCS”). Kronos (NYSE: KRO), NL (NYSE: NL), and CompX (NYSE MKT: CIX) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December31, 2012 that we filed with the SEC on March15, 2013 (the “2012 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December31, 2012 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December31, 2012) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Our results of operations for the interim periods ended September30, 2013 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2012 Consolidated Financial Statements contained in our 2012 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Valhi, Inc and its subsidiaries (NYSE: VHI), taken as a whole.

XML

Noncontrolling Interest in Subsidiaries - Noncontrolling Interest in Subsidiaries (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Noncontrolling interest in net assets:
Noncontrolling interest in subsidiaries	$ 335.9	$ 358.1
Kronos Worldwide, Inc.
Noncontrolling interest in net assets:
Noncontrolling interest in subsidiaries	239.1	267.0
NL
Noncontrolling interest in net assets:
Noncontrolling interest in subsidiaries	83.3	77.8
CompX
Noncontrolling interest in net assets:
Noncontrolling interest in subsidiaries	$ 13.5	$ 13.3

XML

Long-Term Debt - Kronos Term Loan - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended		7 Months Ended	1 Months Ended		3 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Jul. 30, 2013 Kronos Worldwide, Inc. Term Loan	Jul. 31, 2013 Kronos Worldwide, Inc. Term Loan Principal Prepayment	Feb. 28, 2013 Kronos Worldwide, Inc. Term Loan Principal Prepayment	Sep. 30, 2013 Kronos Worldwide, Inc. Term Loan Principal Prepayment
Debt Instrument [Line Items]
Payment of Principal Amount					$ 100	$ 290
Pre Tax Interest Charge	(2.3)	(8.9)	(7.2)			6.6	2.3
Cash used for payment of term loan					50	100
Borrowing from Contran for prepayment of term loan						$ 190
Percentage of average interest rate, during period				6.80%

XML

Other income, net

9 Months Ended

Sep. 30, 2013

Other income, net

Note 12 —Other income, net:

	Ninemonthsended September30,
	2012			2013
	(In millions)
Securities earnings:
Dividends and interest	$	21.3			$	19.7
Securities transactions, net		.2				.2
Total		21.5				19.9
Equity in earnings of investees		(.1	)			(.9	)
Currency transactions, net		(.5	)			(1.5	)
Insurance recoveries		2.6				3.8
Litigation settlement gain		14.7				—
Other, net		1.2				.5
Total	$	39.4			$	21.8

Insurance recoveries reflect, in part, amounts we received from certain of our former insurance carriers and relate to the recovery of prior lead pigment and asbestos litigation defense costs incurred by NL.

In May 2012, we recognized a $14.7 million pre-tax gain related to the third and final closing associated with certain real property formerly owned by NL in New Jersey, based on the excess of the $15.6 million cash proceeds received over the carrying value of the property.  See Note 15 to our 2012 Annual Report. 

XML

Accounts and Other Receivables, Net - Components of Accounts and Other Receivables (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Trade accounts receivable:
VAT and other receivables	$ 40.4	$ 42.2
Refundable income taxes	6.1	18.3
Allowance for doubtful accounts	(1.4)	(1.5)
Total	352.0	302.5
Contran | trade items
Trade accounts receivable:
Receivable from affiliates: Contran - trade items	0.2	0.3
Kronos Worldwide, Inc.
Trade accounts receivable:
Accounts receivable	276.5	229.7
CompX
Trade accounts receivable:
Accounts receivable	10.8	8.7
WCS
Trade accounts receivable:
Accounts receivable	1.3	4.8
Lpc | trade items
Trade accounts receivable:
Receivable from affiliates: LPC - trade items	$ 18.1

XML

Long-Term Debt - Note Payable to Contran - Additional Information (Detail) (Kronos Worldwide, Inc., Contran, USD $) In Millions, unless otherwise specified	1 Months Ended	9 Months Ended
	Feb. 28, 2013	Sep. 30, 2013
Debt Instrument [Line Items]
Promissory Note, maximum capacity	$ 290.0
Payment of Principal Amount		$ 5.0
Percentage of average interest rate, during period		7.375%
Percentage of average interest rate		7.375%
Term loan maturity date	Jun. 30, 2018
LIBOR
Debt Instrument [Line Items]
Interest rate terms		(with LIBOR no less than 1%) plus 5.125%,
Debt instrument interest rate		5.125%
Base Rate
Debt Instrument [Line Items]
Interest rate terms		rate (as defined in the agreement) plus 4.125%.
Debt instrument interest rate		4.125%

XML

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of Changes in Accumulated Other Comprehensive Income

Changes in accumulated other comprehensive loss attributable to Valhi stockholders for the three and nine months ended September30, 2012 and 2013 are presented in the table below, net of related deferred income taxes.

	Threemonthsended September30,						Ninemonthsended September30,
	2012			2013				2012			2013
	(In millions)
Accumulated other comprehensive income (loss), net of tax:
Marketable securities:
Balance at beginning of period	$	(5.6	)	$	1.9			$	6.4		$	2.1
Other comprehensive income (loss) – unrealized gains (losses) during the year		5.4			1.0				(6.6	)		.8
Balance at end of period	$	(.2	)	$	2.9			$	(.2	)	$	2.9
Currency translation adjustment:
Balance at beginning of period	$	19.5		$	36.3			$	37.5		$	53.3
Other comprehensive income (loss)		30.8			16.9				12.8			(.1	)
Balance at end of period	$	50.3		$	53.2			$	50.3		$	53.2
Defined benefit pension plans:
Balance at beginning of period	$	(69.6	)	$	(97.3	)		$	(72.6	)	$	(101.5	)
Other comprehensive income— amortization of prior service cost and net losses included in net periodic pension cost		1.5			2.1				4.5			6.3
Balance at end of period	$	(68.1	)	$	(95.2	)		$	(68.1	)	$	(95.2	)
OPEB plans:
Balance at beginning of period	$	4.9		$	3.6			$	5.4		$	4.1
Other comprehensive loss – amortization of prior service credit		(.3	)		(.3	)			(.8	)		(.8	)
Balance at end of period	$	4.6		$	3.3			$	4.6		$	3.3
Total accumulated other comprehensive loss:
Balance at beginning of period	$	(50.8	)	$	(55.5	)		$	(23.3	)	$	(42.0	)
Other comprehensive income		37.4			19.7				9.9			6.2
Balance at end of period	$	(13.4	)	$	(35.8	)		$	(13.4	)	$	(35.8	)

XML

Marketable Securities (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of Marketable Securities

	Market value		Cost basis			Unrealized gains, net
	(In millions)
December31, 2012:
Current assets:	$	.9		$	.9		$	—
Noncurrent assets:
The Amalgamated Sugar Company LLC	$	250.0		$	250.0		$	—
Other		6.8			6.7			.1
Total	$	256.8		$	256.7		$	.1
September30, 2013:
Current assets	$	1.6		$	1.6		$	—
Noncurrent assets:
The Amalgamated Sugar Company LLC	$	250.0		$	250.0		$	—
Other		3.6			3.6			—
Total	$	253.6		$	253.6		$	—

XML

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of Condensed Income Statement

Selected financial data for the operations of the disposed furniture components business is presented below:

	Threemonthsended September30, 2012		Nine monthsended September30, 2012
	(In millions)
Income statement:
Net sales	$	15.8	$	46.4
Operating income	$	2.7	$	5.8
Income from discontinued operations:
Income before taxes	$	2.7	$	5.7
Income tax expense		.9		2.4
Income from discontinued operations, net of tax		1.8		3.3
Noncontrolling interest in income from discontinued operations		.6		1.0
Total discontinued operations, net of tax and noncontrolling interest	$	1.2	$	2.3

XML

Discontinued Operations - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Cash collected on notes receivable			$ 3.0
CompX | Taiwan Land
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Promissory note receivable				3.0
Cash collected on notes receivable	$ 1.2	$ 1.8	$ 3.0

XML

Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2013

Defined Benefit Pension Plans

Components of Net Periodic Defined Benefit Cost

Defined benefit plans – The components of our net periodic defined benefit pension cost are presented in the table below.

	Threemonthsended September30,						Ninemonthsended September30,
	2012			2013				2012			2013
	(In millions)
Service cost	$	2.5		$	3.2			$	7.7		$	9.7
Interest cost		6.2			6.0				19.1			17.9
Expected return on plan assets		(5.5	)		(5.8	)			(16.5	)		(17.8	)
Amortization of unrecognized:
Prior service cost		.4			.4				1.2			1.2
Net transition obligations		.1			.1				.3			.3
Recognized actuarial losses		2.3			3.4				6.9			10.2
Total	$	6.0		$	7.3			$	18.7		$	21.5

OPEB

Components of Net Periodic Defined Benefit Cost

Other postretirement benefits – The components of our net periodic other postretirement benefit cost are presented in the table below.

	Threemonthsended September30,							Ninemonthsended September30,
	2012			2013				2012				2013
	(In millions)							(In millions)
Service cost	$	.1			$	.1			$	.2			$	.3
Interest cost		.1				.3				.6				.5
Amortization of prior service credit		(.5	)			(.5	)			(1.4	)			(1.4	)
Recognized actuarial losses		.1				—				.1				.1
Total	$	(.2	)		$	(.1	)		$	(.5	)		$	(.5	)

XML

Fair Value Measurements and Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Marketable Securities and Financial Instruments on Fair Value Basis

The following table summarizes the valuation of our marketable securities, financial instruments and other items recorded on a fair value basis as of:

	Fair Value Measurements
	Total			Quoted Pricesin Active Markets (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In millions)
Asset (liability)
December31, 2012:
Marketable securities:
Current	$	.9		$	—		$	.9	$	—
Noncurrent		256.8			3.5			3.3		250.0
Currency forward contracts		1.8			1.8			—		—
September30, 2013:
Marketable securities:
Current	$	1.6		$	—		$	1.6	$	—
Noncurrent		253.6			—			3.6		250.0
Currency forward contracts		(.5	)		(.5	)		—		—

Financial Instruments not Carried at Fair Value

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

	December31, 2012					September30,2013
	Carrying amount		Fair value		Carrying amount			Fair value
	(In millions)
Cash, cash equivalents and restricted cash equivalents	$	395.9	$	395.9	$		143.4	$	143.4
Long-term debt (excluding capitalized leases):
Kronos note payable to Contran	$	—	$	—	$		175.0	$	175.0
Kronos term loan		384.5		396.8			—		—
Snake River Sugar Company fixed rate loans		250.0		250.0			250.0		250.0
WCS fixed rate debt		77.1		77.1			76.2		76.2
Valhi credit facility with Contran		157.6		157.6			173.5		173.5
Kronos variable rate bank credit facilities		13.2		13.2			46.2		46.2
CompX variable rate promissory note		18.5		18.5			—		—
Noncontrolling interest in:
Kronos common stock	$	267.0	$	442.6	$		239.1	$	350.9
NL common stock		77.8		94.8			83.3		94.0
CompX common stock		13.3		23.4			13.5		21.3
Valhi stockholders’ equity	$	733.6	$	4,238.9	$		574.9	$	6,768.8

XML

Inventories, Net - Inventories, Net (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Components Of Inventory [Line Items]
Raw materials	$ 73.3	$ 154.8
Work in process	24.8	33.2
Finished products	240.0	397.7
Inventories, net	407.1	650.3
Chemicals
Components Of Inventory [Line Items]
Raw materials	69.3	151.5
Work in process	18.1	27.3
Finished products	237.8	395.6
Supplies	69.0	64.6
Component products
Components Of Inventory [Line Items]
Raw materials	4.0	3.3
Work in process	6.7	5.9
Finished products	$ 2.2	$ 2.1

XML

Accounts Payable and Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of Accounts Payable and Accrued Liabilities

	December31, 2012		September30, 2013
	(In millions)
Accounts payable	$	169.6		$	126.4
Payable to affiliates:
Contran – income taxes, net		2.6			3.1
Contran – trade items		26.8			26.4
LPC – trade items		23.4			19.5
Employee benefits		38.5			37.4
Accrued litigation settlement		—			35.0
Accrued sales discounts and rebates		14.9			15.0
Environmental remediation and related costs		7.6			6.4
Deferred income		5.4			3.7
Reserve for uncertain tax positions		3.0			3.1
Other		42.8			55.7
Total	$	334.6		$	331.7

XML

Income Taxes - Component of Income Taxes Expenses (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Tax Expenses [Line Items]
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$ (21.0)	$ 9.5	$ (72.0)	$ 104.8
Incremental tax (benefit) on earnings of non-U.S. companies	1.3	(12.8)	(3.4)	(7.1)
Non-U.S. tax rates	0.8	(0.7)	3.3	(12.4)
Adjustment to the reserve for uncertain tax positions, net	0.6	0.3	2.3	1.7
Nondeductible expenses	0.5	0.8	3.1	3.0
U.S. state income taxes and other, net	(1.1)	(0.1)	(1.3)	(0.3)
Income tax expense (benefit)	(18.9)	(3.0)	(68.0)	89.7
Comprehensive provision for income taxes (benefit) allocable to:
Continuing operations	(18.9)	(3.0)	(68.0)	89.7
Discontinued operations		0.9		2.4
Other comprehensive income (loss), net of tax:
Marketable securities	6.3	3.2	7.5	(12.8)
Currency translation	4.1	4.4	2.8	2.7
Total	(7.5)	6.1	(54.6)	84.0
Defined Benefit Pension Plans
Other comprehensive income (loss), net of tax:
Defined benefit plans	1.2	0.8	3.6	2.5
OPEB
Other comprehensive income (loss), net of tax:
Defined benefit plans	$ (0.2)	$ (0.2)	$ (0.5)	$ (0.5)

XML

Commitments and Contingencies - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013 Cases
Other Environmental Cleanup Matters
Commitments And Contingent Liabilities [Line Items]
Accrual for reasonably estimable environmental remediation and related matters	$ 2.0
NL
Commitments And Contingent Liabilities [Line Items]
Number of cases settled and dismissed and found not liable	100
Period by which loss contingency claims settled and dismissed	20 years
NL | Pending Claims | Product Liability And Occupational Exposure Litigation Claims
Commitments And Contingent Liabilities [Line Items]
Cases pending	1,130
Number of plaintiffs involved	1,643
NL | Administratively Dismissed Claims | Product Liability And Occupational Exposure Litigation Claims
Commitments And Contingent Liabilities [Line Items]
Number of plaintiffs involved	8,298
NL | Environmental Remediation Sites Nl Named As Prp Or Defendant
Commitments And Contingent Liabilities [Line Items]
Accrual for reasonably estimable environmental remediation and related matters	58.0
Number of sites associated with remediation ad related costs	50
Upper end range, estimate costs for remediation and related matters	154
Number of sites for which NL not currently able to estimate costs	5
Kronos Worldwide, Inc.
Commitments And Contingent Liabilities [Line Items]
Case conclusion settlement amount	$ 35

XML

Other income, net - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2012
Disclosure Other Income Net Additional Information Detail [Line Items]
Litigation settlement gain	$ 14.7
Real estate-related litigation settlement	15.6
NL | Certain Real Property Litigation Settlement
Disclosure Other Income Net Additional Information Detail [Line Items]
Litigation settlement gain	14.7
Real estate-related litigation settlement	$ 15.6

XML

Business Segment Information - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Segment Reporting Information [Line Items]
Litigation settlement	$ 35	$ 35
Kronos Worldwide, Inc.
Segment Reporting Information [Line Items]
Direct controlling interest in subsidiary	50.00%	50.00%
Indirect controlling interest in subsidiary	30.00%	30.00%
Total controlling interest	80.00%	80.00%
Kronos Worldwide, Inc. | Contran
Segment Reporting Information [Line Items]
Common stock pledged as collateral	12.0	12.0
NL
Segment Reporting Information [Line Items]
Total controlling interest	83.00%	83.00%

XML

Noncontrolling Interest in Subsidiaries - Changes in Ownership Interest in Subsidiaries (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]
Net income (loss) attributable to Valhi stockholders	$ (34.2)	$ 22.9	$ (113.7)	$ 156.2
Transfers from noncontrolling interest — Issuance of subsidiaries’ common stock			(0.3)
Net income (loss) attributable to Valhi stockholders and change from noncontrolling interest in subsidiaries			$ (114.0)	$ 156.2

XML

Business Segment Information (Tables)

9 Months Ended

Sep. 30, 2013

Holding Percentage of Subsidiaries

Business segment	Entity	%controlledat September30, 2013
Chemicals	Kronos		80	%
Component products	CompX		87	%
Waste management	WCS		100	%

Segment Operating Performance

	Threemonthsended September30,						Nine months ended September30,
	2012			2013				2012			2013
	(In millions)
Net sales:
Chemicals	$	472.9		$	419.1			$	1,579.5		$	1,363.8
Component products		21.4			24.2				63.9			69.7
Waste management		14.5			4.9				16.5			29.9
Total net sales	$	508.8		$	448.2			$	1,659.9		$	1,463.4
Cost of sales:
Chemicals	$	387.5		$	372.4			$	1,070.5		$	1,304.8
Component products		15.1			16.7				45.1			48.6
Waste management		8.7			10.5				24.4			31.3
Total cost of sales	$	411.3		$	399.6			$	1,140.0		$	1,384.7
Gross margin:
Chemicals	$	85.4		$	46.7			$	509.0		$	59.0
Component products		6.3			7.5				18.8			21.1
Waste management		5.8			(5.6	)			(7.9	)		(1.4	)
Total gross margin	$	97.5		$	48.6			$	519.9		$	78.7
Operating income (loss):
Chemicals	$	40.4		$	(35.2	)		$	364.1		$	(125.6	)
Component products		1.7			3.0				5.4			7.4
Waste management		(1.0	)		(10.3	)			(21.9	)		(16.3	)
Total operating income (loss)		41.1			(42.5	)			347.6			(134.5	)
Equity in earnings of investees		(.1	)		—				(.1	)		(.8	)
General corporate items:
Securities earnings		7.3			6.6				21.5			19.9
Insurance recoveries		1.2			2.2				2.6			3.8
Litigation settlement gain		—			—				14.7			—
Loss on prepayment of debt		—			(2.3	)			(7.2	)		(8.9	)
General expenses, net		(7.9	)		(10.1	)			(37.4	)		(41.4	)
Interest expense		(14.6	)		(13.7	)			(42.4	)		(43.8	)
Income (loss) from continuing operations before income taxes	$	27.0		$	(59.8	)		$	299.3		$	(205.7	)

XML

CONDENSED CONSOLIDATED STATEMENT OF EQUITY (USD $) In Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained earnings (deficit)	Accumulated other comprehensive income (loss)	Treasury Stock	Non-controlling interest
Balance at Dec. 31, 2012	$ 1,091.7	$ 667.3	$ 3.6	$ 78.9	$ 75.4	$ (42.0)	$ (49.6)	$ 358.1
Net loss	(137.7)				(113.7)			(24.0)
Other comprehensive income, net	21.8					6.2		15.6
Cash dividends	(64.6)			(33.9)	(17.0)			(13.7)
Issuance of common stock and other, net	(0.4)			(0.3)				(0.1)
Balance at Sep. 30, 2013	$ 910.8	$ 667.3	$ 3.6	$ 44.7	$ (55.3)	$ (35.8)	$ (49.6)	$ 335.9

XML

Business Segment Information

9 Months Ended

Sep. 30, 2013

Business Segment Information

Note 2—Business segment information:

Business segment	Entity	%controlledat September30, 2013
Chemicals	Kronos		80	%
Component products	CompX		87	%
Waste management	WCS		100	%

Our control of Kronos includes 50% we hold directly and 30% held directly by NL. We own 83% of NL. Our control of CompX is through NL. At September 30, 2013 we had an aggregate of 12.0million shares of our Kronos common stock pledged as collateral for certain debt obligations of Contran.  We receive a fee from Contran for pledging these Kronos shares, determined by a formula based on the market value of the shares pledged.

	Threemonthsended September30,						Nine months ended September30,
	2012			2013				2012			2013
	(In millions)
Net sales:
Chemicals	$	472.9		$	419.1			$	1,579.5		$	1,363.8
Component products		21.4			24.2				63.9			69.7
Waste management		14.5			4.9				16.5			29.9
Total net sales	$	508.8		$	448.2			$	1,659.9		$	1,463.4
Cost of sales:
Chemicals	$	387.5		$	372.4			$	1,070.5		$	1,304.8
Component products		15.1			16.7				45.1			48.6
Waste management		8.7			10.5				24.4			31.3
Total cost of sales	$	411.3		$	399.6			$	1,140.0		$	1,384.7
Gross margin:
Chemicals	$	85.4		$	46.7			$	509.0		$	59.0
Component products		6.3			7.5				18.8			21.1
Waste management		5.8			(5.6	)			(7.9	)		(1.4	)
Total gross margin	$	97.5		$	48.6			$	519.9		$	78.7
Operating income (loss):
Chemicals	$	40.4		$	(35.2	)		$	364.1		$	(125.6	)
Component products		1.7			3.0				5.4			7.4
Waste management		(1.0	)		(10.3	)			(21.9	)		(16.3	)
Total operating income (loss)		41.1			(42.5	)			347.6			(134.5	)
Equity in earnings of investees		(.1	)		—				(.1	)		(.8	)
General corporate items:
Securities earnings		7.3			6.6				21.5			19.9
Insurance recoveries		1.2			2.2				2.6			3.8
Litigation settlement gain		—			—				14.7			—
Loss on prepayment of debt		—			(2.3	)			(7.2	)		(8.9	)
General expenses, net		(7.9	)		(10.1	)			(37.4	)		(41.4	)
Interest expense		(14.6	)		(13.7	)			(42.4	)		(43.8	)
Income (loss) from continuing operations before income taxes	$	27.0		$	(59.8	)		$	299.3		$	(205.7	)

Segment results we report may differ from amounts separately reported by our various subsidiaries and affiliates due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material.  The operating loss of our Chemicals Segment for the third quarter and first nine months of 2013 includes a $35 million charge related to a litigation settlement, see Note 16.

XML

Accounts and Other Receivables, Net

9 Months Ended

Sep. 30, 2013

Accounts and Other Receivables, Net

Note 5—Accounts and other receivables, net:

	December31, 2012			September30, 2013
	(In millions)
Trade accounts receivable:
Kronos	$	229.7			$	276.5
CompX		8.7				10.8
WCS		4.8				1.3
VAT and other receivables		42.2				40.4
Refundable income taxes		18.3				6.1
Receivable from affiliate:
Contran – trade items		.3				.2
LPC – trade items		—				18.1
Allowance for doubtful accounts		(1.5	)			(1.4	)
Total	$	302.5			$	352.0

XML

Fair Value Measurements and Financial Instruments - Marketable Securities and Financial Instruments on Fair Value Basis (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Current	$ 1.6	$ 0.9
Noncurrent	253.6	256.8
Currency forward contracts	(0.5)	1.8
Quoted Prices in Active Markets (Level 1)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Current
Noncurrent		3.5
Currency forward contracts	(0.5)	1.8
Significant Other Observable Inputs (Level 2)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Current	1.6	0.9
Noncurrent	3.6	3.3
Currency forward contracts
Significant Unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Current
Noncurrent	250.0	250.0
Currency forward contracts

XML

Discontinued Operations

9 Months Ended

Sep. 30, 2013

Discontinued Operations

Note 3—Discontinued operations:

On December28, 2012, CompX completed the sale of its furniture components operations to a competitor of that business. Please refer to Note 3 to our 2012 Annual Report for a complete description of the transaction.

Selected financial data for the operations of the disposed furniture components business is presented below:

	Threemonthsended September30, 2012		Nine monthsended September30, 2012
	(In millions)
Income statement:
Net sales	$	15.8	$	46.4
Operating income	$	2.7	$	5.8
Income from discontinued operations:
Income before taxes	$	2.7	$	5.7
Income tax expense		.9		2.4
Income from discontinued operations, net of tax		1.8		3.3
Noncontrolling interest in income from discontinued operations		.6		1.0
Total discontinued operations, net of tax and noncontrolling interest	$	1.2	$	2.3

In accordance with generally accepted accounting principles, the assets and liabilities relating to the furniture components reporting unit were eliminated from the 2012 Consolidated Balance Sheet at the date of sale. We have reclassified our Condensed Consolidated Statements of Operations for the interim periods ended September 30, 2012 to reflect the disposed operations as discontinued operations. We have not reclassified our September30, 2012 Condensed Consolidated Statement of Cash Flows to reflect discontinued operations.

In conjunction with the sale of CompX’s furniture components reporting unit, the buyer was not interested in retaining certain undeveloped land located in Taiwan owned by CompX’s Taiwanese Furniture Component subsidiary. We had no additional use for the undeveloped land in Taiwan and therefore expected the land to be sold to a third party with CompX receiving the net proceeds. Based on the legal form of how we completed the disposal transaction, our interest in the land was represented by a $3.0 million promissory note receivable at December31, 2012, issued to CompX by its former Taiwanese subsidiary which retained legal ownership in the land to facilitate the future sale of the land to a third party. The proceeds from a future sale of the land were required to be used to settle the note receivable. During the first quarter of 2013, an agreement was entered into with a third party to sell the land for $3.0 million, $1.8 million of which was received during the first quarter and the remaining $1.2 million was received in the second quarter of 2013. Such note receivable was classified as part of other current assets in our Consolidated Balance Sheet at December31, 2012.

XML

Organization and Basis of Presentation - Additional Information (Detail) (Contran)	Sep. 30, 2013
Contran
Basis Of Presentation And Significant Accounting Policies [Line Items]
Controlling interest in subsidiary	94.00%

XML

Accounts and Other Receivables, Net (Tables)

9 Months Ended

Sep. 30, 2013

Components of Accounts and Other Receivables

	December31, 2012			September30, 2013
	(In millions)
Trade accounts receivable:
Kronos	$	229.7			$	276.5
CompX		8.7				10.8
WCS		4.8				1.3
VAT and other receivables		42.2				40.4
Refundable income taxes		18.3				6.1
Receivable from affiliate:
Contran – trade items		.3				.2
LPC – trade items		—				18.1
Allowance for doubtful accounts		(1.5	)			(1.4	)
Total	$	302.5			$	352.0

XML

Other Noncurrent Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Other Noncurrent Liabilities

	December31, 2012		September30, 2013
	(In millions)
Reserve for uncertain tax positions	$	29.4		$	41.4
Asset retirement obligations		23.8			25.1
Insurance claims and expenses		9.7			9.8
Employee benefits		11.3			10.9
Deferred income		1.0			1.0
Other		3.1			3.1
Total	$	78.3		$	91.3

XML

Commitments and Contingencies - Changes in Accrued Environmental Remediation and Related Costs (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Commitments And Contingent Liabilities [Line Items]
Balance at the beginning of the year	$ 50.2
Additions charged to expense, net	12.7
Payments, net	(2.8)
Changes in currency exchange rates	(0.1)
Balance at the end of period	60.0
Amounts recognized in our Condensed Consolidated Balance Sheet at the end of the period:
Current liabilities	6.4	7.6
Accrued environmental remediation and related costs	53.6	42.6
Total	$ 60.0

XML

Noncontrolling Interest in Subsidiaries (Tables)

9 Months Ended

Sep. 30, 2013

Noncontrolling Interest in Net Assets of Subsidiaries

	December31, 2012		September30, 2013
	(In millions)
Noncontrolling interest in net assets:
Kronos	$	267.0	$	239.1
NL		77.8		83.3
CompX		13.3		13.5
Total	$	358.1	$	335.9

Noncontrolling Interest in Net Income (loss) of Subsidiaries

	Ninemonthsended September30,
	2012		2013
	(In millions)
Noncontrolling interest in net income (loss) of subsidiaries:
Kronos	$	46.2	$	(20.8	)
NL		9.7		(3.8	)
CompX		.8		.6
Total	$	56.7	$	(24.0	)

Changes In Ownership Interest In Subsidiaries

The changes in our ownership interest in our subsidiaries and the effect on our equity is as follows:

	Ninemonthsended September30,
	2012		2013
	(In millions)
Net income (loss) attributable to Valhi stockholders	$	156.2	$	(113.7	)
Transfers from noncontrolling interest — Issuance of subsidiaries’ common stock		—		(.3	)
Net income (loss) attributable to Valhi stockholders and change from noncontrolling interest in subsidiaries	$	156.2	$	(114.0	)

XML

Accumulated Other Comprehensive Loss - Schedule of Changes in Accumulated Other Comprehensive Income (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Accumulated Comprehensive Income Loss [Line Items]
Marketable securities, Balance at beginning of year	$ 1.9	$ (5.6)	$ 2.1	$ 6.4
Marketable securities, Unrealized gain (loss) arising during the year	1.0	5.4	0.8	(6.6)
Marketable securities, Balance at end of year	2.9	(0.2)	2.9	(0.2)
Currency translation adjustment, Balance at beginning of year	36.3	19.5	53.3	37.5
Other comprehensive income (loss)	16.9	30.8	(0.1)	12.8
Currency translation adjustment, Balance at end of year	53.2	50.3	53.2	50.3
Balance at beginning of period	(55.5)	(50.8)	(42.0)	(23.3)
Total other comprehensive income (loss), net	19.7	37.4	6.2	9.9
Balance at end of period	(35.8)	(13.4)	(35.8)	(13.4)
Defined Benefit Pension Plans
Accumulated Comprehensive Income Loss [Line Items]
Balance at beginning of year	(97.3)	(69.6)	(101.5)	(72.6)
Pension and other postretirement benefit plan	2.1	1.5	6.3	4.5
Balance at end of year	(95.2)	(68.1)	(95.2)	(68.1)
OPEB
Accumulated Comprehensive Income Loss [Line Items]
Balance at beginning of year	3.6	4.9	4.1	5.4
Balance at end of year	3.3	4.6	3.3	4.6
Amortization of prior service credit	$ (0.3)	$ (0.3)	$ (0.8)	$ (0.8)

XML

Long-Term Debt - Valhi Contran Credit Facility - Additional Information (Detail) (Contran, Line of Credit, USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Contran | Line of Credit
Line Of Credit Facility [Line Items]
Net borrowings	$ 15.9
Percentage of average interest rate	4.25%
Percentage of average interest rate, during period	4.25%
Amount available for borrowing	$ 51.5

XML

Other Noncurrent Assets - Other Noncurrent Assets (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Other Noncurrent Assets [Line Items]
Investment in affiliates	$ 121.3	$ 126.1
Other assets:
Restricted cash	22.4	20.9
Deferred financing costs	2.6	7.0
IBNR receivables	7.0	6.7
Capital lease deposit	6.2	6.2
Pension asset	5.8	5.1
Assets held for sale	1.1	2.6
Other	68.0	46.9
Total	174.6	161.1
TiO2 manufacturing joint venture, Louisiana Pigment Company, L.P. (“LPC”)
Other Noncurrent Assets [Line Items]
Investment in affiliates	105.9	109.9
Other
Other Noncurrent Assets [Line Items]
Investment in affiliates	15.4	16.2
Capitalized Operating Permits
Other assets:
Waste disposal site operating permits, net	$ 61.5	$ 65.7

XML

Discontinued Operations - Schedule of Condensed Income Statement (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2012
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Income from discontinued operations, net of tax	$ 1.8	$ 3.3
Compx Furniture Components
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Net sales	15.8	46.4
Operating income	2.7	5.8
Income before taxes	2.7	5.7
Income tax expense	0.9	2.4
Income from discontinued operations, net of tax	1.8	3.3
Noncontrolling interest in income from discontinued operations	0.6	1.0
Compx Furniture Components | Net of Noncontrolling Interest
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Total discontinued operations, net of tax and noncontrolling interest	$ 1.2	$ 2.3

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues and other income:
Net sales	$ 448.2	$ 508.8	$ 1,463.4	$ 1,659.9
Other income, net	8.7	7.6	21.8	39.4
Total revenues and other income	456.9	516.4	1,485.2	1,699.3
Costs and expenses:
Cost of sales	399.6	411.3	1,384.7	1,140.0
Selling, general and administrative	101.1	63.1	253.5	210.0
Loss on prepayment of debt	2.3		8.9	7.2
Assets held for sale write-down		0.4		0.4
Interest	13.7	14.6	43.8	42.4
Total costs and expenses	516.7	489.4	1,690.9	1,400.0
Income (loss) from continuing operations before income taxes	(59.8)	27.0	(205.7)	299.3
Income tax expense (benefit)	(18.9)	(3.0)	(68.0)	89.7
Income (loss) from continuing operations	(40.9)	30.0	(137.7)	209.6
Income from discontinued operations, net of tax		1.8		3.3
Net income (loss)	(40.9)	31.8	(137.7)	212.9
Noncontrolling interest in net income (loss) of subsidiaries	(6.7)	8.9	(24.0)	56.7
Net income (loss) attributable to Valhi stockholders	(34.2)	22.9	(113.7)	156.2
Amounts attributable to Valhi stockholders:
Income (loss) from continuing operations	(34.2)	21.7	(113.7)	153.9
Income from discontinued operations		1.2		2.3
Net income (loss) attributable to Valhi stockholders	$ (34.2)	$ 22.9	$ (113.7)	$ 156.2
Basic and diluted net income (loss) per share:
Income (loss) from continuing operations	$ (0.10)	$ 0.06	$ (0.33)	$ 0.45
Income from discontinued operations		$ 0.01		$ 0.01
Net income (loss) per share	$ (0.10)	$ 0.07	$ (0.33)	$ 0.46
Cash dividends per share	$ 0.05	$ 0.05	$ 0.15	$ 0.142
Basic and diluted weighted average shares outstanding	342.0	342.0	342.0	342.0

XML

Accounts Payable and Accrued Liabilities

9 Months Ended

Sep. 30, 2013

Accounts Payable and Accrued Liabilities

Note 8—Accounts payable and accrued liabilities:

	December31, 2012		September30, 2013
	(In millions)
Accounts payable	$	169.6		$	126.4
Payable to affiliates:
Contran – income taxes, net		2.6			3.1
Contran – trade items		26.8			26.4
LPC – trade items		23.4			19.5
Employee benefits		38.5			37.4
Accrued litigation settlement		—			35.0
Accrued sales discounts and rebates		14.9			15.0
Environmental remediation and related costs		7.6			6.4
Deferred income		5.4			3.7
Reserve for uncertain tax positions		3.0			3.1
Other		42.8			55.7
Total	$	334.6		$	331.7

The accrued litigation settlement is discussed in Note 16.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ (137.7)	$ 212.9
Depreciation and amortization	55.7	50.3
Litigation settlement gain		(14.7)
Loss on prepayment of debt	8.9	7.2
Call premium and interest paid on Senior Notes redeemed		(6.2)
Assets held for sale write-down		0.4
Reversal of accrued contingent consideration		(0.8)
Benefit plan expense greater (less) than cash funding requirements:
Defined benefit pension expense	1.7	0.4
Other postretirement benefit expense	(0.9)	(1.1)
Deferred income taxes	(78.5)	37.9
Net distributions from (contributions to) Ti02 manufacturing joint venture, net	4.0	(30.1)
Other, net	6.4	0.9
Change in assets and liabilities:
Accounts and other receivables, net	(35.5)	(53.8)
Inventories, net	241.0	(157.8)
Accounts payable and accrued liabilities	20.1	(36.8)
Accounts with affiliates	(24.7)	54.1
Income taxes	(8.8)	(6.8)
Other, net	(3.3)	(9.8)
Net cash provided by operating activities	48.4	46.2
Cash flows from investing activities:
Capital expenditures	(54.4)	(66.0)
Capitalized permit costs	(0.6)	(2.9)
Purchases of marketable securities	(5.2)	(5.7)
Proceeds from:
Disposal of mutual funds		21.1
Disposal of other marketable securities	7.8	8.1
Disposal of assets held for sale	1.6
Collection of note receivable	3.0
Real estate-related litigation settlement		15.6
Change in restricted cash equivalents, net	0.9	(5.0)
Other, net	(0.4)	2.7
Net cash used in investing activities	(47.3)	(32.1)
Indebtedness:
Borrowings	377.7	503.3
Principal payments	(565.0)	(422.6)
Deferred financing costs paid		(7.1)
Valhi cash dividends paid	(50.9)	(48.0)
Distributions to noncontrolling interest in subsidiaries	(13.7)	(13.9)
Other, net	(0.7)
Net cash provided by (used in) financing activities	(252.6)	11.7
Cash and cash equivalents – net change from:
Operating, investing and financing activities	(251.5)	25.8
Effect of exchange rate on cash	0.3	1.3
Cash and cash equivalents at beginning of period	366.9	96.4
Cash and cash equivalents at end of period	115.7	123.5
Cash paid (received) for:
Interest, net of capitalized interest (including call premium paid)	42.5	51.3
Income taxes, net	16.0	64.4
Noncash investing activities:
Accrual for capital expenditures	3.5	8.6
Accrual for capitalized permit costs	0.4	1.6
Noncash financing activities:
Accrued construction retainage payable converted to note payable	$ 2.8

XML

Long-Term Debt - Revolving Credit Facility - Additional Information (Detail) (Kronos Worldwide, Inc.) In Millions, unless otherwise specified	9 Months Ended		9 Months Ended		8 Months Ended	9 Months Ended
	Sep. 30, 2013 Revolving North American credit facility USD ($)	Sep. 30, 2013 Bank Of Montreal CAD	Sep. 30, 2013 Economic Development Agency Credit Facility Canada USD ($)	Sep. 30, 2013 Economic Development Agency Credit Facility Canada CAD	Aug. 31, 2013 Revolving European credit facility	Sep. 30, 2013 Revolving European credit facility USD ($)	Sep. 30, 2013 Revolving European credit facility EUR (€)
Line Of Credit Facility [Line Items]
Percentage of average interest rate, during period	2.46%				2.02%
Amount available for borrowing	$ 56.6					$ 32.4
Revolving credit facility, borrowings	90.3		1.8	1.8		12.8	10.0
Repayment of credit facility	44.1					26.5	20.0
Percentage of average interest rate	2.63%
Aggregate letter of credit outstanding amount		7.5
Issuance of letter of credit		10.0
Imputed interest on borrowings			$ 0.5	0.5

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 115.7	$ 366.9
Restricted cash equivalents	5.3	8.1
Accounts and other receivables, net	352.0	302.5
Inventories, net	407.1	650.3
Other current assets	26.7	26.0
Deferred income taxes	22.9	9.6
Total current assets	929.7	1,363.4
Other assets:
Marketable securities	253.6	256.8
Investment in affiliates	121.3	126.1
Goodwill	379.7	379.7
Deferred income taxes	162.3	120.3
Other noncurrent assets	174.6	161.1
Total other assets	1,091.5	1,044.0
Property and equipment:
Land	48.7	48.3
Buildings	280.2	280.5
Equipment	1,136.4	1,127.7
Treatment, storage and disposal facility	158.9	158.7
Mining properties	64.6	72.3
Construction in progress	61.4	40.7
Gross property and equipment	1,750.2	1,728.2
Less accumulated depreciation	994.0	965.1
Net property and equipment	756.2	763.1
Total assets	2,777.4	3,170.5
Current liabilities:
Current maturities of long-term debt	29.7	29.6
Accounts payable and accrued liabilities	331.7	334.6
Income taxes	0.2	23.1
Deferred income taxes	11.2	11.2
Total current liabilities	372.8	398.5
Noncurrent liabilities:
Long-term debt	701.6	880.5
Deferred income taxes	431.3	454.8
Accrued pension costs	195.4	202.9
Accrued environmental remediation and related costs	53.6	42.6
Accrued postretirement benefits costs	20.6	21.2
Other liabilities	91.3	78.3
Total noncurrent liabilities	1,493.8	1,680.3
Equity: Valhi stockholders equity:
Preferred stock	667.3	667.3
Common stock	3.6	3.6
Additional paid-in capital	44.7	78.9
Retained earnings (deficit)	(55.3)	75.4
Accumulated other comprehensive loss	(35.8)	(42.0)
Treasury stock	(49.6)	(49.6)
Total Valhi stockholders’ equity	574.9	733.6
Noncontrolling interest in subsidiaries	335.9	358.1
Total equity	910.8	1,091.7
Total liabilities and equity	2,777.4	3,170.5
Commitments and contingencies (Notes 13 and 16)

XML

Other Noncurrent Assets - Additional Information (Detail) (CompX, USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
CompX
Other Noncurrent Assets [Line Items]
Net proceeds from sale	$ 1.6

XML

Fair Value Measurements and Financial Instruments - Additional Information (Detail)				9 Months Ended
	Sep. 30, 2013 USD ($)	Dec. 31, 2012 USD ($)	Sep. 30, 2013 Amalgamated Sugar Company LLC USD ($)	Sep. 30, 2013 Chemicals Forward Contracts USD ($)	Sep. 30, 2013 Chemicals Canadian Dollar Forward Contracts USD ($)	Sep. 30, 2013 Chemicals Canadian Dollar Forward Contracts Minimum	Sep. 30, 2013 Chemicals Canadian Dollar Forward Contracts Maximum	Sep. 30, 2013 Chemicals Norwegian Kroner Forward Contracts United States Dollar USD ($)	Sep. 30, 2013 Chemicals Norwegian Kroner Forward Contracts United States Dollar Minimum	Sep. 30, 2013 Chemicals Norwegian Kroner Forward Contracts United States Dollar Maximum	Sep. 30, 2013 Chemicals Norwegian Kroner Forward Contracts Euro EUR (€)	Sep. 30, 2013 Chemicals Norwegian Kroner Forward Contracts Euro Minimum EUR (€)	Sep. 30, 2013 Chemicals Norwegian Kroner Forward Contracts Euro Maximum EUR (€)	Dec. 31, 2012 Kronos Worldwide, Inc. Term Loan Per Thousand Dollar Principal Amount USD ($)
Financial Instrument At Fair Value [Line Items]
Notional amount currency forward contract					$ 45,000,000			$ 25,000,000			€ 16,000,000
Exchange floor rate						1.02	1.06		5.84	6.14		7.55	8.07
Maturity rate of derivative					3,000,000			5,000,000				2,000,000	5,000,000
Estimated fair value of currency forward contracts	(500,000)	1,800,000		500,000
Accounts and other receivables				800,000
Accounts payable and accrued liabilities				1,300,000
Currency transaction loss				500,000
Estimated market price of the notes														1,017.5
Principal amount of debt instrument														1,000
Redemption price of investment			$ 250,000,000

XML

Inventories, Net (Tables)

9 Months Ended

Sep. 30, 2013

Inventories, Net

	December31, 2012		September30, 2013
	(In millions)
Raw materials:
Chemicals	$	151.5		$	69.3
Component products		3.3			4.0
Total raw materials		154.8			73.3
Work in process:
Chemicals		27.3			18.1
Component products		5.9			6.7
Total in-process products		33.2			24.8
Finished products:
Chemicals		395.6			237.8
Component products		2.1			2.2
Total finished products		397.7			240.0
Supplies (chemicals)		64.6			69.0
Total	$	650.3		$	407.1

XML

Fair Value Measurements and Financial Instruments

9 Months Ended

Sep. 30, 2013

Fair Value Measurements and Financial Instruments

Note 17—Fair value measurements and financial instruments:

The following table summarizes the valuation of our marketable securities, financial instruments and other items recorded on a fair value basis as of:

	Fair Value Measurements
	Total			Quoted Pricesin Active Markets (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In millions)
Asset (liability)
December31, 2012:
Marketable securities:
Current	$	.9		$	—		$	.9	$	—
Noncurrent		256.8			3.5			3.3		250.0
Currency forward contracts		1.8			1.8			—		—
September30, 2013:
Marketable securities:
Current	$	1.6		$	—		$	1.6	$	—
Noncurrent		253.6			—			3.6		250.0
Currency forward contracts		(.5	)		(.5	)		—		—

See Note 4 for information on how we determine fair value of our noncurrent marketable securities.

Certain of our Chemicals Segment’s sales generated by its non-U.S. operations are denominated in U.S. dollars. Our Chemicals Segment periodically uses currency forward contracts to manage a very nominal portion of currency exchange rate risk associated with trade receivables denominated in a currency other than the holder’s functional currency or similar exchange rate risk associated with future sales.  We have not entered into these contracts for trading or speculative purposes in the past, nor do we currently anticipate entering into such contracts for trading or speculative purposes in the future. Derivatives used to hedge forecasted transactions and specific cash flows associated with financial assets and liabilities denominated in currencies other than the U.S. dollar and which meet the criteria for hedge accounting are designated as cash flow hedges. Consequently, the effective portion of gains and losses is deferred as a component of accumulated other comprehensive income and is recognized in earnings at the time the hedged item affects earnings. Contracts that do not meet the criteria for hedge accounting are marked-to-market at each balance sheet date with any resulting gain or loss recognized in income currently as part of net currency transactions. The fair value of the currency forward contracts is determined using Level 1 inputs based on the currency spot forward rates quoted by banks or currency dealers.

At September30, 2013, our Chemicals Segment had currency forward contracts to exchange:

an aggregate of $45.0 million for an equivalent value of Canadian dollars at  exchange rates ranging from Cdn. $1.02 to Cdn. $1.06 per U.S. dollar;these contracts with Wells Fargo Bank, N.A. mature from October 2013 through December 2014 at a rate of $3.0 million per month, subject to early redemption provisions at our option;

an aggregate $25.0 million for an equivalent value of Norwegian kroner at exchange rates ranging from kroner 5.84 to kroner 6.14per U.S. dollar;these contracts with DnB Nor Bank ASA mature at a rate of $5.0 million per month in certain months from October 2013 through April 2014; and

an aggregate €16.0million for an equivalent value of Norwegian kroner at exchange rates ranging from kroner 7.55 to kroner 8.07per euro;these contracts with DnB Nor Bank ASA mature at a rate ranging from €2.0million to €5.0 million per month in certain months from October 2013 through April 2014.

The estimated fair value of our currency forward contracts at September30, 2013 was a net liability of $.5 million, of which $.8 million is recognized as part of accounts and other receivables and $1.3 million is recognized as part of accounts payable and accrued liabilities in our Condensed Consolidated Balance Sheets. There is also a corresponding $.5 million currency transaction loss recognized in our Condensed Consolidated Statement of Operations. Our Chemicals Segment is not currently using hedge accounting for its outstanding currency forward contracts at September30, 2013, and it did not use hedge accounting for any of such contracts previously held in 2012.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

	December31, 2012					September30,2013
	Carrying amount		Fair value		Carrying amount			Fair value
	(In millions)
Cash, cash equivalents and restricted cash equivalents	$	395.9	$	395.9	$		143.4	$	143.4
Long-term debt (excluding capitalized leases):
Kronos note payable to Contran	$	—	$	—	$		175.0	$	175.0
Kronos term loan		384.5		396.8			—		—
Snake River Sugar Company fixed rate loans		250.0		250.0			250.0		250.0
WCS fixed rate debt		77.1		77.1			76.2		76.2
Valhi credit facility with Contran		157.6		157.6			173.5		173.5
Kronos variable rate bank credit facilities		13.2		13.2			46.2		46.2
CompX variable rate promissory note		18.5		18.5			—		—
Noncontrolling interest in:
Kronos common stock	$	267.0	$	442.6	$		239.1	$	350.9
NL common stock		77.8		94.8			83.3		94.0
CompX common stock		13.3		23.4			13.5		21.3
Valhi stockholders’ equity	$	733.6	$	4,238.9	$		574.9	$	6,768.8

The fair value of our publicly-traded marketable securities, noncontrolling interest in NL, Kronos and CompX and our common stockholders’ equity are all based upon quoted market prices, Level 1 inputs at each balance sheet date. At December31, 2012, the estimated market price of Kronos’ term loan was $1,017.5 per $1,000 principal amount.   The fair value of Kronos’ term loan was based on quoted market prices; however, these quoted market prices represent Level 2 inputs because the markets in which the term loan trades were not active. The fair value of our fixed-rate nonrecourse loans from Snake River Sugar Company is based upon the $250 million redemption price of our investment in Amalgamated, which collateralizes the nonrecourse loans (this is a Level 3 input). Fair value variable interest debt and other fixed-rate debt are deemed to approximate book value, which represents Level 2 inputs. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. See Notes 5 and 8.

XML

Business Segment Information - Segment Operating Performance (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Net sales	$ 448.2	$ 508.8	$ 1,463.4	$ 1,659.9
Cost of sales	399.6	411.3	1,384.7	1,140.0
Gross margin	48.6	97.5	78.7	519.9
Operating income (loss)	(42.5)	41.1	(134.5)	347.6
Equity in earnings of investees			(0.9)	(0.1)
Securities earnings	6.6	7.3	19.9	21.5
Insurance recoveries	2.2	1.2	3.8	2.6
Litigation settlement gain				14.7
Loss on prepayment of debt	(2.3)		(8.9)	(7.2)
General expenses, net	(10.1)	(7.9)	(41.4)	(37.4)
Interest expense	(13.7)	(14.6)	(43.8)	(42.4)
Income (loss) from continuing operations before income taxes	(59.8)	27.0	(205.7)	299.3
Chemicals
Segment Reporting Information [Line Items]
Net sales	419.1	472.9	1,363.8	1,579.5
Cost of sales	372.4	387.5	1,304.8	1,070.5
Gross margin	46.7	85.4	59.0	509.0
Operating income (loss)	(35.2)	40.4	(125.6)	364.1
Component products
Segment Reporting Information [Line Items]
Net sales	24.2	21.4	69.7	63.9
Cost of sales	16.7	15.1	48.6	45.1
Gross margin	7.5	6.3	21.1	18.8
Operating income (loss)	3.0	1.7	7.4	5.4
Waste management
Segment Reporting Information [Line Items]
Net sales	4.9	14.5	29.9	16.5
Cost of sales	10.5	8.7	31.3	24.4
Gross margin	(5.6)	5.8	(1.4)	(7.9)
Operating income (loss)	(10.3)	(1.0)	(16.3)	(21.9)
Corporate Segment
Segment Reporting Information [Line Items]
Equity in earnings of investees		$ (0.1)	$ (0.8)	$ (0.1)

XML

Long-Term Debt - Long-Term Debt (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Long-term debt
Total debt	$ 731.3	$ 910.1
Less current maturities	29.7	29.6
Total long-term debt	701.6	880.5
Other Subsidiary Debt
Long-term debt
Other	10.4	9.2
Subsidiary Debt
Long-term debt
Total subsidiary debt	307.8	502.5
VALHI, INC.
Long-term debt
Total Valhi debt	423.5	407.6
VALHI, INC. | Snake River | Notes Payable, Other Payables
Long-term debt
Debt instrument	250.0	250.0
VALHI, INC. | Contran
Long-term debt
Debt instrument	173.5	157.6
Kronos Worldwide, Inc. | Contran
Long-term debt
Debt instrument	175.0
Kronos Worldwide, Inc. | Term Loan
Long-term debt
Debt instrument		384.5
Kronos Worldwide, Inc. | Revolving European credit facility
Long-term debt
Debt instrument		13.2
Kronos Worldwide, Inc. | Revolving North American credit facility
Long-term debt
Debt instrument	46.2
CompX | Timet Finance Management Company
Long-term debt
Debt instrument		18.5
WCS
Long-term debt
Financing capital lease	68.9	69.9
WCS | Promissory Notes
Long-term debt
Debt instrument	$ 7.3	$ 7.2

XML

Income Taxes - Additional Information (Detail) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended			3 Months Ended
	Sep. 30, 2012 USD ($)	Sep. 30, 2013 USD ($)	Sep. 30, 2013 Proposed adjustment to certain foreign tax liabilities USD ($)	Sep. 30, 2013 Kronos Worldwide, Inc. Bank Of Montreal CAD	Sep. 30, 2012 France	Sep. 30, 2012 France Chemicals USD ($)
Income Taxes Disclosure [Line Items]
Letter of credit collateralized				7.5
Potential cash tax liability full amount for the proposed adjustment			15.7
Unrecognized tax benefits		4.4
Net Incremental tax benefit	11.1
Nondeductible surtax on dividend distributions					3.00%
Distributed dividend						1.8
Undistributed earnings						$ 10.9

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2013

Change in Accrued Environmental Remediation and Related Costs

Changes in the accrued environmental remediation and related costs during the first nine months of 2013 are presented in the table below.

	Amount
	(In millions)
Balance at the beginning of the year	$	50.2
Additions charged to expense, net		12.7
Payments, net		(2.8	)
Changes in currency exchange rates		(.1	)
Balance at the end of period	$	60.0
Amounts recognized in our Condensed Consolidated Balance Sheet at the end of the period:
Current liabilities	$	6.4
Noncurrent liabilities		53.6
Total	$	60.0

XML

Other Income, Net (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of Components of Other Income

	Ninemonthsended September30,
	2012			2013
	(In millions)
Securities earnings:
Dividends and interest	$	21.3			$	19.7
Securities transactions, net		.2				.2
Total		21.5				19.9
Equity in earnings of investees		(.1	)			(.9	)
Currency transactions, net		(.5	)			(1.5	)
Insurance recoveries		2.6				3.8
Litigation settlement gain		14.7				—
Other, net		1.2				.5
Total	$	39.4			$	21.8

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2013

Component of Income Taxes Expenses

	Threemonthsended September30,						Ninemonthsended September30,
	2012			2013				2012				2013
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$	9.5		$	(21.0	)			$	104.8			$	(72.0	)
Incremental tax (benefit) on earnings of non-U.S. companies		(12.8	)		1.3					(7.1	)			(3.4	)
Non-U.S. tax rates		(.7	)		.8					(12.4	)			3.3
Adjustment to the reserve for uncertain tax positions, net		.3			.6					1.7				2.3
Nondeductible expenses		.8			.5					3.0				3.1
U.S. state income taxes and other, net		(.1	)		(1.1	)				(.3	)			(1.3	)
Income tax expense (benefit)	$	(3.0	)	$	(18.9	)			$	89.7			$	(68.0	)

	Threemonthsended September30,						Nine months ended September30,
	2012			2013				2012				2013
	(In millions)
Comprehensive provision for income taxes (benefit) allocable to:
Continuing operations	$	(3.0	)	$	(18.9	)			$	89.7			$	(68.0	)
Discontinued operations		.9			—					2.4				—
Other comprehensive income (loss):
Marketable securities		3.2			6.3					(12.8	)			7.5
Currency translation		4.4			4.1					2.7				2.8
Pension plans		.8			1.2					2.5				3.6
OPEB plans		(.2	)		(.2	)				(.5	)			(.5	)
Total	$	6.1		$	(7.5	)			$	84.0			$	(54.6	)

XML

Other Noncurrent Assets

9 Months Ended

Sep. 30, 2013

Other Noncurrent Assets

Note 7—Other noncurrent assets:

	December31, 2012		September30, 2013
	(In millions)
Investment in affiliates:
TiO2 manufacturing joint venture, Louisiana Pigment Company, L.P. (“LPC”)	$	109.9		$	105.9
Other		16.2			15.4
Total	$	126.1		$	121.3
Other assets:
Waste disposal site operating permits, net	$	65.7		$	61.5
Restricted cash		20.9			22.4
Deferred financing costs		7.0			2.6
IBNR receivables		6.7			7.0
Capital lease deposit		6.2			6.2
Pension asset		5.1			5.8
Assets held for sale		2.6			1.1
Other		46.9			68.0
Total	$	161.1		$	174.6

In the fourth quarter of 2012, CompX entered into an agreement to sell one of its facilities classified as an asset held for sale. The transaction closed during the first quarter of 2013. The net proceeds from the sale of $1.6 million approximated the carrying value of the assets as of the date of the sale.

XML

Other Income, Net - Schedule of Components of Other Income (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Securities earnings:
Dividends and interest			$ 19.7	$ 21.3
Securities transactions, net			0.2	0.2
Total	6.6	7.3	19.9	21.5
Equity in earnings of investees			(0.9)	(0.1)
Currency transactions, net			(1.5)	(0.5)
Insurance recoveries	2.2	1.2	3.8	2.6
Litigation settlement gain				14.7
Other, net			0.5	1.2
Total	$ 8.7	$ 7.6	$ 21.8	$ 39.4

XML

Other Noncurrent Assets (Tables)

9 Months Ended

Sep. 30, 2013

Other Noncurrent Assets

	December31, 2012		September30, 2013
	(In millions)
Investment in affiliates:
TiO2 manufacturing joint venture, Louisiana Pigment Company, L.P. (“LPC”)	$	109.9		$	105.9
Other		16.2			15.4
Total	$	126.1		$	121.3
Other assets:
Waste disposal site operating permits, net	$	65.7		$	61.5
Restricted cash		20.9			22.4
Deferred financing costs		7.0			2.6
IBNR receivables		6.7			7.0
Capital lease deposit		6.2			6.2
Pension asset		5.1			5.8
Assets held for sale		2.6			1.1
Other		46.9			68.0
Total	$	161.1		$	174.6

XML

Business Segment Information - Holding Percentage of Subsidiaries (Detail)	Sep. 30, 2013
Kronos Worldwide, Inc.
Segment Reporting Information [Line Items]
Controlling interest in business segments	80.00%
CompX
Segment Reporting Information [Line Items]
Controlling interest in business segments	87.00%
WCS
Segment Reporting Information [Line Items]
Controlling interest in business segments	100.00%

XML

Long-Term Debt

9 Months Ended

Sep. 30, 2013

Long-Term Debt

Note 10 —Long-term debt:

	December31, 2012		September30, 2013
	(In millions)
Valhi:
Snake River Sugar Company	$	250.0		$	250.0
Contran credit facility		157.6			173.5
Total Valhi debt		407.6			423.5
Subsidiary debt:
Kronos:
Note payable to Contran		—			175.0
Term loan		384.5			—
Revolving European credit facility		13.2			—
Revolving North American credit facility		—			46.2
CompX:
Promissory note payable to Timet Finance Management Company		18.5			—
WCS:
Financing capital lease		69.9			68.9
6% promissory notes		7.2			7.3
Other		9.2			10.4
Total subsidiary debt		502.5			307.8
Total debt		910.1			731.3
Less current maturities		29.6			29.7
Total long-term debt	$	880.5		$	701.6

Valhi – Contran credit facility – During the first nine months of 2013, we had net borrowings of $15.9 million under our Contran credit facility. The average interest rate on the existing balance as of and for the nine months ended September30, 2013 was 4.25%. At September30, 2013, the equivalent of $51.5 million was available for borrowing under this facility.

Kronos – Term loan – In February 2013, Kronos voluntarily prepaid an aggregate $290 million principal amount of its term loan. We recognized a non-cash pre-tax interest charge of $6.6 million in the first quarter related to this prepayment consisting of the write-off of the unamortized original issue discount costs and deferred financing costs associated with such prepayment. Funds for such prepayment were provided by $100 million of Kronos’ cash on hand as well as borrowings of $190 million under a new loan from Contran as described below.  In July 2013 Kronos voluntarily prepaid the remaining $100 million principal amount outstanding under its term loan, using $50 million of its cash on hand as well as borrowings of $50 million under its North American revolving credit facility.  We recognized a non-cash pre-tax interest charge of $2.3 million in the third quarter of 2013 related to this prepayment consisting of the write-off of the unamortized original issue discount costs and deferred financing costs associated with such prepayment.  The average interest rate on the term loan for the year-to-date period ended July 30, 2013 (the payoff date) was 6.8%

Note payable to Contran – As discussed above, in February 2013 Kronos entered into a promissory note with Contran that allows it to borrow up to $290 million. This new loan from Contran contains terms and conditions similar to the terms and conditions of the term loan, except that the loan from Contran is unsecured and contains no financial maintenance covenant. The independent members of Kronos’ board of directors approved the terms and conditions of the loan from Contran. The note requires quarterly principal payments of $5.0 million which commenced in March 2013, with any remaining outstanding principal due by June 2018. Voluntary principal prepayments are permitted at any time without penalty. The note bears interest at LIBOR (with LIBOR no less than 1%) plus 5.125%, or the base rate (as defined in the agreement) plus 4.125%. Kronos is required to use the base rate method until such time as both (1)the term loan discussed above has been fully repaid and (2)the European credit facility has been amended on terms satisfactory to Contran, at which time Kronos would have the option to use either the base rate or LIBOR rate methods. The average interest rate on these borrowings as of and for the period from issuance to September30, 2013 was 7.375%.

Revolving European credit facility – During the first nine months of 2013, Kronos borrowed €10 million ($12.8 million when borrowed) and repaid  the entire outstanding balance of €20 million ($26.5 million when repaid) in August under its European credit facility. The average interest rate on these borrowings for the year-to-date period ended August 31, 2013 when paid off was 2.02%. At September30, 2013, there were no outstanding borrowings under this facility.  Our European revolving credit facility requires the maintenance of certain financial ratios.  At September 30, 2013, based on the current earnings before income tax, interest, depreciation and amortization expense of the borrowers, Kronos would not have met the financial test if it had any net debt outstanding under this facility, and accordingly its effective available borrowing under this facility at September 30, 2013 is approximately $32.4 million, the aggregate amount of cash held by the borrowers, net of the borrowers’ other outstanding indebtedness.  Kronos is in discussions with the lender to amend the facility to modify the covenant.  However, we do not currently anticipate the need to draw on this facility for the foreseeable future. 

Revolving North American credit facility – During the first nine months of 2013, Kronos borrowed $90.3 million and repaid an aggregate of $44.1 million. The average interest rate on these borrowings as of and for the period from borrowing to September30, 2013 was 2.63% and 2.46%, respectively. At September30, 2013 approximately $56.6 million was available for borrowing under this facility.

Canada – At September30, 2013, an aggregate of Cdn. $7.5 million letters of credit were outstanding under Kronos’ Canadian subsidiary’s loan agreement with the Bank of Montreal which exists solely for the issuance of up to Cdn. $10.0 million in letters of credit.

In January 2013, Kronos borrowed Cdn. $1.8 million (USD $1.8 million) under its Canadian subsidiary’s agreement with an economic development agency of the Province of Quebec, Canada which was recorded net of Cdn. $.5 million (USD $.5 million) imputed interest.

CompX – In July 2013, CompX prepaid the remaining outstanding principal amount of the note, plus accrued interest, without penalty.  The average interest rate on the promissory note payable for the year-to-date period ended July 18, 2013 (the pay-off date) was 1.3%.  

Restrictions and other – Certain of the credit facilities with unrelated, third-party lenders described above require the respective borrowers to maintain minimum levels of equity, require the maintenance of certain financial ratios, limit dividends and additional indebtedness and contain other provisions and restrictive covenants customary in lending transactions of this type. We are in compliance with all of our debt covenants at September30, 2013.

XML

Fair Value Measurements and Financial Instruments - Financial Instruments not Carried at Fair Value (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash, cash equivalents and restricted cash equivalents	$ 143,400,000	$ 395,900,000
Noncontrolling interest, Carrying amount	335,900,000	358,100,000
Valhi stockholders' equity, Carrying amount	574,900,000	733,600,000
Cash, cash equivalents and restricted cash equivalents, fair value	143,400,000	395,900,000
Valhi stockholders' equity, Fair value	6,768,800,000	4,238,900,000
Kronos Worldwide, Inc. | Common Stock
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Noncontrolling interest, Carrying amount	239,100,000	267,000,000
Noncontrolling interest	350,900,000	442,600,000
Kronos Worldwide, Inc. | Note Payable | Contran
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Long term debt - Kronos note payable to Contran	175,000,000
Debt instrument, fair value	175,000,000
Kronos Worldwide, Inc. | Term Loan
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Loans, Carrying amount		384,500,000
Debt instrument, fair value		396,800,000
Kronos Worldwide, Inc. | Bank Credit Facility
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Variable rate credit facility, Carrying Amount	46,200,000	13,200,000
Variable rate credit facility, Fair Value	46,200,000	13,200,000
Snake River | Fixed Rate Loans
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Loans, Carrying amount	250,000,000	250,000,000
Debt instrument, fair value	250,000,000	250,000,000
WCS | Fixed Rate Loans
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Loans, Carrying amount	76,200,000	77,100,000
Debt instrument, fair value	76,200,000	77,100,000
Valhi | Credit Facility | Contran
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Variable rate credit facility, Carrying Amount	173,500,000	157,600,000
Variable rate credit facility, Fair Value	173,500,000	157,600,000
CompX | Common Stock
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Noncontrolling interest, Carrying amount	13,500,000	13,300,000
Noncontrolling interest	21,300,000	23,400,000
CompX | Promissory Note
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Variable rate promissory note, Carrying amount		18,500,000
Debt instrument, fair value		18,500,000
NL | Common Stock
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Noncontrolling interest, Carrying amount	83,300,000	77,800,000
Noncontrolling interest	$ 94,000,000	$ 94,800,000

XML

Inventories, Net

9 Months Ended

Sep. 30, 2013

Inventories, Net

Note 6—Inventories, net:

	December31, 2012		September30, 2013
	(In millions)
Raw materials:
Chemicals	$	151.5		$	69.3
Component products		3.3			4.0
Total raw materials		154.8			73.3
Work in process:
Chemicals		27.3			18.1
Component products		5.9			6.7
Total in-process products		33.2			24.8
Finished products:
Chemicals		395.6			237.8
Component products		2.1			2.2
Total finished products		397.7			240.0
Supplies (chemicals)		64.6			69.0
Total	$	650.3		$	407.1

XML

Organization and Basis of Presentation

9 Months Ended

Sep. 30, 2013

Organization and Basis of Presentation

Note 1—Organization and basis of presentation:

Organization—We are majority owned by Contran Corporation and one of its subsidiaries, which own approximately 94% of our outstanding common stock at September30, 2013. Substantially all of Contran’s outstanding voting stock is held by trusts established for the benefit of certain children and grandchildren of Harold C. Simmons (for which Mr.Simmons is the sole trustee) or is held directly by Mr.Simmons or other persons or entities related to Mr.Simmons. Consequently, Mr.Simmons may be deemed to control Contran and us.

Basis of Presentation—Consolidated in this Quarterly Report are the results of our majority-owned and wholly-owned subsidiaries, including NL Industries, Inc., Kronos Worldwide, Inc., CompX International Inc., Tremont LLC and Waste Control Specialists LLC (“WCS”). Kronos (NYSE: KRO), NL (NYSE: NL), and CompX (NYSE MKT: CIX) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December31, 2012 that we filed with the SEC on March15, 2013 (the “2012 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December31, 2012 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December31, 2012) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Our results of operations for the interim periods ended September30, 2013 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2012 Consolidated Financial Statements contained in our 2012 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Valhi, Inc and its subsidiaries (NYSE: VHI), taken as a whole.

XML

Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Schedule Of Other Liabilities [Line Items]
Accounts payable	$ 126.4	$ 169.6
Employee benefits	37.4	38.5
Accrued sales discounts and rebates	15.0	14.9
Environmental remediation and related costs	6.4	7.6
Deferred income	3.7	5.4
Reserve for uncertain tax positions	3.1	3.0
Other	55.7	42.8
Total	331.7	334.6
Contran | Income Taxes
Schedule Of Other Liabilities [Line Items]
Payable to affiliates	3.1	2.6
Contran | Trade Accounts Payables
Schedule Of Other Liabilities [Line Items]
Payable to affiliates	26.4	26.8
Lpc | Trade Accounts Payables
Schedule Of Other Liabilities [Line Items]
Payable to affiliates	19.5	23.4
Kronos Worldwide, Inc.
Schedule Of Other Liabilities [Line Items]
Accrued litigation settlement	$ 35.0

XML

Marketable Securities - Schedule of Marketable Securities (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Current assets
Schedule Of Available For Sale Securities [Line Items]
Market value	$ 1.6	$ 0.9
Cost basis	1.6	0.9
Unrealized gains, net
Noncurrent assets
Schedule Of Available For Sale Securities [Line Items]
Market value	253.6	256.8
Cost basis	253.6	256.7
Unrealized gains, net		0.1
Noncurrent assets | Other
Schedule Of Available For Sale Securities [Line Items]
Market value	3.6	6.8
Cost basis	3.6	6.7
Unrealized gains, net		0.1
Amalgamated Sugar Company LLC | Noncurrent assets
Schedule Of Available For Sale Securities [Line Items]
Market value	250.0	250.0
Cost basis	250.0	250.0
Unrealized gains, net

XML

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2013

Long-Term Debt

	December31, 2012		September30, 2013
	(In millions)
Valhi:
Snake River Sugar Company	$	250.0		$	250.0
Contran credit facility		157.6			173.5
Total Valhi debt		407.6			423.5
Subsidiary debt:
Kronos:
Note payable to Contran		—			175.0
Term loan		384.5			—
Revolving European credit facility		13.2			—
Revolving North American credit facility		—			46.2
CompX:
Promissory note payable to Timet Finance Management Company		18.5			—
WCS:
Financing capital lease		69.9			68.9
6% promissory notes		7.2			7.3
Other		9.2			10.4
Total subsidiary debt		502.5			307.8
Total debt		910.1			731.3
Less current maturities		29.6			29.7
Total long-term debt	$	880.5		$	701.6

XML

Income Taxes - Component of Income Taxes Expenses (Parenthetical) (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Tax Expenses [Line Items]
U.S. federal statutory income tax rate	35.00%	35.00%	35.00%	35.00%

XML

Long-Term Debt - CompX - Additional Information (Detail) (CompX, Promissory Note)	6 Months Ended
	Jul. 18, 2013
CompX | Promissory Note
Line Of Credit Facility [Line Items]
Percentage of average interest rate, during period	1.30%
Percentage of average interest rate	1.30%

XML

Income Taxes

9 Months Ended

Sep. 30, 2013

Income Taxes

Note 13 —Income taxes:

	Threemonthsended September30,						Ninemonthsended September30,
	2012			2013				2012				2013
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$	9.5		$	(21.0	)			$	104.8			$	(72.0	)
Incremental tax (benefit) on earnings of non-U.S. companies		(12.8	)		1.3					(7.1	)			(3.4	)
Non-U.S. tax rates		(.7	)		.8					(12.4	)			3.3
Adjustment to the reserve for uncertain tax positions, net		.3			.6					1.7				2.3
Nondeductible expenses		.8			.5					3.0				3.1
U.S. state income taxes and other, net		(.1	)		(1.1	)				(.3	)			(1.3	)
Income tax expense (benefit)	$	(3.0	)	$	(18.9	)			$	89.7			$	(68.0	)

	Threemonthsended September30,						Nine months ended September30,
	2012			2013				2012				2013
	(In millions)
Comprehensive provision for income taxes (benefit) allocable to:
Continuing operations	$	(3.0	)	$	(18.9	)			$	89.7			$	(68.0	)
Discontinued operations		.9			—					2.4				—
Other comprehensive income (loss):
Marketable securities		3.2			6.3					(12.8	)			7.5
Currency translation		4.4			4.1					2.7				2.8
Pension plans		.8			1.2					2.5				3.6
OPEB plans		(.2	)		(.2	)				(.5	)			(.5	)
Total	$	6.1		$	(7.5	)			$	84.0			$	(54.6	)

Our income tax benefit in the third quarter of 2012 includes an incremental tax benefit of $11.1 million as we determined in the third quarter 2012 that due to global changes in our business, we would not remit certain dividends from our Chemicals Segment’s non-U.S. jurisdictions.  As a result, certain tax attributes were available for carryback to offset prior year tax expense.

In the third quarter of 2012, France enacted certain changes in their income tax laws, including a 3% nondeductible surtax on all dividend distributions which is assessed at the time of the distribution against the company making such distribution. Consequently, our Chemicals Segment’s French subsidiary will be required to pay an additional 3% tax on all future dividend distributions.  Our undistributed earnings in France are deemed to be permanently reinvested and such tax will be recognized as part of our income tax expense in the period during which the dividend is declared and will be remitted to the French government in accordance with the applicable tax law. During the third quarter of 2012, our Chemicals Segment’s French subsidiary distributed a $1.8 million dividend.There have been no dividend distributions from our Chemicals Segment’s French subsidiary during 2013.  At September 30, 2013, our French subsidiary has undistributed earnings of approximately $10.9 million that, if distributed, would be subject to the 3% surtax.

Tax authorities are examining certain of our U.S. and non-U.S. tax returns and have or may propose tax deficiencies, including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives and court and tax proceedings, we cannot guarantee that these matters will be resolved in our favor, and therefore our potential exposure, if any, is also uncertain. In 2011 and 2012, Kronos received notices of re-assessment from the Canadian federal and provincial tax authorities related to the years 2002 through 2004. We object to the re-assessments and believe the position is without merit. Accordingly, we are appealing the re-assessments and in connection with such appeal we were required to post letters of credit aggregating Cdn. $7.5 million (see Note 10). If the full amount of the proposed adjustment were ultimately to be assessed against us, the cash tax liability would be approximately $15.7 million. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. We currently estimate that our unrecognized tax benefits may change by $4.4 million during the next twelve months related to certain adjustments to our prior year returns and the expiration of certain statutes of limitations.

XML

Other Noncurrent Liabilities

9 Months Ended

Sep. 30, 2013

Other Noncurrent Liabilities

Note 9 —Other noncurrent liabilities:

	December31, 2012		September30, 2013
	(In millions)
Reserve for uncertain tax positions	$	29.4		$	41.4
Asset retirement obligations		23.8			25.1
Insurance claims and expenses		9.7			9.8
Employee benefits		11.3			10.9
Deferred income		1.0			1.0
Other		3.1			3.1
Total	$	78.3		$	91.3

XML

Noncontrolling Interest in Subsidiaries - Noncontrolling Interest in Net Income (loss) of Subsidiaries (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Noncontrolling interest in net income (loss) of subsidiaries:
Noncontrolling interest in net income (loss) of subsidiaries	$ (6.7)	$ 8.9	$ (24.0)	$ 56.7
Kronos Worldwide, Inc.
Noncontrolling interest in net income (loss) of subsidiaries:
Noncontrolling interest in net income (loss) of subsidiaries			(20.8)	46.2
NL
Noncontrolling interest in net income (loss) of subsidiaries:
Noncontrolling interest in net income (loss) of subsidiaries			(3.8)	9.7
CompX
Noncontrolling interest in net income (loss) of subsidiaries:
Noncontrolling interest in net income (loss) of subsidiaries			$ 0.6	$ 0.8

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2013

Commitments and Contingencies

Note 16—Commitments and contingencies:

Lead pigment litigation—NL

NL’s former operations included the manufacture of lead pigments for use in paint and lead-based paint. NL, other former manufacturers of lead pigments for use in paint and lead-based paint, and the Lead Industries Association (which discontinued business operations in 2002), have been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions have been filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others have been asserted as class actions. These lawsuits seek recovery under a variety of theories, including public and private nuisance, negligent product design, negligent failure to warn, strict liability, breach of warranty, conspiracy/concert of action, aiding and abetting, enterprise liability, market share or risk contribution liability, intentional tort, fraud and misrepresentation, violations of state consumer protection statutes, supplier negligence and similar claims.

The plaintiffs in these actions generally seek to impose on the defendants responsibility for lead paint abatement and health concerns associated with the use of lead-based paints, including damages for personal injury, contribution and/or indemnification for medical expenses, medical monitoring expenses and costs for educational programs. To the extent the plaintiffs seek compensatory or punitive damages in these actions, such damages are generally unspecified. In some cases, the damages are unspecified pursuant to the requirements of applicable state law. A number of cases are inactive or have been dismissed or withdrawn. Most of the remaining cases are in various pre-trial stages. Some are on appeal following dismissal or summary judgment rulings in favor of either the defendants or the plaintiffs. In addition, various other cases (in which we are not a defendant) are pending that seek recovery for injury allegedly caused by lead pigment and lead-based paint. Although NL is not a defendant in these cases, the outcome of these cases may have an impact on cases that might be filed against NL in the future.

We believe that these actions are without merit, and we intend to continue to deny all allegations of wrongdoing and liability and to defend against all actions vigorously. We do not believe it is probable that we have incurred any liability with respect to all of the lead pigment litigation cases to which we are a party, and liability to us that may result, if any, in this regard cannot be reasonably estimated, because:

NL has never settled any of the market share, risk contribution, intentional tort, fraud, nuisance, supplier negligence, breach of warranty, conspiracy, misrepresentation, aiding and abetting, enterprise liability, or statutory cases;

no final, non-appealable adverse verdicts have ever been entered against NL; and

NL has never ultimately been found liable with respect to any such litigation matters, including over 100 cases over a twenty-year period for which NL was previously a party and for which NL has been dismissed without any finding of liability.

Accordingly, we have not accrued any amounts for any of the pending lead pigment and lead-based paint litigation cases. In addition, we have determined that liability to us which may result, if any, cannot be reasonably estimated because there is no prior history of a loss of this nature on which an estimate could be made, and there is no substantive information available upon which an estimate could be based.

New cases may continue to be filed against us. We cannot assure you that we will not incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against us or NL otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against us as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Environmental matters and related litigation

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. We have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, we may be subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe that all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations, including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (“PRP”) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (“CERCLA”), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities we or our predecessors, or our subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (“EPA”) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are also a party to a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the:

complexity and differing interpretations of governmental regulations,

number of PRPs and their ability or willingness to fund such allocation of costs,

financial capabilities of the PRPs and the allocation of costs among them,

solvency of other PRPs,

multiplicity of possible solutions,

number of years of investigatory, remedial and monitoring activity required,

uncertainty over the extent, if any, to which our former operations might have contributed to the conditions allegedly giving rise to such personal injury, property damage, natural resource and related claims, and

number of years between former operations and notice of claims and lack of information and documents about the former operations.

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. We cannot assure you that actual costs will not exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and we cannot assure you that costs will not be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our consolidated financial statements, results of operations and liquidity.

We record liabilities related to environmental remediation and related matters when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable. At December31, 2012 and September30, 2013, we have not recognized any receivables for recoveries.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of our accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

Changes in the accrued environmental remediation and related costs during the first nine months of 2013 are presented in the table below.

	Amount
	(In millions)
Balance at the beginning of the year	$	50.2
Additions charged to expense, net		12.7
Payments, net		(2.8	)
Changes in currency exchange rates		(.1	)
Balance at the end of period	$	60.0
Amounts recognized in our Condensed Consolidated Balance Sheet at the end of the period:
Current liabilities	$	6.4
Noncurrent liabilities		53.6
Total	$	60.0

NL – On a quarterly basis, NL evaluates the potential range of its liability for environmental remediation and related costs at sites where it has been named as a PRP or defendant. At September30, 2013, NL had accrued approximately $58 million related to approximately 50 sites associated with remediation and related matters that it believes are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to NL for remediation and related matters for which we believe it is possible to estimate costs is approximately $154 million, including the amount currently accrued.

NL believes that it is not reasonably possible to estimate the range of costs for certain sites. At September30, 2013, there were approximately 5 sites for which NL is not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and NL is unable to determine whether or not it actually had any association with the site, the nature of its responsibility, if any, for the contamination at the site and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of NL’s control, such as when the party alleging liability provides information to NL. At certain of these previously inactive sites, NL has received general and special notices of liability from the EPA and/or state agencies alleging that NL, sometimes with other PRPs, is liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that NL, along with any other alleged PRPs, is liable for past and/or future clean-up costs. As further information becomes available to NL for any of these sites which would allow NL to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our consolidated financial statements, results of operations and liquidity.

Other – We have also accrued approximately $2.0 million at September30, 2013 for other environmental cleanup matters. This accrual is near the upper end of the range of our estimate of reasonably possible costs for such matters.

Insurance coverage claims

We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors and we cannot assure you that such insurance coverage will be available.

We have agreements with three former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery.

For additional discussion of certain litigation involving NL and certain of its former insurance carriers, please refer to our 2012 Annual Report.

Other litigation

NL — NL has been named as a defendant in various lawsuits in several jurisdictions, alleging personal injuries as a result of occupational exposure primarily to products manufactured by our former operations containing asbestos, silica and/or mixed dust. In addition, some plaintiffs allege exposure to asbestos from working in various facilities previously owned and/or operated by NL. There are 1,130 of these types of cases pending, involving a total of approximately 1,643 plaintiffs. In addition, the claims of approximately 8,298 plaintiffs have been administratively dismissed or placed on the inactive docket in Ohio, Indiana and Texas state courts. We do not expect these claims will be re-opened unless the plaintiffs meet the courts’ medical criteria for asbestos-related claims. We have not accrued any amounts for this litigation because of the uncertainty of liability and inability to reasonably estimate the liability, if any. To date, we have not been adjudicated liable in any of these matters. Based on information available to us, including:

facts concerning historical operations,

the rate of new claims,

the number of claims from which we have been dismissed and

our prior experience in the defense of these matters.

We believe that the range of reasonably possible outcomes of these matters will be consistent with our historical costs (which are not material). Furthermore, we do not expect any reasonably possible outcome would involve amounts material to our consolidated financial position, results of operations or liquidity. We have sought and will continue to vigorously seek, dismissal and/or a finding of no liability from each claim. In addition, from time to time, we have received notices regarding asbestos or silica claims purporting to be brought against former subsidiaries, including notices provided to insurers with which we have entered into settlements extinguishing certain insurance policies. These insurers may seek indemnification from us.

WCS – Previously, the Sierra Club has filed various lawsuits in Texas District Court against the Texas State Commission on Environmental Quality (“TCEQ”). WCS has intervened in these lawsuits.  These lawsuits challenge WCS’ by-product and low-level radioactive waste disposal licenses. Subsequently, the District Court upheld the TCEQ’s determination that the Sierra Club lacked standing to pursue a challenge to the by-product disposal license. The Sierra Club appealed.WCS’ by-product disposal license remains in effect pending resolution of the appeal. In May 2012, the same District Court subsequently held that TCEQ erred in denying Sierra Club’s request for an administrative contested case hearing regarding the low-level radioactive waste disposal license, and ordered the TCEQ to undertake a contested case hearing in which the Sierra Club could participate.

Shortly thereafter, both the TCEQ and WCS appealed the District Court’s order withrespect to the low-level radioactive waste disposal license, and the District Court’s order is suspended.  WCS’ low-level radioactive waste disposal license remains in effect, pending resolution of this appeal. On the same day that WCS filed its appeal with regard to the District Court’s order withrespect toits low-level radioactive waste disposal license, the Sierra Club filed another lawsuit in the same District Court, challenging a routine TCEQ action relating to administration of the low-level radioactive waste disposal license. Both the TCEQ and WCS filed a motion to dismiss this latest lawsuit filed by the Sierra Club for lack of jurisdiction, which the District Court denied. TCEQ and WCS took an interlocutory appeal to the denial of TCEQ’s plea to jurisdiction.  The interlocutory appeal remains pending and the Sierra Club filed a related petition for writ of injunction with the same appellate court in Austin; that petition was denied. WCS believes all of these actions by the Sierra Club are without merit and that the Sierra Club has no proper standing to challenge any of its licenses and permits. This position has been reinforced by two recent Texas Supreme Court rulings narrowing the basis for a challenge to environmental permits.  WCS intends to continue to defend against any and all such actions vigorously, and to continue to operate its West Texas facilities in accordance with the terms of its licenses and permits.

Kronos – In March 2010, Kronos was served with two complaints which were subsequently consolidated as Haley Paint et al. v. E.I. Du Pont de Nemours and Company, et al. (United States District Court, for the District of Maryland, Case No. 1:10-cv-00318-RDB).  A third plaintiff intervened into the case in July 2011.  The defendants included Kronos, E.I. Du Pont de Nemours & Company, Huntsman International LLC, Millennium Inorganic Chemicals, Inc. and the National Titanium Dioxide Company Limited (d/b/a Cristal).  Plaintiffs sought to represent a class consisting of all persons and entities that purchased titanium dioxide in the United States directly from one or more of the defendants on or after March 1, 2002.  The complaint alleged that the defendants conspired and combined to fix, raise, maintain, and stabilize the price at which titanium dioxide was sold in the United States and engaged in other anticompetitive conduct.  In May 2010, defendants filed a motion to dismiss, which plaintiffs opposed.  In March 2011, the court denied the motion to dismiss.  In February 2012, the plaintiffs submitted their motion for class certification, which defendants opposed.  In August 2012, the court granted the plaintiffs’ motion for class certification and trial was set for September 2013.  On September 10, 2013, and following the agreement by the three other defendants in the third quarter of 2013 to enter into settlement agreements with the class plaintiffs, Kronos also entered into a settlement agreement with the class plaintiffs, without admitting any fault or wrongdoing, and agreed to pay an aggregate of $35 million (payable in two installments at specified times, expected to occur by mid-2014).  Following the service of the Class Action Fairness Notice and the Order of Final Approval from the court, we, and the other defendants, will be dismissed with prejudice from this matter.  Selling, general and administrative expense in the third quarter of 2013 includes a $35 million charge related to this settlement.  See also Note 8.

In March 2013, Kronos was served with the complaint, Los Gatos Mercantile, Inc. d/b/a Los Gatos Ace Hardware, et al v. E.I. Du Pont de Nemours and Company, et al. (United States District Court, for the Northern District of California, Case No. 3:13-cv-01180-SI).  The defendants include Kronos, E.I. Du Pont de Nemours & Company, Huntsman International LLC and Millennium Inorganic Chemicals, Inc.  Plaintiffs seek to represent a class consisting of indirect purchasers of titanium dioxide in the states of Arizona, Arkansas, California, the District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, South Carolina, South Dakota, Tennessee, Utah, Vermont, West Virginia and Wisconsin that indirectly purchased titanium dioxide from one or more of the defendants on or after March 1, 2002.  The complaint alleges that the defendants conspired and combined to fix, raise, maintain, and stabilize the price at which titanium dioxide was sold in the United States and engaged in other anticompetitive conduct.  This matter had been stayed by the court pending a resolution in the Haley Paint Matter.  The case is now proceeding in the trial court.  We believe the action is without merit, will deny all allegations of wrongdoing and liability and intend to defend against the action vigorously.

Other – For a discussion of other legal proceedings to which we are a party, please refer to our 2012 Annual Report.

In addition to the litigation described above, we and certain of our affiliates are also involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect any additional material insurance coverage for our environmental claims.

We currently believe that the disposition of all of these various other claims and disputes, individually or in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

XML

Noncontrolling Interest in Subsidiaries

9 Months Ended

Sep. 30, 2013

Noncontrolling Interest in Subsidiaries

Note 14 —Noncontrolling interest in subsidiaries:

	December31, 2012		September30, 2013
	(In millions)
Noncontrolling interest in net assets:
Kronos	$	267.0	$	239.1
NL		77.8		83.3
CompX		13.3		13.5
Total	$	358.1	$	335.9

	Ninemonthsended September30,
	2012		2013
	(In millions)
Noncontrolling interest in net income (loss) of subsidiaries:
Kronos	$	46.2	$	(20.8	)
NL		9.7		(3.8	)
CompX		.8		.6
Total	$	56.7	$	(24.0	)

A portion of the noncontrolling interest in the net income of CompX in 2012 relates to discontinued operations. See Note 3.

The changes in our ownership interest in our subsidiaries and the effect on our equity is as follows:

	Ninemonthsended September30,
	2012		2013
	(In millions)
Net income (loss) attributable to Valhi stockholders	$	156.2	$	(113.7	)
Transfers from noncontrolling interest — Issuance of subsidiaries’ common stock		—		(.3	)
Net income (loss) attributable to Valhi stockholders and change from noncontrolling interest in subsidiaries	$	156.2	$	(114.0	)

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 01, 2013
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Trading Symbol	VHI
Entity Registrant Name	VALHI INC /DE/
Entity Central Index Key	0000059255
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		339,120,449

XML

Accumulated Other Comprehensive Ioss

9 Months Ended

Sep. 30, 2013

Accumulated Other Comprehensive Loss

Note 15 —Accumulated other comprehensive loss:

Changes in accumulated other comprehensive loss attributable to Valhi stockholders for the three and nine months ended September30, 2012 and 2013 are presented in the table below, net of related deferred income taxes.

	Threemonthsended September30,						Ninemonthsended September30,
	2012			2013				2012			2013
	(In millions)
Accumulated other comprehensive income (loss), net of tax:
Marketable securities:
Balance at beginning of period	$	(5.6	)	$	1.9			$	6.4		$	2.1
Other comprehensive income (loss) – unrealized gains (losses) during the year		5.4			1.0				(6.6	)		.8
Balance at end of period	$	(.2	)	$	2.9			$	(.2	)	$	2.9
Currency translation adjustment:
Balance at beginning of period	$	19.5		$	36.3			$	37.5		$	53.3
Other comprehensive income (loss)		30.8			16.9				12.8			(.1	)
Balance at end of period	$	50.3		$	53.2			$	50.3		$	53.2
Defined benefit pension plans:
Balance at beginning of period	$	(69.6	)	$	(97.3	)		$	(72.6	)	$	(101.5	)
Other comprehensive income— amortization of prior service cost and net losses included in net periodic pension cost		1.5			2.1				4.5			6.3
Balance at end of period	$	(68.1	)	$	(95.2	)		$	(68.1	)	$	(95.2	)
OPEB plans:
Balance at beginning of period	$	4.9		$	3.6			$	5.4		$	4.1
Other comprehensive loss – amortization of prior service credit		(.3	)		(.3	)			(.8	)		(.8	)
Balance at end of period	$	4.6		$	3.3			$	4.6		$	3.3
Total accumulated other comprehensive loss:
Balance at beginning of period	$	(50.8	)	$	(55.5	)		$	(23.3	)	$	(42.0	)
Other comprehensive income		37.4			19.7				9.9			6.2
Balance at end of period	$	(13.4	)	$	(35.8	)		$	(13.4	)	$	(35.8	)

See Note 11 for amounts related to our defined benefit pension plans and OPEB plans.

XML

Employee Benefit Plans - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013
Defined Benefit Pension Plans
Expected contribution	$ 28.5
OPEB
Expected contribution	$ 1.6

XML

Employee Benefit Plans - Components of Net Periodic Defined Benefit Pension Benefit Cost (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 3.2	$ 2.5	$ 9.7	$ 7.7
Interest cost	6.0	6.2	17.9	19.1
Expected return on plan assets	(5.8)	(5.5)	(17.8)	(16.5)
Prior service cost	0.4	0.4	1.2	1.2
Net transition obligations	0.1	0.1	0.3	0.3
Recognized actuarial losses	3.4	2.3	10.2	6.9
Total	7.3	6.0	21.5	18.7
OPEB
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.1	0.1	0.3	0.2
Interest cost	0.3	0.1	0.5	0.6
Prior service cost	(0.5)	(0.5)	(1.4)	(1.4)
Recognized actuarial losses		0.1	0.1	0.1
Total	$ (0.1)	$ (0.2)	$ (0.5)	$ (0.5)